Waters Annual Report
Waters the world leading
specialty measurement company
delivering benefit through
innovations and people that
enable customer success the
life materials and food sciences
dedicate the annual report the memory William Miller our beloved Director
who passed away Christmas Eve Bill joined the Waters Board Directors
when were relatively new public company and served with great distinction for two
decades Bill made countless contributions every aspect governance Waters Most
recently Bill served Chairman the Compensation Committee and was active member
the Audit Committee Moreover Bill was man the highest intellect and character
generously shared his unique brand understated wisdom every topic the Board
discussed Whenever Bill spoke everyone listened carefully His inner peace confidence and
empathy touched all miss him dearly
Annual Report
Dear Customers Employees and Shareholders
pleased report that Waters Corporation delivered strong fiscal year and poised for continued success given
the current health our customers around the world and the confidence have our growth strategies and people
Before review describe our current business environment and outline our framework for long term value creation
would like recognize and thank our customers Now third year CEO continue amazed the vision
passion and contributions our customers make society like say customer success our mission It true You will
hear talk about our values and vision Waters but when comes mission the women and men Waters are
fundamentally driven the missions our customers and their most demanding analytical measurement needs Whether
it ensuring the integrity chemical entity production validating the design complex protein advancing higher
performance composite material solving vexing environmental riddle our customers are changing the world one
experiment time salute you and thank you for placing your trust Waters
Fiscal Year
Two thousand and seventeen was strong and rewarding
software and our recently introduced ACQUITY Arc
year for Waters For the fiscal year our revenue grew our
liquid chromatography systems had particularly strong
non GAAP adjusted earnings per fully diluted share grew
uptake China Waters European pharmaceutical business
and our non GAAP adjusted free cash flow grew
experienced broad based growth led our world class
the highlight the year was the revenue balance
precision chemistries and service offerings Strength
achieved across our end markets geographies and product
these areas recurring revenue reflected the extensive
lines resulting consistent sales performance and double
installed base Waters technologies well the trust
digit earnings per share growth each quarter Just
our customers have our service engineers
delivered solid featuring growth and
operating leverage while investing promising growth
initiatives that give confidence sustainable performance
The consistency our pharmaceutical business recent
years demonstrates ever increasing customer diversification
attractive geographical balance and strong positions
Sales our broadly defined pharmaceutical business
our small molecule large molecule and medical research
grew top increase saw
applications Our ongoing strategy work continues
continued pharmaceutical strength China and Europe
emphasize the vast opportunities our core pharmaceutical
well encouraging uptick demand from United States
business where believe are well positioned broaden
customers the second half the year China demand
our applications meet the growing and increasingly
was driven the ongoing government effort enhance
complex requirements our customers
drug development production quality and data integrity
Waters market leading Empower chromatography data
Our worldwide industrial category which includes the
materials characterization food safety environmental
and fine chemical markets grew solid behind
favorable economic conditions and balanced growth
across all key geographies and major product lines Our
materials business was led strength Instruments
branded products including thermal analysis and rheology
technologies The newly launched Discovery Series
thermal analyzers has received particularly enthusiastic
customer response due its unprecedented performance
the global population grows
and standards living rise the
vast majority countries and
people are demanding increasingly
greater access and quality the
medications they take the products
they use and the food they eat
and ease use Looking ahead continue see
opportunities capitalize the accelerating pace
innovation highly engineered high performance materials
wide range consumer and industrial companies
will strengthen our unique materials technology
portfolio encompassing both and Waters branded
products help customers better understand the
relationship between the chemical structure and physical
properties the materials they are developing
Finally our academic and governmental category grew
saw strong spending from academic institutions around
the world focused biomedical research particularly
the second half the year believe this reflects
the enthusiasm that researchers have for seeking new
discoveries the life sciences combination new
therapeutic strategies and novel diagnostic approaches
EUROPE
AMERICAS
ASIA
REVENUE GEOGRAPHY Millions Dollars
The Bigger Picture
The year was also important for Waters further refining
are only scratching the surface understanding the
our strategic plans and communicating clearer
structures properties and functions the underlying
framework for long term value creation During
molecules that make the world around
initiated rigorous new strategic planning process
better understand our market environment and changing
customers needs leading new strategic framework
that outlined last year stakeholder letter March
held comprehensive Investor Day New York
introduce our strategic plan and translate into clear
five point value creation model have since continued
communicate actively with investors and other stakeholders
The current global economic backdrop encouraging
many measures the world largest economies are
healthy and balanced now have seen decades
The combination economic growth positive employment
trends and low inflation has created favorable environment
for customer investments leading consistent demand
for our products which are tied innovation and rising
production Additionally Tax Reform appears have
benefitted both oriented companies the form
lower corporate tax rates well global companies
like Waters that now have permanent tax efficient access
global cash result expect see more capital
deployed the and for the economy healthier
and more sustainable
The broader global context for advanced analytical
measurement technologies also promising the global
population grows and standards living rise the vast
majority countries and people are demanding increasingly
greater access and quality the medications they take
the products they use and the food they eat These rising
expectations are reinforced strengthening and globallyharmonizing regulatory standards where more being
There growing appetite for more and better
measurement the most rigorous kind answer more
questions than ever before all stakeholders consumers
corporations regulators governments and academics
are raising the standard measurement characterize
understand and assure the performance complex
molecules every facet human life unmet need
the world and one that Waters Corporation wellpositioned continue addressing
pursue these opportunities see three key market
shifts that are shaping our strategic and investment focus
First customer measurement needs the life materials
and food sciences are becoming more application specific
and customers are demanding simpler more robust and
integrated workflow solutions For Waters continue
lead our core pharmaceutical business and fully scale our
materials food clinical and biomedical research businesses
need evolve our innovation and commercial approach
address the more specific needs different customers
Second Waters has experienced meaningful shift from
driven growth Asia driven growth Asia
represented worldwide revenue including
China Japan and India Asia has delivered
Waters corporate growth over the past three years
driven rising regulatory standards and global regulatory
harmonization economies like China and India Asia will
central our strategic innovation and commercial
planning priorities
asked manufacturers terms the performance
Finally demographic changes our customers and our
quality safety efficacy authenticity and compliance
employee base are challenging operate differently
the products they are selling
Our customer base evolving getting younger more
the core these consumer and regulatory trends
the increasing need for understanding matter all
kinds drugs materials food and human pathology
the molecular level Yet biology and chemistry and the
increasing biochemical diversity the world remain
relatively under explored scientific community
diverse and looking for new ways access knowledge
and interact with Waters Likewise our employees are
becoming increasingly diverse and bringing multigenerational perspectives How well engage our
changing customers and employees will pivotal
our ability sustain success
Long Term Value Creation Framework
Given the environmental trends and our evolving business
context Waters has established clear five point framework
for sustained value creation
First will remain sharply focused our highlydifferentiated strategic positions structurally attractive
measurement markets While many companies compete
the basis breadth and diversification Waters committed
our specialty focus which deliberately participate
subset the market for analytical instruments and
related solutions Our customer defined markets the life
materials and food sciences well our unique mix
scientific community
are only scratching the
surface understanding the
structures properties and
functions the underlying
molecules that make the
world around
instruments software precision chemistries and service
are faster growing and more profitable than the overall
analytical instrument market Our strategic plan designed
enhance our performance our focused business
portfolio which believe will support industry leading
organic growth for the foreseeable future
disciplined external investments and acquisitions will
also seek optimize our capital structure and maintain
Second our growth strategy primarily driven organic
attractive cost capital Capital beyond growth and balance
innovation Over the past five years have increased
sheet needs will returned shareholders through our
our commitment innovation raising from
ongoing share repurchase program While Tax Reform
product sales Furthermore are evolving
has greatly increased our access capital will proceed
our organization deliver core product development
carefully and thoughtfully view our significant cash balance
well transformational engineering and breakthrough
strategic asset that should wait patiently for the right
innovation Our innovation approach increasingly market
opportunities invest high ROIC initiatives
driven systems oriented and disciplined
Fifth and most importantly will continue cultivate
Third are driving systematic plan achieve continuous
performance oriented culture and management team
operational improvement While many admire our industry
Waters values oriented purpose driven company where
leading margins believe can continuously improve
employees strive achieve great things Our leadership
our efficiency maximize investment the business while
team working hard enhance the conditions that enable
delivering strong profitability Waters has comprehensive
our employees Deliver Benefit all our stakeholders
operational improvement process reinforced rigorous
Core our people agenda talent and leadership
balanced scorecard have stated consistently will
development together with continual enhancement
strive balance growth investment and modest operating
the diversity our team and leadership Waters has
leverage ensure consistent near term performance well
established rigorous new process for organizational
sustainable long term growth
development incorporating these priorities including
Fourth will continue judicious allocators capital
Our top priority for capital deployment invest the
business through internal innovation capital expenditure
and only where supports our strategies highly
new senior leadership development curriculum that
personally teaching
Conclusion
almost every measure Waters high performing and well positioned for continuing success focus
structurally attractive markets enjoy strong market position and compete through widely respected products
and services built upon decades innovation and value
This year will celebrate Waters anniversary company Waters has sustained its success staying
committed enduring values while aiming higher business Looking forward see opportunity Deliver
Benefit more ways than ever before are determined deliver leading financial results well compelling
societal value helping our customers enhance human health and well being through our innovations and the
hard work our team
Sincerely
Christopher Connell
Chairman and Chief Executive Officer
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington
Form
ANNUAL REPORT PURSUANT SECTION
THE SECURITIES EXCHANGE ACT
For the fiscal year ended December
TRANSITION REPORT PURSUANT SECTION
THE SECURITIES EXCHANGE ACT
Commission File Number
Waters Corporation
Exact name registrant specified its charter
Delaware
State other jurisdiction
incorporation organization
Employer
Identification
Maple Street
Milford Massachusetts
Address including zip code principal executive offices
Registrant telephone number including area code
Securities registered pursuant Section the Act
Securities registered pursuant Section the Act
Common Stock par value per share
New York Stock Exchange Inc
None
Act
Indicate check mark the registrant well known seasoned issuer defined Rule the Securities
Yes
Act
Indicate check mark the registrant not required file reports pursuant Section Section the
Yes
Indicate check mark whether the registrant has filed all reports required filed Section the
Securities Exchange Act during the preceding months for such shorter period that the registrant was required file
such reports and has been subject such filing requirements for the past days Yes
Indicate check mark whether the registrant has submitted electronically and posted its corporate website any every
Interactive Data File required submitted and posted pursuant Rule Regulation this chapter during
the preceding months for such shorter period that the registrant was required submit and post such
files Yes
Indicate check mark disclosure delinquent filers pursuant Item Regulation this chapter
not contained herein and will not contained the best registrant knowledge definitive proxy information statements
incorporated reference Part III this Form any amendment this Form
Indicate check mark whether the registrant large accelerated filer accelerated filer non accelerated filer smaller
reporting company emerging growth company See the definitions large accelerated filer accelerated filer smaller
reporting company and emerging growth company Rule the Exchange Act Check one
Large accelerated filer
Accelerated filer
Non accelerated filer
not check smaller reporting company
Smaller reporting company
Emerging growth company
emerging growth company indicate check mark the registrant has elected not use the extended transition period
for complying with any new revised financial accounting standards provided pursuant Section the Exchange Act
Indicate check mark whether the registrant shell company defined Rule the Act Yes
State the aggregate market value the registrant common stock held non affiliates the registrant July
Indicate the number shares outstanding the registrant common stock February
DOCUMENTS INCORPORATED REFERENCE
Portions the registrant definitive proxy statement that will filed for the Annual Meeting Stockholders are
incorporated reference Part III
WATERS CORPORATION AND SUBSIDIARIES
ANNUAL REPORT FORM
INDEX
Item
Page
PART
Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosures
Executive Officers the Registrant
PART
Market for Registrant Common Equity Related Stockholder Matters and Issuer Purchases
Equity Securities
Selected Financial Data
Management Discussion and Analysis Financial Condition and Results Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Changes and Disagreements with Accountants Accounting and Financial Disclosure
Controls and Procedures
Other Information
PART III
Directors Executive Officers and Corporate Governance
Executive Compensation
Security Ownership Certain Beneficial Owners and Management and Related Stockholder
Matters
Certain Relationships and Related Transactions and Director Independence
Principal Accountant Fees and Services
PART
Exhibits and Financial Statement Schedules
Form Summary
Signatures
PART
Item Business
General
Waters Corporation the Company specialty measurement company that has pioneered analytical
workflow solutions involving liquid chromatography mass spectrometry and thermal analysis innovations
serving the life materials and food sciences for nearly years The Company primarily designs manufactures
sells and services high performance liquid chromatography HPLC ultra performance liquid chromatography
UPLC and together with HPLC referred LC and mass spectrometry MS technology systems and
support products including chromatography columns other consumable products and comprehensive postwarranty service plans These systems are complementary products that are frequently employed together
MS and sold integrated instrument systems using common software platforms addition the
Company designs manufactures sells and services thermal analysis rheometry and calorimetry instruments
through its TA product line The Company also developer and supplier advanced software based
products that interface with the Company instruments well other manufacturers instruments
The Company products are used life science pharmaceutical biochemical industrial nutritional
safety environmental academic and governmental customers working research and development quality
assurance and other laboratory applications standard technique and utilized broad range
industries detect identify monitor and measure the chemical physical and biological composition
materials and purify full range compounds technology principally conjunction with
chromatography employed drug discovery and development including clinical trial testing the analysis
proteins disease processes known proteomics nutritional safety analysis and environmental testing
instruments combine liquid phase sample introduction and separation system with mass spectrometric
compound identification and quantification The Company thermal analysis rheometry and calorimetry
instruments are used predicting the suitability and stability fine chemicals pharmaceuticals water
polymers metals and viscous liquids for various industrial consumer goods and healthcare products well
for life science research
Waters Corporation organized Delaware corporation holding company that owns all the
outstanding common stock Waters Technologies Corporation its operating subsidiary Waters Corporation
became publicly traded company with its initial public offering IPO November Since the IPO the
Company has added two significant and complementary technologies its range products with the
acquisitions Instruments May and Micromass Limited September
Business Segments
The Company business activities for which discrete financial information available are regularly reviewed
and evaluated the chief operating decision maker result this evaluation the Company determined that
has two operating segments Waters and TA The Waters operating segment primarily the business
designing manufacturing distributing and servicing and instrument systems columns and other
precision chemistry consumables that can integrated and used along with other analytical instruments The
operating segment primarily the business designing manufacturing distributing and servicing thermal
analysis rheometry and calorimetry instruments The Company two operating segments have similar economic
characteristics product processes products and services types and classes customers methods distribution
and regulatory environments Because these similarities the two segments have been aggregated into one
reporting segment for financial statement purposes
Information concerning revenues and long lived assets attributable each the Company products
services and geographic areas set forth Note the Notes the Consolidated Financial Statements which
incorporated herein reference
Waters Products and Markets
High Performance and Ultra Performance Liquid Chromatography
HPLC standard technique used identify and analyze the constituent components variety chemicals
and other materials The Company believes that HPLC performance capabilities enable separate identify
and quantify high proportion all known chemicals result HPLC used analyze substances wide
variety industries for research and development purposes quality control and process engineering
applications
The most significant end use markets for HPLC are those served the pharmaceutical and life science
industries these markets HPLC used extensively understand diseases identify new drugs develop
manufacturing methods and assure the potency and purity new pharmaceuticals HPLC also used
variety other applications such analyses foods and beverages for nutritional labeling and compliance
with safety regulations and the testing water and air purity within the environmental testing industry well
applications other industries such chemical and consumer products HPLC also used universities
research institutions and governmental agencies such the United States Food and Drug Administration
FDA and the United States Environmental Protection Agency EPA and their foreign counterparts that
mandate safety and efficacy testing
Waters introduced novel technology that the Company describes ultra performance liquid
chromatography that utilizes packing material with small uniform diameter particles and specialized
instrument the ACQUITY UPLC accommodate the increased pressure and narrower chromatographic bands
that are generated these small and tightly packed particles using the ACQUITY UPLC researchers and
analysts are able achieve more comprehensive chemical separations and faster analysis times comparison
with many analyses previously performed HPLC addition using the ACQUITY UPLC researchers have
the potential extend the range applications beyond that HPLC enabling them uncover more levels
scientific information While offering significant performance advantages the ACQUITY UPLC also
compatible with the Company software products and the general operating protocols HPLC For these
reasons the Company customers and field sales and support organizations are well positioned utilize this
new technology and instrument the Company introduced the ACQUITY Arc System and its enabling
Arc Multi flow pathTM technology which bridges the gap between HPLC and UPLC emulating variety
HPLC systems without altering the method gradient table and enabling improved chromatographic
performance methods leveraging micron particle column technologies
Waters manufactures instruments that are offered configurations that allow for varying degrees
automation from component configured systems for academic teaching and research applications fully
automated systems for regulated and high sample throughput testing and that have variety detection
technologies from optical based ultra violet UV absorbance refractive index and fluorescence detectors
suite based detectors optimized for certain analyses
The primary consumable products for are chromatography columns These columns are packed with
separation media used the testing process and are typically replaced regular intervals The
chromatography column contains one several types packing material typically stationary phase particles
made from silica polymeric resins pressurized sample introduced the column inlet and permeates
through the packed column separated into its constituent components
Waters HPLC columns can used Waters branded and competitors systems The Company
believes that one few suppliers the world that processes silica and polymeric resins packs columns
and distributes its own products doing the Company believes can better ensure product consistency
key attribute for its customers quality control laboratories and can react quickly new customer
requirements The Company believes that its ACQUITY UPLC lines columns are used primarily its
ACQUITY UPLC instrument systems and furthermore that its ACQUITY UPLC instruments primarily use
ACQUITY UPLC columns the Company introduced the Oasis PRiME HLB cartridges which process
samples faster and deliver samples that are cleaner with fewer matrix effects than
samples prepared using other extraction techniques addition the ACQUITY UPLC Glycoprotein BEH
Amide columns were introduced help biopharmaceutical companies better understand where glycan
groups bonded sugars are located within the therapeutic proteins they are developing and manufacturing
the Company continued expand its column chemistry capabilities through the introduction
CORTECS CORTECS Phenyl CORTECS and CORTECS Shield
The Company precision chemistry consumable products also include environmental and nutritional safety
testing products including Certified Reference Materials CRM and Proficiency Testing PT products
Laboratories around the world and across multiple industries use these products for quality control and
proficiency testing and also purchase product support services required help with their federal and state
mandated accreditation requirements with quality control over critical pharmaceutical analysis
Mass Spectrometry and Liquid Chromatography Mass Spectrometry
powerful analytical technology that used identify unknown compounds quantify known materials
and elucidate the structural and chemical properties molecules measuring the masses molecules that
have been converted into ions
The Company technology and market leader the development manufacture sale and distribution
instruments and components These instruments are typically integrated and used along with other
complementary analytical instruments and systems such chemical electrophoresis and gas
chromatography wide variety instrumental designs fall within the overall category instrumentation
including devices that incorporate quadrupole ion trap time flight Tof magnetic sector and ion mobility
technologies Furthermore these technologies are often used tandem maximize the speed and
efficacy certain experiments
Currently the Company offers wide range instrument systems utilizing various combinations
quadrupole Tof and ion mobility designs These instrument systems are used drug discovery and
development well for environmental clinical and nutritional safety testing The overwhelming majority
mass spectrometers sold the Company are designed utilize system and liquid compatible interface
such electrospray ionization source the sample introduction device These products supply diverse
market with strong emphasis the life science pharmaceutical biomedical clinical food and beverage and
environmental market segments worldwide
increasingly important detection technology for The Company smaller sized mass
spectrometers such the single quadrupole detector SQD and the tandem quadrupole detector TQD are
often referred detectors and are typically sold part system system upgrade
Larger quadrupole systems such the Xevo and Xevo instruments are used primarily for
experiments performed for late stage drug development including clinical trial testing Quadrupole time flight
TofTM instruments such the Company SYNAPT are often used analyze the role proteins
disease processes application sometimes referred proteomics the Company introduced the
GlycoWorks RapiFluor MS Glycan Kit which enables fast glycosylation and labeling reduces sample
preparation time and allows mass detection for characterization and development with enhanced sensitivity
the Company introduced the Xevo mass spectrometry system enabled the newly designed
StepWaveTM ion guide which features unique combination ion optics detection and ionization
technologies resulting levels sensitivity not previously seen The Company also introduced SONAR
which new data acquisition technology for use with the Xevo that allows for the quantification
and identification lipids metabolites and proteins complex samples more efficient manner
November the Company acquired all the outstanding stock MPE Orbur Group Limited and its
sole operating subsidiary Midland Precision Equipment Company Ltd MPE manufacturer
instrumentation components for million net cash acquired MPE highly skilled manufacturer and
former Waters supplier that produces critical components that support the Company instrument systems
and are typically embodied within analytical system tailored for either dedicated class
analyses general purpose analytical device increasing percentage the Company customers are
purchasing and components simultaneously and has become common for and instrumentation
used within the same laboratory and operated the same user The descriptions and above
reflect the historical segmentation these analytical technologies and the historical categorization their
respective practitioners Increasingly today instrument market this segmentation and categorization
becoming obsolete high percentage instruments used the laboratory embody both and
technologies part single device response this development and further promote the high
utilization these hybrid instruments the Company has organized its Waters operating segment develop
manufacture sell and service integrated systems
Based upon reports from independent marketing research firms and publicly disclosed sales figures from
competitors the Company believes that one the world largest manufacturers and distributors and
instrument systems chromatography columns and other consumables and related services
The Company has been developer and supplier software based products that interface with the
Company instruments well other suppliers instruments The Company newest software technology
UNIFI scientific information system that the culmination multi year effort substantially bring all
Waters preexisting distinct software systems under one operating system UNIFI joins Waters suite
informatics products Empower Chromatography Data Software MassLynx Mass Spectrometry Software
and NuGenesis Scientific Data Management System each which used support innovations within
world leading institutions UNIFI the industry first comprehensive software that seamlessly integrates UPLC
chromatography mass spectrometry and informatics data workflows the Company introduction the
Vion IMS Tof Mass Spectrometer marks the first Waters mass spectrometer fully supported UNIFI
the Company announced two reference libraries available within UNIFI the Metabolic Profiling CCS
Library and the RapiFluor MS Glycan Scientific Library The Company also introduced Symphony Data
Pipeline software which client server application that automates the movement and transformation
large amounts data speed analytical workflows and liberate scientists from mundane yet
necessary tasks associated with managing data files
Waters Service
Services provided Waters enable customers maximize technology productivity support customer
compliance activities and provide transparency into enterprise resource management efficiencies The customer
benefits from improved budget control data driven technology adoption and accelerated workflow site
global perspective The Company considers its service offerings highly differentiated from our
competition evidenced consistent increase annual service revenues The Company principal
competitors the service market include PerkinElmer Inc Agilent Technologies Inc Thermo Fisher
Scientific Inc and General Electric Company These competitors can provide certain services Waters
instruments varying degrees and always present competitive risk
The servicing and support instruments software and accessories important source revenue and
represents over sales for Waters These revenues are derived primarily through the sale support plans
demand services spare parts customer performance validation services and customer training Support plans
typically involve scheduled instrument maintenance and agreement promptly repair non functioning
instrument return for fee described contract that priced according the configuration the
instrument
Products and Markets
Thermal Analysis Rheometry and Calorimetry
Thermal analysis measures the physical thermodynamic characteristics materials function
temperature Changes temperature affect several characteristics materials such their heat flow
characteristics physical state weight dimension and mechanical and electrical properties which may
measured one more thermal analysis techniques including calorimetry Consequently thermal analysis
techniques are widely used the development production and characterization materials various industries
such plastics chemicals automobiles pharmaceuticals and electronics
Rheometry instruments often complement thermal analyzers characterizing materials Rheometry
characterizes the flow properties materials and measures their viscosity elasticity and deformation under
different types loading other conditions The information obtained under such conditions provides insight
into material behavior during processing packaging transport usage and storage
Thermal analysis rheometry and calorimetry instruments are heavily used material testing laboratories
and many cases provide information useful predicting the suitability and stability industrial polymers
fine chemicals pharmaceuticals water metals and viscous liquids various industrial consumer goods and
healthcare products well for life science research with systems offered Waters range
instrument configurations available with increasing levels sample handling and information processing
automation addition systems and accompanying software packages can tailored for specific applications
introduced the TAM and TAM which extend the operating temperature range
with long term temperature stability for measuring processes also introduced the Affinity
ITC and ITC Auto which are designed for the most challenging life science laboratory environments that require
high sensitivity high productivity and the most advanced isothermal titration calorimetry
introduced new line differential scanning calorimeters and thermogravimetric analyzers These new
Discovery DSC systems feature enhanced sensing technologies resulting unprecedented performance
baseline flatness sensitivity resolution and reproducibility addition introduced the ACS Air Chiller
System ElectroForce test instrument and DuraPulseTM Stent Graft test instrument
introduced the TAM Air microcalorimeter Although designed characterize the curing cement this
instrument ideal platform for imaginative experimental design wide range applications including
cement and concrete material science food pharmaceuticals and environmental analysis also introduced
three new dilatometer product lines its platform which are high precision systems designed measure
dimensional changes specimen brought about dynamic thermal events wide range applications
including material science ceramics and metals introduced the Discovery SDT which
simultaneous differential scanning calorimeter thermogravimetric analyzer and believe the only system
capable simultaneous DSC TGA measurement addition introduced the Discovery
benchtop high pressure TGA that utilizes patented ultra high resolution magnetic suspension balance and new
high precision temperature control system Late introduced the Discovery DMA which
measures the viscoelastic mechanical properties material under controlled conditions temperature
environment and mechanical stimulus stress strain The DMA features frictionless air bearing supports
and linear optical encoder which ensures stable accurate high resolution displacement measurement across
the full travel range and enables displacement control
May the Company acquired the net assets the ElectroForce business the Bose Corporation
ElectroForce manufacturer testing systems for million cash ElectroForce core business the
manufacturing dynamic mechanical testing systems used characterize medical devices biologic and
engineered materials The ElectroForce test instruments are based unique motor designs that are quiet energyefficient and scalable while delivering precise performance over wide range force and frequency
introduced the WinTest software package which will standard all new ElectroForce products
addition introduced the ElectroForce DMA which combines fatigue and dynamic mechanical
analysis into single mechanical test platform
September the Company acquired all the outstanding stock Rubotherm GmbH
Rubotherm manufacturer gravimetric analysis systems for approximately million cash million
which was paid closing and additional million paid after closing settle certain liabilities Rubotherm
develops and manufactures analytical test instruments for thermogravimetric and sorption measurements that are
used both industrial and academic research laboratories disciplines that include chemistry material science
and engineering The Rubotherm acquisition will help support and further expand product offerings within TA
thermal analysis business
Service
Similar Waters the servicing and support TA instruments important source revenue and
represents more than sales for operates independently from the Waters operating segment
though many its overseas offices are situated Waters facilities achieve operational efficiencies has
dedicated field sales and service operations Service sales are primarily derived from the sale support plans
replacement parts and billed labor fees associated with the repair maintenance and upgrade installed systems
Global Customers
The Company typically has broad and diversified customer base that includes pharmaceutical accounts other
industrial accounts universities and governmental agencies Purchase the Company instrument systems
often dependent its customers capital spending funding the cases governmental academic and
research institutions which often fluctuate from year year The pharmaceutical segment represents the
Company largest sector and includes multinational pharmaceutical companies generic drug manufacturers
contract research organizations CRO and biotechnology companies The Company other industrial
customers include chemical manufacturers polymer manufacturers food and beverage companies and
environmental testing laboratories The Company also sells universities and governmental agencies
worldwide The Company technical sales and support staff members work closely with its customers
developing and implementing applications that meet their full range analytical requirements During
the Company sales were pharmaceutical accounts other industrial accounts and
governmental agencies and academic institutions
The Company typically experiences increase sales the fourth quarter result purchasing habits
for capital goods many customers who tend exhaust their spending budgets calendar year end The
Company does not rely any single customer for material portion its sales During fiscal years
and single customer accounted for more than the Company net sales
Sales and Service
The Company has one the largest direct sales and service organizations focused exclusively the analytical
workflows offered the Company Across these product technologies using respective specialized sales and
service workforces the Company serves its customer base with sales offices throughout the world
December and approximately and field representatives and
respectively This investment sales and service personnel serves maintain and expand the Company
installed base instruments The Company sales representatives have direct responsibility for account
relationships while service representatives work the field install instruments train customers and minimize
instrument downtime house and field based technical support representatives work directly with customers
providing them assistance with applications and procedures Company products The Company provides
customers with comprehensive information through various corporate and regional internet websites and product
literature and also makes consumable products available through electronic ordering facilities and dedicated
catalog
Manufacturing and Distribution
The Company provides high product quality overseeing each stage the production its instruments
columns and chemical reagents
The Company currently assembles portion its instruments its facility Milford Massachusetts
where performs machining assembly and testing The Milford facility maintains quality management and
environmental management systems accordance with the requirements ISO ISO
and ISO and adheres applicable regulatory requirements including the FDA Quality System
Regulation and the European Vitro Diagnostic Directive The Company outsources manufacturing certain
electronic components such computers monitors and circuit boards outside vendors that meet the
Company quality requirements addition the Company outsources the manufacturing certain
instrument systems and components well established contract manufacturing firms Singapore The
Company Singapore entity ISO certified and manages all Asian outsourced manufacturing well
the distribution all products from Asia The Company may pursue outsourcing opportunities they arise
but believes maintains adequate supply chain and manufacturing capabilities the event disruption
natural disasters
The Company manufactures specialty Supercritical Fluid Chromatography SFC and Supercritical Fluid
Extraction SFE products its facility Sharpsburg Pennsylvania The Sharpsburg facility aligned with
the policies and procedures for product manufacturing and distribution adhered the Milford
Massachusetts facility and under the same structural leadership organization
The Company primarily manufactures and distributes its columns its facilities Taunton
Massachusetts and Wexford Ireland The Taunton facility processes sizes and treats silica and polymeric media
that are packed into columns solid phase extraction cartridges and bulk shipping containers both Taunton and
Wexford The Wexford facility also manufactures and distributes certain data instruments and software
components for the Company and product lines The Company Taunton facility certified
ISO The Wexford facility certified ISO and ISO ISO
VICAM manufactures antibody linked resins and magnetic beads that are packed into columns and kits
Milford Massachusetts and Nixa Missouri The Company manufactures and distributes its Analytical Standards
and Reagents and Environmental Resource Associates ERA product lines its facility Golden Colorado
which certified ISO and accredited ISO IEC ISO IEC and ISO Guide Some
ERA products are also manufactured the Wexford Ireland facility which also accredited ISO IEC
ISO IEC
The Company manufactures and distributes its products its facilities Wilmslow England and
Wexford Ireland Certain components modules the Company instruments are manufactured its
facility Solihull England and long standing outside contractors Each stage this supply chain closely
monitored the Company maintain high quality and performance standards The instruments components
modules are then returned the Company facilities where its engineers perform final assembly calibrations
customer specifications and quality control procedures The Company facilities are certified ISO
and ISO ISO and adhere applicable regulatory requirements
including the FDA Quality System Regulation and the European Vitro Diagnostic Directive
TA thermal analysis rheometry and calorimetry products are manufactured and distributed the
Company New Castle Delaware Wakefield Massachusetts Eden Prairie Minnesota Lindon Utah Bochum
Germany Huellhorst Germany Wetzlar Germany and Ede Netherlands facilities Similar elements
TA products are manufactured outside contractors and are then returned the Company facilities for final
assembly calibration and quality control The Company New Castle facility certified ISO
standards and the Eden Prairie facility certified both ISO and ISO IEC standards
Raw Materials
The Company purchases variety raw materials primarily consisting high temperature alloy sheet metal
and castings forgings pre plated metals and electrical components from various vendors The materials used
the Company operations are generally available from number sources and sufficient quantities meet
current requirements subject normal lead times
The Company subject rules the Securities and Exchange Commission SEC under the DoddFrank Wall Street Reform and Consumer Protection Act requiring disclosure whether certain materials
tantalum tin gold and tungsten known conflict minerals which may contained the Company
products are mined from the Democratic Republic the Congo and adjoining countries the Company
was not able determine with certainty the country origin some the conflict minerals its
manufactured products However the Company does not have knowledge that any its conflict minerals
originated from the Democratic Republic the Congo adjoining countries The Company the process
evaluating its supply chain and the Company plans file its Form with the SEC May
The results this and future evaluations may impose additional costs and may introduce new risks related the
Company ability verify the origin any conflict minerals contained its products
addition the Company continues monitor environmental health and safety regulations countries
which operates throughout the world particular European Union and China Restrictions the use
certain Hazardous Substances electrical and electronic equipment RoHS and European Union Waste
Electrical and Electronic Equipment directives Further information regarding these regulations available
the Company website waters under the caption About Waters Environmental Health Safety
Research and Development
The Company maintains active research and development program focused the development and
commercialization products that extend complement and update its existing product offering The Company
research and development expenditures for and were million million and
million respectively addition and the Company incurred charges million and
million respectively for acquired process research and development related milestone payments
associated with licensing arrangement for certain intellectual property relating mass spectrometry
technologies yet commercialized and for which there was future alternative use the acquisition
date These licensing arrangements are significantly related new biologically focused applications well
other applications and require the Company make additional future payments million certain
milestones are achieved well royalties future net sales
Nearly all the Company products have been developed the Company main research and
development center located Milford Massachusetts with input and feedback from the Company extensive
field organizations and customers The majority the Company products are developed facilities
England and most the Company current materials characterization products are developed the Company
research and development center New Castle Delaware December and there were
and employees respectively involved the Company research and development efforts The
Company has increased research and development expenses from its continued commitment invest
significantly new product development and existing product enhancements and result acquisitions
Despite the Company active research and development programs there can assurance that the
Company product development and commercialization efforts will successful that the products developed
the Company will accepted the marketplace
Employees
The Company employed approximately and employees December and
respectively with approximately the Company employees located the United States The
Company believes its employee relations are generally good The Company employees are not unionized
affiliated with any internal external labor organizations The Company firmly believes that its future success
largely depends upon its continued ability attract and retain highly skilled employees
Competition
The analytical instrument systems supplies and services market highly competitive The Company encounters
competition from several worldwide suppliers and other companies both domestic and foreign markets for
each its three primary technologies The Company competes its markets primarily the basis product
performance reliability service and lesser extent price Competitors continuously introduce new products
and have instrument businesses that are generally more diversified than the Company business Some
competitors have greater financial resources and broader distribution than the Company
the markets served Waters the Company principal competitors include Agilent Technologies Inc
Shimadzu Corporation Bruker Corporation Danaher Corporation and Thermo Fisher Scientific Inc the
markets served the Company principal competitors include PerkinElmer Inc Mettler Toledo
International Inc NETZSCH Geraetebau GmbH Thermo Fisher Scientific Inc Malvern PANalytical Ltd
subsidiary Spectris plc and Anton Paar GmbH
The market for consumable products including separation columns highly competitive and generally
more fragmented than the analytical instruments market The Company encounters competition the
consumable columns market from chemical companies that produce column sorbents and small specialized
companies that primarily pack purchased sorbents into columns and subsequently package and distribute
columns The Company believes that one the few suppliers that processes silica and polymeric resins
packs columns and distributes its own products The Company competes this market the basis
performance reproducibility reputation and lesser extent price recent years the Company principal
competitors for consumable products have included Danaher Corporation Merck KGaA Darmstadt Germany
Agilent Technologies Inc General Electric Company and Thermo Fisher Scientific Inc The ACQUITY UPLC
instrument designed offer predictable level performance when used with ACQUITY UPLC columns
and the Company believes that the expansion the ACQUITY UPLC instrument base will enhance its
chromatographic column business because the high level synergy between ACQUITY UPLC columns and
the ACQUITY UPLC instruments
Patents Trademarks and Licenses
The Company owns number United States and foreign patents and has patent applications pending the
United States and abroad Certain technology and software has been acquired licensed from third parties
The Company also owns number trademarks The Company patents trademarks and licenses are viewed
valuable assets its operations However the Company believes that one patent group patents
trademark license and itself essential the Company such that its loss would materially affect the
Company business whole
Environmental Matters and Climate Change
The Company subject federal state and local laws regulations and ordinances that govern activities
operations that may have adverse environmental effects such discharges air and water well handling
and disposal practices for solid and hazardous wastes and impose liability for the costs cleaning and
certain damages resulting from sites past spills disposals other releases hazardous substances The
Company believes that currently conducts its operations and has operated its business the past substantial
compliance with applicable environmental laws From time time Company operations have resulted may
result noncompliance with environmental laws liability for cleanup pursuant environmental laws The
Company does not currently anticipate any material adverse effect its operations financial condition
competitive position result its efforts comply with environmental laws
The Company sensitive the growing global debate with respect climate change internal
sustainability working group develops increasingly robust data with respect the Company utilization
carbon producing substances effort continuously reduce the Company carbon footprint the
Company published sustainability report identifying the various actions and behaviors the Company has
adopted concerning its commitment both the environment and the broader topic social responsibility See
Item Risk Factors The effects climate change could harm the Company business for more
information the potential significance climate change legislation See also Note the Notes the
Consolidated Financial Statements for financial information about geographic areas
Available Information
The Company files furnishes all required reports with the SEC The public may read and copy any materials
the Company files furnishes with the SEC the SEC Public Reference Room Street
Washington The public may obtain information the operation the Public Reference Room
calling the SEC SEC
The Company electronic filer and the SEC maintains website that contains reports proxy and
information statements and other information regarding issuers that file electronically with the SEC The address
the SEC electronic filing website http sec gov The Company also makes available free charge
its website its annual report Form quarterly reports Form current reports Form and
any amendments those reports soon reasonably practicable after such material electronically filed with
furnished the SEC The website address for Waters Corporation http waters and SEC filings
can found under the caption Investors
Forward Looking Statements
Certain the statements this Form and the documents incorporated herein may contain forward looking
statements within the meaning Section the Securities Act amended and Section the
Securities Exchange Act amended the Exchange Act with respect future results and events
including any statements regarding among other items anticipated trends growth the Company business
including but not limited the impact foreign currency translation financial results development
products acquired businesses the growth rate sales and research and development expenses the impact
costs associated with developing new technologies and bringing these new technologies market the impact
new product launches and the associated costs such the amortization expense related software platforms
geographic sales mix business development products acquired businesses and the amount contingent
payments the sellers acquired business anticipated expenses including interest expense capitalized
software costs and effective tax rates the impact the newly enacted tax reform the the impact and
outcome the Company various ongoing tax audit examinations the achievement contractual milestones
preserve foreign tax rates the impact and outcome litigation matters the impact the loss intellectual
property protection the impact new accounting standards and pronouncements the adequacy the
Company supply chain and manufacturing capabilities and facilities the impact regulatory compliance the
Company expected cash flow borrowing capacity debt repayment and refinancing the Company ability
fund working capital capital expenditures service debt repay outstanding lines credit make authorized share
repurchases fund potential acquisitions and pay any adverse litigation tax audit liabilities particularly the
future impairment charges the Company contributions defined benefit plans the Company
expectations regarding changes its financial position compliance with applicable environmental laws and the
impact recent acquisitions sales and earnings
Many these statements appear particular under the heading Management Discussion and Analysis
Financial Condition and Results Operations Part Item this Form Statements that are not
statements historical fact may deemed forward looking statements You can identify these forward looking
statements the use the words feels believes anticipates plans expects may will would
intends suggests appears estimates projects should and similar expressions whether the
negative affirmative These statements are subject various risks and uncertainties many which are
outside the control the Company including and without limitation
Foreign currency exchange rate fluctuations that could adversely affect translation the Company
future sales financial operating results and the condition its non operations especially when
currency weakens against the dollar
Current global economic sovereign and political conditions and uncertainties particularly regarding the
effect the voting exit the European Union well the Chinese government ongoing
tightening restrictions procurement government funded customers the Company ability
access capital and maintain liquidity volatile market conditions changes timing and demand the
Company customers and various market sectors particularly they should reduce capital expenditures
are unable obtain funding the cases governmental academic and research institutions the
effect mergers and acquisitions customer demand and the Company ability sustain and enhance
service
Negative industry trends changes the competitive landscape result changes ownership
mergers and continued consolidation among the Company competitors introduction competing
products other companies and loss market share pressures prices from customers resulting
from competition regulatory economic and competitive obstacles new product introductions lack
acceptance new products expansion our business developing markets spending certain
end markets ability obtain alternative sources for components and modules and the possibility that
future sales new products related acquisitions which trigger contingent purchase payments may
exceed the Company expectations
Increased regulatory burdens the Company business evolves especially with respect the FDA and
EPA among others well regulatory environmental and logistical obstacles affecting the distribution
the Company products completion purchase order documentation our customers and ability
customers obtain letters credit other financing alternatives
Risks associated with lawsuits particularly involving claims for infringement patents and other
intellectual property rights
The impact and costs incurred from changes accounting principles and practices such the recently
adopted accounting pronouncement regarding employee share based payments the impact and costs
changes statutory contractual tax rates jurisdictions which the Company operates specifically
relates the newly enacted tax reform the shifts taxable income among jurisdictions with
different effective tax rates and the outcome and costs associated with ongoing and future tax audit
examinations changes respective country legislation affecting the Company effective rates
Certain these and other factors are further described below Item Risk Factors this Form
Actual results events could differ materially from the plans intentions and expectations disclosed the
forward looking statements whether because these factors for other reasons All forward looking
statements speak only the date this annual report Form and are expressly qualified their
entirety the cautionary statements included this report Except required law the Company does not
assume any obligation update any forward looking statements
Item
Risk Factors
The Company subject risks common companies the analytical instrument industry including but not
limited the following
The Company international operations may negatively affected political events wars terrorism and
regulatory changes related either specific country larger region These potential political currency
and economic disruptions well foreign currency exchange rate fluctuations could have material adverse
effect the Company results operations financial condition
Approximately and the Company net sales and respectively were outside the
United States and were primarily denominated foreign currencies addition the Company has considerable
manufacturing operations Ireland and the United Kingdom well significant subcontractors located
Singapore result significant portion the Company sales and operations are subject certain risks
including adverse developments the political regulatory and economic environment particular uncertainty
regarding possible changes foreign and domestic trade policy the effect the voting exit the
European Union well the financial difficulties and debt burden experienced number European
countries the instability and potential impact war terrorism the instability and possible dissolution the
Euro single currency sudden movements country foreign exchange rates due change
country sovereign risk profile foreign exchange regulatory practices tariffs and other trade barriers
difficulties staffing and managing foreign operations and associated adverse operational contractual and tax
consequences
Additionally the dollar value the Company net sales cost sales operating expenses interest
taxes and net income varies with foreign currency exchange rate fluctuations Significant increases decreases
the value the dollar relative certain foreign currencies particularly the Euro Japanese yen and
British pound could have material adverse effect benefit the Company results operations financial
condition
Global economic conditions may decrease demand for the Company products and harm the Company
financial results
The Company global business that may adversely affected changes global economic conditions
These changes global economic conditions both inside and outside the may affect the demand for the
Company products and services This may result decline sales the future increased rate order
cancellations delays increased risk excess obsolete inventories longer sales cycles and potential
difficulty collecting sales proceeds There can assurance regarding demand for the Company products
and services the future
The Company financial results are subject changes customer demand which may decrease for number
reasons many beyond the Company control
The demand for the Company products dependent upon the size the markets for its thermal
analysis rheometry and calorimetry products the timing and level capital spending and expenditures the
Company customers changes governmental regulations particularly affecting drug food and drinking water
testing funding available governmental academic and research institutions general economic conditions and
the rate economic growth the Company major markets and competitive considerations The Company
typically experiences increase sales its fourth quarter result purchasing habits for capital goods
customers that tend exhaust their spending budgets calendar year end There can assurance that the
Company results operations financial condition will not adversely impacted change any the
factors listed above the continuation uncertain global economic conditions
Additionally the analytical instrument market may from time time experience low sales growth
Approximately the Company net sales both and were the worldwide pharmaceutical
and biotechnology industries which may periodically subject unfavorable market conditions and
consolidations Unfavorable industry conditions could have material adverse effect the Company results
operations financial condition
Disruption worldwide financial markets could adversely impact the Company access capital and financial
condition
Financial markets the Europe and Asia have experienced times extreme disruption recent years
including among other things sharp increases the cost new capital credit rating downgrades and bailouts
severely diminished capital availability and severely reduced liquidity money markets Financial and banking
institutions have also experienced disruptions resulting large asset write downs higher costs capital rating
downgrades and reduced desire lend money There can assurance that there will not future
deterioration prolonged disruption financial markets financial institutions Any future deterioration
prolonged disruption financial markets financial institutions which the Company participates may impair
the Company ability access its existing cash utilize its existing syndicated bank credit facility funded
such financial institutions and impair its ability access sources new capital The cost the Company any
new capital raised and interest expense would increase this were occur
Competitors may introduce more effective less expensive products than the Company which could result
decreased sales The competitive landscape may transform result potential changes ownership
mergers and continued consolidations among the Company competitors which could harm the Company
business
The analytical instrument market and particular the portion related the Company HPLC UPLC
thermal analysis rheometry and calorimetry product lines highly competitive and subject rapid changes
technology The Company encounters competition from several international instrument suppliers and other
companies both domestic and foreign markets Some competitors have instrument businesses that are
generally more diversified than the Company business but are typically less focused the Company chosen
markets Over the years some competitors have merged with other competitors for various reasons some
which include increasing product line offerings improving market share and reducing costs There can
assurance that the Company competitors will not introduce more effective and less costly products than those
the Company that the Company will able increase its sales and profitability from new product
introductions There can assurance that the Company sales and marketing forces will compete
successfully against the Company competitors the future
Strategies for organic growth require developing new technologies and bringing these new technologies
market which could negatively impact the Company financial results
The Company the process developing new products with recently acquired technologies The future
development these new products will require significant amount spending over the next few years before
significant robust sales will realized These new products will sold into both the clinical and non clinical
markets and any new products requiring FDA clearance may take longer bring market There can
assurance given the timing these new product launches and the ultimate realization sales and
profitability the future
addition despite testing prior the release and throughout the lifecycle product service the
Company software hardware may contain coding manufacturing errors that could impact their function
performance and security and result other negative consequences The detection and correction any errors
released software hardware can time consuming and costly This could delay the development release
new products services new versions products services create security vulnerabilities the Company
products services and adversely affect market acceptance products services the Company experiences
errors delays releasing its software hardware new versions thereof its sales could affected and
revenues could decline Errors software hardware could expose the Company product liability performance
and warranty claims well harm brand and reputation which could impact future sales
Disruption operations the Company manufacturing facilities could harm the Company financial
condition
The Company manufactures instruments facilities Milford Massachusetts and through subcontractor
Singapore precision chemistry separation columns its facilities Taunton Massachusetts and Wexford
Ireland products its facilities Wilmslow England Solihull England and Wexford Ireland thermal
analysis and rheometry products its facilities New Castle Delaware and other instruments and consumables
various other locations result the Company acquisitions Any prolonged disruption the operations
any these facilities whether due labor difficulties destruction damage any facility other reasons
could have material adverse effect the Company results operations financial condition
The loss key members management and the risks inherent succession planning could adversely affect the
Company results operations financial condition
The operation the Company requires managerial and operational expertise None the Company key
management employees with the exception the President and Chief Executive Officer and the Senior Vice
President and Chief Financial Officer have employment contract with the Company and there can
assurance that such individuals will remain with the Company for any reason other such key personnel not
continue active management the Company results operations financial condition could
adversely affected
Failure adequately protect intellectual property could have materially adverse effects the Company
results operations financial condition
The Company vigorously protects its intellectual property rights and seeks patent coverage all developments
that regards material and patentable However there can assurance that any patents held the
Company will not challenged invalidated circumvented that the rights granted thereunder will provide
competitive advantages the Company Conversely there could successful claims against the Company
third party patent holders with respect certain Company products that may infringe the intellectual property
rights such third parties The Company patents including those licensed from others expire various
dates the Company unable protect its intellectual property rights could have adverse and material
effect the Company results operations financial condition
The Company business would suffer the Company were unable acquire adequate sources supply
Most the raw materials components and supplies purchased the Company are available from number
different suppliers however number items are purchased from limited single sources supply and
disruption these sources could have minimum temporary adverse effect shipments and the financial
results the Company prolonged inability obtain certain materials components could have adverse
effect the Company financial condition results operations and could result damage its
relationships with its customers and accordingly adversely affect the Company business
The Company sales would deteriorate the Company outside contractors fail provide necessary
components modules
Certain components modules the Company and instruments are manufactured outside
contractors including the manufacturing instrument systems and related components contract
manufacturing firms Singapore Disruptions service these outside contractors could have adverse
effect the supply chain and the financial results the Company prolonged inability obtain these
components modules could have adverse effect the Company financial condition results
operations
The Company business could harmed actions distributors and other third parties that sell our
products
The Company sells some products through third parties including distributors and value added resellers This
exposes various risks including competitive pressure concentration sales volumes credit risks and
compliance risks may rely one few key distributors for product market and the loss these
distributors could reduce our revenue net earnings Distributors may also face financial difficulties including
bankruptcy which could harm our collection accounts receivable Violations the Foreign Corrupt
Practices Act FCPA the Bribery Act similar anti bribery laws distributors other third party
intermediaries could materially impact our business Risks related our use distributors may reduce sales
increase expenses and weaken our competitive position
The Company may harmed improper conduct any our employees agents business partners
cannot provide assurance that our internal controls and compliance systems will always protect the Company
from acts committed employees agents business partners that would violate domestic and international
laws including laws governing payments government officials bribery fraud kickbacks and false claims
pricing sales and marketing practices conflicts interest competition export and import compliance money
laundering and data privacy particular the FCPA the Bribery Act and similar anti bribery laws
generally prohibit companies and their intermediaries from making improper payments government officials
for the purpose obtaining retaining business and operate many parts the world that have
experienced governmental corruption some degree Any such improper actions allegations such acts
could damage our reputation and subject civil criminal investigations the and other
jurisdictions and related shareholder lawsuits could lead substantial civil and criminal monetary and
non monetary penalties and could cause incur significant legal and investigatory fees addition the
government may seek hold liable successor for violations committed companies which invest
that acquire also rely our suppliers adhere our supplier standards conduct and material
violations such standards conduct could occur that could have material effect our business reputation
and financial statements
The Company financial results are subject unexpected shifts pre tax income between tax jurisdictions
changing application tax law and tax audit examinations
The Company subject rates income tax that range from excess various jurisdictions
which conducts business addition the Company typically generates substantial portion its income
the fourth quarter each fiscal year Geographical shifts income from previous quarters projections caused
factors including but not limited changes volume and product mix and fluctuations foreign currency
translation rates could therefore have potentially significant favorable unfavorable effects the Company
income tax expense effective tax rate and results operations
Governments the jurisdictions which the Company operates implement changes tax laws and
regulations from time time Any changes corporate income tax rates regulations regarding transfer
pricing repatriation dividends capital well changes the interpretation existing tax laws and
regulations the jurisdictions which the Company operates could adversely affect the Company cash flow
and lead increases its overall tax burden which would negatively affect the Company profitability
December the enacted legislation informally referred the Tax Cuts and Jobs Act the
Tax Act The Tax Act changed the tax system territorial tax system including base
broadening measures non earnings whereby historical unremitted earnings foreign subsidiaries are
deemed have been repatriated the regardless when the assets are actually remitted the
well reducing eliminating certain domestic deductions and credits and limiting the deductibility
interest expense and executive compensation Earnings deemed have been distributed the
accordance with the aforementioned Tax Act deemed distribution rules are subject Transition Toll Tax
Transition Tax which one time mandatory deemed repatriation tax the accumulated foreign earnings
that have not been previously taxed the extent those earnings are deemed have been invested cash and
cash equivalents they will taxed rate the remainder those earnings will taxed rate
result the Company historical unremitted foreign earnings were deemed repatriated and the
Company incurred million estimated tax provision which primarily consisted estimated Transition
Tax well estimated income tax provisions for state and withholding taxes and provision associated with
the remeasurement the Company deferred tax assets and liabilities from the new corporate
income tax rate The Transition Tax will paid over eight year period starting and will not
accrue interest The final impact the Tax Act may differ from these estimates due among other
things changes interpretations analysis and assumptions made the Company additional guidance that may
issued the Department the Treasury and tax planning actions that the Company may undertake
The Company continues permanently reinvested relation the cumulative historical outside basis
difference that not related the unremitted earnings that were taxed will continue evaluate our
assertions including intentions and plans the cumulative historical outside basis differences not related the
unremitted earnings that were taxed our foreign subsidiaries December accordance with
authoritative guidance issued the SEC expect finalize our analysis and accounting related the toll
charge deferred tax assets and liabilities and any remaining outside basis differences our foreign subsidiaries
during the measurement period however there can assurance given that these amounts will not need
revised the future affecting the future financial condition and results operations the Company
Going forward the Company estimates that its effective tax rate will increase approximately one three
percentage points the future however there can assurance given that the estimated future effective
income tax rate increase will not different and there can assurances that will not have material
impact the Company results operations financial condition
The Company has contractual tax rate Singapore through March based upon the
achievement and continued satisfaction certain operational and financial milestones which the Company
expects continue meet Currently the Company has determined that more likely than not realize the
contractual tax rate Singapore and has not recognized any uncertain tax benefit its balance sheet
related the achievement the contractual milestones Singapore the event that appears that the
milestone targets will not met the Company will longer entitled contractual tax rate benefit
income earned Singapore dating back the start date the agreement April which time all tax
benefits previously recorded would reversed and income tax charge equal the statutory tax
income earned during that period would recorded
global business the Company subject tax audit examinations various jurisdictions throughout
the world The Company must manage the cost and disruption responding governmental audits
investigation and proceedings whether not they have merit addition the impact the settlement
pending future tax audit examination could have unfavorable effect the Company income tax expense
effective tax rate and results operations
The Company financial condition and results operations could adversely affected the Company
unable maintain sufficient level cash flow
The Company had million debt and million cash cash equivalents and investments
December December the Company also had the ability borrow additional
million from its existing committed credit facility All but small portion the Company debt was
the There substantial cash requirement the fund operations and capital expenditures service
debt interest obligations finance potential acquisitions and continue authorized stock repurchase programs
the majority the Company cash generated from foreign operations with million the
Company cash cash equivalents and investments held foreign subsidiaries December the
Company cash cash equivalents and investments generated from foreign subsidiaries have effectively been
repatriated the providing the Company with the ability access the cash cash equivalents and
investments satisfy cash requirements however the Company financial condition and results
operations could still adversely impacted the Company unable maintain sufficient level cash flow
address these requirements through cash from operations the Company ability access its existing
cash and revolving credit facility the ability expand the Company borrowing capacity and other
sources capital obtained acceptable cost
Debt covenants and the Company failure comply with them could negatively impact the Company capital
and financial results
The Company debt subject restrictive debt covenants that limit the Company ability engage certain
activities that could otherwise benefit the Company These debt covenants include restrictions the Company
ability enter into certain contracts agreements which may limit the Company ability make dividend
other payments secure other indebtedness enter into transactions with affiliates and consolidate merge
transfer all substantially all the Company assets The Company also required meet specified financial
ratios under the terms the Company debt agreements The Company ability comply with these financial
restrictions and all other covenants dependent the Company future performance which subject but
not limited prevailing economic conditions and other factors including factors that are beyond the Company
control such foreign exchange rates interest rates changes technology and changes the level
competition December the Company was compliance with all debt covenants
Disruption cyber attack unforeseen problems with the security maintenance upgrade the Company
information and web based systems could have adverse effect the Company operations and financial
condition
The Company relies its technology infrastructure and that its software and banking partners among other
functions interact with suppliers sell products and services fulfill contract obligations ship products collect
and make electronic wire and check based payments and otherwise conduct business The Company technology
infrastructure may vulnerable damage interruption from but not limited natural disasters power loss
telecommunication failures terrorist attacks computer viruses unauthorized access customer employee
data unauthorized access and funds transfers from Company bank accounts and other attempts harm the
Company systems Any prolonged disruption the Company technology infrastructure any its
facilities could have material adverse effect the Company results operations financial condition
the Company security measures are compromised fail adequately protect its technology infrastructure
research and development efforts manufacturing operations the Company products and services may
perceived vulnerable unreliable the information the Company controls and processes may subject
unauthorized access acquisition modification the Company brand and reputation could damaged the
services that the Company provides its customers could disrupted and customers may stop using the
Company products and services all which could reduce the Company revenue and earnings increase its
expenses and expose the Company legal claims and regulatory actions
The Company the business designing manufacturing selling and servicing analytical instruments life
science pharmaceutical biochemical industrial nutritional safety and environmental academic and
governmental customers working research and development quality assurance and other laboratory
applications and the Company also developer and supplier software based products that support
instrument systems Many the Company customers are highly regulated industries While the Company
has invested time and resources implementing measures designed protect the integrity and security its
technology infrastructure research and development processes manufacturing operations products and services
and the internal and external data managed the Company there risk these measures will defeated
compromised that they are otherwise insufficient protect against existing emerging threats The Company
also has acquired companies products services and technologies over time and may inherit risk when integrating
these acquisitions into the Company addition times the Company faces attempts third parties defeat
its security measures exploit vulnerabilities its systems These risks will increase the Company continues
grow and expand geographically and its systems products and services become increasingly digital and
sensor and web based
The Company could suffer significant damage its brand and reputation security incident resulted
unauthorized access acquisition modification the Company technology infrastructure research and
development processes manufacturing operations its products and services well the internal and external
data managed the Company Such incident could disrupt the Company operations and customers could
lose confidence the Company ability deliver quality and reliable products services This could
negatively impact sales and could increase costs related fixing and addressing these incidents and any
vulnerabilities exposed them well lawsuits regulatory investigations claims legal liability
including contractual liability costs and expenses owed customers and business partners
Compliance failures could harm the Company business
The Company subject regulation various federal state and foreign governments and agencies areas
including among others health and safety import export privacy and data protection FCPA and environmental
laws and regulations portion the Company operations are subject regulation the FDA and similar
foreign regulatory agencies These regulations are complex and govern array product activities including
design development labeling manufacturing promotion sales and distribution Any failure the Company
comply with applicable governmental regulations could result product recalls the imposition fines
restrictions the Company ability conduct expand its operations the cessation all portion its
operations
Regulators globally are increasingly imposing greater fines and penalties for privacy and data protection
violations and the European Union has enacted broad data protection regulation with fines based
percentage global revenues Changes laws regulations associated with enhanced protection certain
sensitive types personal information such information related health could greatly increase the cost
compliance and the cost providing the Company products services Any failure perceived failure
the Company comply with laws and regulations privacy data security consumer protection other
policies public perception standards self regulatory requirements legal obligations could result lost
restricted business proceedings actions fines brought against the Company levied governmental entities
others could otherwise adversely affect the business and harm the Company reputation
Some the Company operations are subject domestic and international laws and regulations with
respect the manufacturing handling use sale toxic hazardous substances This requires the Company
devote substantial resources maintain compliance with those applicable laws and regulations the
Company fails comply with such requirements the manufacturing distribution its products could
face civil and criminal penalties and potentially prohibited from distributing selling such products until
they are compliant
Some the Company products are also subject the rules certain industrial standards bodies such
the International Standards Organization The Company must comply with these rules well those other
agencies such the United States Occupational Safety and Health Administration Failure comply with such
rules could result the loss certification and the imposition fines and penalties which could have
material adverse effect the Company operations
publicly traded company the Company subject the rules the SEC and the New York Stock
Exchange addition the Company must comply with the Sarbanes Oxley rules which require the Company
establish and maintain adequate internal control over financial reporting The Company efforts comply with
such laws and regulations are time consuming and costly While continue enhance our controls cannot
certain that will able prevent future significant deficiencies material weaknesses Failure
comply with such rules having inadequate internal controls could have material adverse effect the
Company financial condition and operations which could cause investors lose confidence our reported
financial information and could have negative effect the trading price our stock and our access capital
The Company subject the rules the SEC under the Dodd Frank Wall Street Reform and Consumer
Protection Act requiring disclosure whether certain materials tantalum tin gold and tungsten known
conflict minerals which may contained the Company products are mined from the Democratic Republic
the Congo and adjoining countries the Company was not able determine with certainty the country
origin some the conflict minerals its manufactured products However the Company does not have
knowledge that any its conflict minerals originated from the Democratic Republic the Congo adjoining
countries The Company the process evaluating its supply chain and the Company plans file its
Form with the SEC May The results this and future evaluations may impose additional costs
and may introduce new risks related the Company ability verify the origin any conflict minerals
contained its products
The Company financial condition and results operations could adversely affected changes the
Company retirement plans retirement plan assets
The Company sponsors various retirement plans both inside and outside the Any changes regulations
made governments countries which the Company sponsors retirement plans could adversely impact the
Company cash flows results operations connection with these retirement plans the Company
exposed market risks associated with changes the various capital markets For example changes longterm interest rates affect the discount rate that used measure the Company retirement plan obligations and
related expense addition changes the market value investments held the retirement plans could
materially impact the funded status the retirement plans and affect the related pension expense and level and
timing contributions required under applicable laws
Estimates and assumptions made accounting for the Company results from operations are dependent
future results which involve significant judgments and may imprecise and may differ materially from actual
results
The preparation consolidated financial statements conformity with generally accepted accounting principles
requires the Company make estimates and judgments that affect the reported amounts assets liabilities
revenues and expenses and related disclosure contingent liabilities the dates the financial statements
These estimates and assumptions must made due certain information used preparation our financial
statements which dependent future events cannot calculated with high degree precision from data
available not capable being readily calculated based generally accepted methodologies The Company
believes that the accounting related revenue recognition product returns and allowances bad debts inventory
valuation goodwill and intangible assets income taxes warranty and installation provisions litigation
retirement plan obligations stock based compensation equity investments business combinations and asset
acquisitions uncertain tax positions and contingencies involves significant judgments and estimates Actual
results for all estimates could differ materially from the estimates and assumptions used which could have
material adverse effect our financial condition and results operations
The effects climate change could harm the Company business
The Company manufacturing processes for certain its products involve the use chemicals and other
substances that are regulated under various international federal state and local laws governing the environment
the event that any future climate change legislation would require that stricter standards imposed
domestic international environmental regulatory authorities with respect the use and levels possible
emissions from such chemicals and other substances the Company may required make certain changes
and adaptations its manufacturing processes Any such changes could have material adverse effect the
financial statements the Company
Another potential effect climate change increase the severity global weather conditions The
Company manufacturing facilities are located the United States United Kingdom Ireland and Germany
addition the Company manufactures growing percentage its HPLC UPLC and products both
Singapore and Ireland Severe weather and geological conditions events including earthquakes hurricanes
and tsunamis could potentially cause significant damage the Company manufacturing facilities each
these countries The effects such damage and the resulting disruption manufacturing operations and the
impact lost sales could have material adverse impact the financial results the Company
Item
Unresolved Staff Comments
None
Item
Properties
Waters Corporation operates United States facilities and international facilities including field offices The
Company believes its facilities are suitable and adequate for its current production level and for reasonable
growth over the next several years The Company primary facilities are summarized the table below
Primary Facility Locations
Location
Golden
New Castle
Milford
Taunton
Wakefield
Eden Prairie
Nixa
Sharpsburg
Lindon
New Castle England
Solihull England
Wilmslow England
Quentin France
Huellhorst Germany
Bochum Germany
Budapest Hungary
Wexford Ireland
Ede Netherlands
Etten Leur Netherlands
Brasov Romania
Singapore
Function
Owned Leased
Leased
Owned
Owned
Owned
Leased
Leased
Leased
Leased
Leased
Leased
Owned
Owned
Leased
Owned
Leased
Leased
Owned
Leased
Owned
Leased
Leased
Manufacturing Research Sales and Service Distribution Administration
The Company operates and maintains field offices the United States and field offices abroad addition
sales offices the primary facilities listed above The Company field office locations are listed below
Field Office Locations
United States
International
Irvine
Pleasanton
Wood Dale
Carmel
Columbia
Beverly
Durham
Morrisville
Parsippany
Plymouth Meeting
Bellaire
Australia
Austria
Belgium
Brazil
Canada
Czech Republic
Denmark
Finland
France
Germany
Hungary
India
Ireland
Israel
Italy
Japan
Korea
Malaysia
Mexico
Netherlands
Norway
People Republic China
Portugal
Poland
Puerto Rico
Spain
Sweden
Switzerland
Taiwan
United Kingdom
The Company operates more than one field office within certain states and foreign countries
Item
Legal Proceedings
From time time the Company and its subsidiaries are involved various litigation matters arising the
ordinary course business The Company believes has meritorious arguments its current litigation matters
and believes any outcome either individually the aggregate will not material the Company financial
position results operations
Item
Mine Safety Disclosures
Not applicable
EXECUTIVE OFFICERS THE REGISTRANT
Officers the Company are elected annually the Board Directors and hold office the discretion the
Board Directors The following persons serve executive officers the Company
Christopher Connell has served Director the Company since September when
assumed the position President and Chief Executive Officer the Company December
Connell was appointed the Chairman the Board Directors the Company Connell served
Executive Vice President and President Restorative Therapies Group Medtronic plc from August
August From August Connell served the following positions Medtronic plc
Senior Vice President and President Medtronic Diabetes President Medtronic Physio Control Vice
President Sales and Marketing for the Cardiac Rhythm Management business Vice President General
Manager the Patient Management Business Vice President Corporate Strategy Director Investor
Relations and Corporate Development Associate
Mark Beaudouin was appointed Senior Vice President General Counsel and Secretary February
and was Vice President General Counsel and Secretary the Company since April Prior joining
Waters Corporation served Senior Vice President General Counsel and Secretary PAREXEL
International Corporation bio pharmaceutical services company from January April Previously
from May January Beaudouin served several senior legal management positions including
Vice President General Counsel and Secretary International Inc development stage biotechnology
company First Senior Vice President General Counsel and Secretary Baker Inc diversified retail
company and General Counsel and Secretary GenRad Inc high technology test equipment manufacturer
Sherry Buck was appointed Senior Vice President and Chief Financial Officer January
Previously Buck served the Vice President Chief Financial Officer Libbey Inc since August
From Buck held several positions Whirlpool Corporation including Vice President
Finance Chief Financial Officer Global Product and Enterprise Cost Leadership Vice President Finance
Vice President Cost Leadership Vice President Finance International and Vice President Business
Performance Management
Michael Harrington was appointed Senior Vice President Global Markets February
Harrington joined Waters Corporation and has held several senior positions with Waters Corporation
including Vice President Europe and Asia Pacific Operations Senior Director Sales Operations Director
Chemistry Sales and General Manager Phase Separations Prior joining Waters Corporation
Harrington held senior sales positions Celsis Inc
Terrance Kelly was appointed Senior Vice President and President Instruments February
Kelly has served President instruments since February Kelly started his career
finance and accounting ICI joined DuPont held various sales and marketing positions
with DuPont and later Instruments Kelly joined Waters Corporation when Instruments was
acquired
Ian King was appointed Senior Vice President Global Products July King joined Waters
and previously served Senior Vice President Instrument Technology Vice President Separations
Technologies and Vice President and General Manager Consumable Division well variety scientific
and management positions Waters Corporation international subsidiaries Prior joining Waters
Corporation King worked Edinburgh University research scientist
Elizabeth Rae was appointed Senior Vice President Global Human Resources February and
was Vice President Human Resources since October and Vice President Worldwide Compensation
and Benefits since January Rae joined Waters Corporation January Director Worldwide
Compensation Prior joining Waters Corporation she held senior human resources positions retail
healthcare and financial services companies
David Terricciano was appointed Senior Vice President Global Operations February
Terricciano previously served Vice President Global Operations since August Prior joining
Waters Corporation worked Vice President and General Manager Operations for Perkin Elmer
Instruments Previously held variety executive positions Goodrich Aerospace Honeywell Aerospace
and Textron Corporation
PART
Item
Market for Registrant Common Equity Related Stockholder Matters and Issuer Purchases
Equity Securities
The Company common stock registered under the Exchange Act and listed the New York Stock
Exchange under the symbol WAT February the Company had common stockholders
record The Company has not declared paid any dividends its common stock its past three fiscal years
The Company has not made any sales unregistered equity securities the years ended December
Securities Authorized for Issuance under Equity Compensation Plans
Equity compensation plan information incorporated reference from Part III Item Security Ownership
Certain Beneficial Owners and Management and Related Stockholder Matters this document and should
considered integral part this Item
Stock Price Performance Graph
The following performance graph and related information shall not deemed soliciting material
filed with the SEC nor shall such information incorporated reference into any future filing under the
Securities Act amended the Exchange Act except the extent that the Company specifically
incorporates reference into such filing
The following graph compares the cumulative total return invested December the last
day public trading the Company common stock fiscal year through December the last
day public trading the common stock fiscal year the Company common stock the NYSE
Market Index the SIC Code Index the Index and the Health Care Index The return the
indices calculated assuming reinvestment dividends during the period presented The Company has not paid
any dividends since its IPO The stock price performance shown the graph below not necessarily indicative
future price performance
COMPARISON CUMULATIVE TOTAL RETURN SINCE DECEMBER
AMONG WATERS CORPORATION NYSE MARKET INDEX SIC CODE INDEX
LABORATORY ANALYTICAL INSTRUMENTS INDEX
AND HEALTH CARE INDEX
DOLLARS
WATERS CORPORATION
NYSE MARKET INDEX
SIC CODE INDEX
INDEX
WATERS CORPORATION
NYSE MARKET INDEX
SIC CODE INDEX
INDEX
Market for Registrant Common Equity
The quarterly range high and low sales prices for the Company common stock reported the New York
Stock Exchange follows
Price Range
High
Low
For the Quarter Ended
April
July
October
December
April
July
September
December
Purchases Equity Securities the Issuer
The following table provides information about purchases the Company during the three months ended
December equity securities registered the Company under the Exchange Act thousands except
per share data
Average
Price Paid
per Share
Total Number
Shares Purchased
Part Publicly
Announced
Programs
Maximum Dollar
Value Shares
that May Yet
Purchased Under
the Programs
Total
Number
Shares
Purchased
October October
October November
November December
Total
Period
The Company repurchased million common stock related the vesting restricted stock units
during
May the Company Board Directors authorized the repurchase billion its
outstanding common stock open market transactions over three year period
Item
Selected Financial Data
The following table sets forth selected historical consolidated financial and operating data for the periods
indicated The statement operations and balance sheet data derived from financial statements for the years
and The Company financial statements December and and
for each the three years the period ended December are included Item Financial Statements
and Supplementary Data Part this Form
thousands except per share
and employees data
STATEMENT OPERATIONS
DATA
Net sales
Income from operations before income
taxes
Net income
Net income per basic common share
Weighted average number basic common
shares
Net income per diluted common share
Weighted average number diluted
common shares and equivalents
BALANCE SHEET AND OTHER
DATA
Cash cash equivalents and investments
Working capital including current
maturities debt
Total assets
Long term debt
Stockholders equity
Employees
The provision for income taxes for includes million estimate for the impact the enactment
the Tax Act which was signed into law December The million income tax
provision reduced net income per share The million income tax provision primarily consists
estimated Transition Tax well estimated income tax provisions for state and withholding taxes
and provision associated with the remeasurement the Company deferred tax assets and liabilities from
the new corporate income tax rate
The Company adopted new accounting guidance related stock based compensation The new
accounting guidance requires the excess tax benefits deficiencies related stock based compensation
reflected the consolidated statements operations component the provision for income taxes
whereas they were previously recognized equity This aspect the new accounting guidance was
required adopted prospective basis for the statement operations and retroactive restatement
not permitted the Company recognized excess tax benefit which decreased income tax expense
million and added net income per diluted share
the Company adopted new accounting guidance related the presentation debt issuance costs
and deferred income taxes both standards have been applied above retrospectively Certain debt issuance
costs have been reclassified from intangible assets and are presented direct deduction from the carrying
value the associated debt Current deferred tax assets and liabilities have been reclassified non current
deferred tax assets and liabilities
Item
Management Discussion and Analysis Financial Condition and Results Operations
Business and Financial Overview
The Company has two operating segments Waters and TA Waters products and services primarily consist
high performance liquid chromatography HPLC ultra performance liquid chromatography UPLC and
together with HPLC referred LC mass spectrometry MS and precision chemistry consumable
products and related services products and services primarily consist thermal analysis rheometry and
calorimetry instrument systems and service sales The Company products are used pharmaceutical
biochemical industrial nutritional safety environmental academic and governmental customers These
customers use the Company products detect identify monitor and measure the chemical physical and
biological composition materials and predict the suitability and stability fine chemicals pharmaceuticals
water polymers metals and viscous liquids various industrial consumer goods and healthcare products
The Company operating results are follows for the years ended December and
dollars thousands except per share data
Year Ended December
change
Operating income
Operating income sales
Interest expense net
Income before income taxes
Provision for income taxes
Revenues
Product sales
Service sales
Total net sales
Costs and operating expenses
Cost sales
Selling and administrative expenses
Research and development expenses
Litigation provisions
Purchased intangibles amortization
Acquired process research and development
Net income
Net income per diluted common share
the Company sales increased compared This growth was balanced across all
customer and product classes Instrument system sales increased and and respectively The
increased demand for instrument system sales was balanced across our and instrument
systems while the increase was primarily due instrument systems Recurring revenues
combined sales precision chemistry consumables and services increased and and
respectively result larger installed base customers and higher billing demand for service sales
Geographically the Company experienced sales growth both Europe and Asia while sales
the Americas was flat compared the previous year The Americas sales growth was negatively
impacted natural disasters the Mexico and Puerto Rico well weaker customer sentiment the
first half Europe sales growth can primarily attributed the increase customer demand from the
improvement the European economy well the effect foreign currency translation which added
sales growth Asia sales growth was result the double digit sales growth China and India
strong demand for our products and services those countries and spite lower customer demand India
the second half resulting from the implementation the new Goods and Services Tax system
the Company sales grew compared with strong sales our pharmaceutical and
industrial markets including balance across all product classes The effect foreign currency translation
increased sales and decreased sales across all products and services Recent
acquisitions had minimal impact sales growth both and
Sales pharmaceutical customers grew and and respectively These increases were
driven the increasing need for global access prescription drugs and the testing newer and more complex
biologic drugs Geographically the growth within our pharmaceutical market was driven double digit
growth China India and Europe while sales growth was driven double digit growth China and
Japan
Combined sales industrial customers which includes materials characterization food environmental and
fine chemical markets grew and and respectively The growth both and was
driven recent product introductions and rising global regulatory standards both food and materials markets
Geographically industrial market sales growth was highest China and India with modest growth
other regions offset flat sales the Americas industrial market sales growth was highest Europe
followed Asia and offset weakness the
Combined sales governmental and academic customers increased and decreased
The increase sales governmental and academic customers was broad based across all geographies
with double digit growth Europe and the Americas The decreases were result these institutions
reducing their spending the Company products combined sales governmental and academic
customers grew China and India but declined all other regions Sales governmental and academic
customers are highly dependent when institutions receive funding purchase our instrument systems and
such sales growth rates can vary significantly from period period
Operating income was million increase compared This increase was
primarily result the effect higher sales volume achieved being somewhat offset the impact
million severance costs primarily associated with the closure facility Germany and costs associated
with providing employees with early retirement transition incentive million litigation settlement
provision and related costs and million charge relating milestone payment for the licensing certain
intellectual property relating mass spectrometry technologies yet commercialized The change
operating income compared with was also impacted million expense related
the acceleration certain stock awards compared million similar expense Operating income
increased compared result higher sales volumes achieved and the positive
impact foreign currency translation our manufacturing and research and development costs result
the significantly weaker British Pound
The provision for income taxes for includes million estimate for the impact the enactment
the legislation informally referred the Tax Cuts and Jobs Act the Tax Act which was signed into
law December The Tax Act changed the tax system territorial system including base
broadening measures requiring the taxation the Company historical unremitted foreign earnings through
deemed repatriation which resulted million income tax provision that reduced net income per share
for the twelve months ended December well eliminating reducing certain domestic
deductions and credits and limiting the deductibility interest expense and executive compensation The
million income tax provision primarily consists estimated Transition Toll Tax Transition Tax
million well estimated income tax provisions for state and withholding taxes million and
million provision associated with the remeasurement the Company deferred tax assets and liabilities
from the new corporate income tax rate The Transition Tax will paid over eight year
period starting and will not accrue interest result the Tax Act the Company was able
gain access its cash and investment balances held outside the tax efficient manner that can used
for any general corporate purposes the Going forward the Company estimates that its effective income
tax rate will increase approximately one three percentage points the future The final impact the Tax
Act may differ from these estimates due among other things changes interpretations analysis and
assumptions made the Company additional guidance that may issued the Department the
Treasury and tax planning actions that the Company may undertake
the first quarter the Company adopted new accounting standard that requires the excess tax
benefit deficiency stock based compensation included the statement operations component
the provision for income taxes whereas previously was recognized equity result the Company
recorded tax benefit stock based compensation that decreased income tax expense million
and added net income per diluted share respectively Additionally this standard required the Company
present the tax benefit the consolidated statements cash flows operating activity whereas the past
this tax benefit was reflected financing activity All prior periods presented the cash flow have been
adjusted accordingly
The Company generated million million and million net cash flows from operations
and respectively The increases operating cash flow each year were primarily result
the increase sales and operating income Beginning and for the next four years the Company
required make annual federal tax payments approximately million tax authorities connection
with the estimated million Tax Act liabilities The remaining this liability required
paid over three year period beginning Also result the Tax Act the Company expecting
make million state and withholding tax payments during
Cash flows used investing activities included capital expenditures related property plant equipment
and software capitalization million million and million and respectively
the Company made million payment for investment developer analytical system solutions
used make measurements predict stability and accelerate product discovery the routine analytic process
monitoring and quality control release processes for life science and biopharmaceutical markets addition the
Company made milestone payment million acquire and license intellectual property
September the Company acquired Rubotherm GmbH for approximately million cash February
the Company Board Directors approved expanding its precision chemistry consumable manufacturing
operations The Company anticipates spending estimated million build and equip this new
state the art manufacturing facility which will paid for with existing cash and investments and the
Company does not expect issue any debt relation this expansion
November the Company entered into new credit agreement the Credit Agreement that
provides for billion revolving facility and million term loan The revolving facility and term loan
both mature November and require scheduled prepayments before that date The Company used
billion the proceeds from the Credit Agreement repay the outstanding amounts under the
Company existing multi borrower credit agreement dated June the Credit Agreement which
was terminated early without penalty May the Company Board Directors authorized the Company
repurchase billion its outstanding common stock over three year period During and
the Company repurchased million million and million the Company outstanding
common stock respectively under authorized share repurchase programs The Company believes that has the
financial flexibility fund these share repurchases given current cash and investment levels and debt borrowing
capacity well invest research technology and business acquisitions further grow the Company
sales and profits especially now that the Tax Act provides the Company with access its offshore cash
much lower income tax rates result the Company currently anticipates using billion cash repatriated
into the reduce debt and repurchase common stock shares the open market during
Results Operations
Sales Geography
Geographic sales information presented below for the years ended December and
thousands
Year Ended December
change
Total Asia
Other
Total net sales
Net Sales
United States
Europe
Asia
China
Japan
Asia Other
the sales growth Asia was driven double digit increases China sales across all product
and customer classes The increase Asia Other was driven strong sales India across all product
and customer classes Japan sales were flat the effect foreign currency decreased sales
Japan sales were driven recurring revenue sales governmental and academic customers Europe
sales were balanced across all product lines and driven sales pharmaceutical governmental and
academic customers Sales growth the was driven instrument system sales and recurring
revenues sales the rest the world were impacted decrease demand from industrial
customers resulting from recent natural disasters
sales growth the was driven increases recurring revenues which were offset
declines instrument systems sales sales increased pharmaceutical customers but declined
non pharmaceutical end markets Europe sales were also driven recurring revenues and primarily
due increases pharmaceutical and industrial customers China achieved strong sales growth all product
and customer classes with double digit growth instrument systems and precision chemistry
consumables well double digit growth pharmaceutical customers Japan increase sales was
largely driven the benefit foreign currency translation which increased sales The increase sales
the rest Asia was driven instrument systems and precision chemistry consumables sales
pharmaceutical and industrial customers Sales the rest Asia decreased due the negative effect
foreign currency translation Sales the rest the world were broad based across all product classes
sales increased industrial customers but declined across all other customer classes
Waters Products and Services Net Sales
Net sales for Waters products and services are follows for the years ended December and
thousands
Total
Year Ended December
Total
Total
change
Waters instrument systems
Chemistry consumables
Total Waters product sales
Waters service
Total Waters net sales
The increase Waters instrument system sales and technology based both and
primarily attributable higher sales systems that incorporate the Company tandem quadrupole
technologies Precision chemistry consumables sales increased both and the uptake columns
and application specific testing kits Waters service sales both and benefited from increased sales
service plans and higher service demand billings higher installed base customers The effect foreign
currency translation had minimal impact Waters sales both and
Waters sales increased both Europe and Asia and were flat the Americas Waters sales
increased China and were broad based across all product and customer classes Waters sales Japan
decreased primarily due foreign currency translation which decreased sales Waters sales the
rest Asia increased and were driven recurring revenues across all customer classes
Waters sales increased the Europe Asia and the rest the world
Waters sales increased China and were broad based across all product and customer classes Waters sales
Japan increased primarily due the benefit foreign currency translation which increased sales
Waters sales the rest Asia increased and were driven product sales pharmaceutical and
industrial customers offset weakness within governmental and academic markets
Product and Services Net Sales
Net sales for products and services are follows for the years ended December and
thousands
Year Ended December
Total
Total
Total
change
instrument systems
service
Total net sales
instrument system sales rebounded across all major product categories after flat sales growth
instrument system sales grew from thermal instrument systems which were fueled continued
acceptance the recently introduced Discovery product line addition TA rheology instrument systems saw
strong performance across the entire range products the portfolio driven the Discovery Hybrid
Rheometer and Rubber Rheometer instrument systems service sales increased both and due
sales service plans and billings higher installed base customers The effect foreign currency
translation and recent acquisitions had minimal impact TA sales both and
sales increased Asia Europe and the Americas achieved double digit
sales growth Asia with the exception Japan where sales growth included negative impact
foreign currency translation sales the increased while the rest the Americas declined
after strong sales the prior year sales increased both the Americas and Asia and increased
Europe sales were flat the but achieved double digit increase the rest the
Americas TA sales Japan increased with increase due the benefit foreign currency
translation
Cost Sales
The increase cost sales for both and were consistent with the increase sales volumes The
effect foreign currency translation had minimal impact cost sales cost sales
included the benefit weaker British pound which reduced the Company manufacturing costs when
translated into dollars
Cost sales are affected many factors including but not limited foreign currency translation
product mix product costs instrument systems and amortization software platforms current foreign
currency exchange rates the Company expects that the impact foreign currency translation may increase sales
and still negatively impact gross profit during the foreign currency translation benefit expected Euro
and Japanese yen sales would somewhat mitigated the unfavorable effect stronger British pound the
Company manufacturing costs
Selling and Administrative Expenses
Selling and administrative expenses increased and increased Selling and administrative
expenses both and were impacted headcount additions and higher merit compensation costs
well million and million respectively stock compensation expense related the modification
certain stock awards upon the retirement senior executives the Company incurred million
severance costs connection with the closure facility Germany and early retirement transition
incentive program Severance related costs and were million and million respectively
connection with reduction workforce The effect foreign currency translation increased selling and
administrative expenses and lowered these expenses
percentage net sales selling and administrative expenses were and for
and respectively
Research and Development Expenses
Research and development expenses increased both and Research and development expenses
both and were impacted additional headcount merit compensation and costs associated with
new products and the development new technology initiatives addition the effect foreign currency
translation reduced research and development expenses and and respectively primarily
due the weakening the British pound the Company based research and development expenses
research and development expenses also included benefit million from government grant
Acquired Process Research and Development
During and the Company incurred charges million and million respectively for acquired
process research and development related milestone payments associated with licensing arrangement for
certain intellectual property relating mass spectrometry technologies yet commercialized and for which
there was future alternative use the acquisition date These licensing arrangements are significantly
related new biologically focused applications well other applications and require the Company make
additional future payments million certain milestones are achieved well royalties future
net sales These future payments may significant and occur over multiple years
Litigation Provision
the Company incurred million litigation provision related the issuance verdict German
patent litigation case addition the Company recorded million litigation settlement provisions and
related costs both and
Interest Expense Net
The decreases net interest expense and were primarily attributable higher income earned
increased cash cash equivalents and investment balances
Provision for Income Taxes
The four principal jurisdictions which the Company manufactures are the Ireland the and
Singapore where the marginal effective tax rates were approximately and
respectively December The Company has contractual tax rate Singapore qualifying
activities Singapore through March based upon the achievement certain contractual milestones which
the Company expects continue meet The current statutory tax rate Singapore The effect
applying the contractual tax rate rather than the statutory tax rate income from qualifying activities
Singapore increased the Company net income and million million and
million respectively and increased the Company net income per diluted share and
respectively
The Company effective tax rate influenced many significant factors including but not limited the
wide range income tax rates jurisdictions which the Company operates sales volumes and profit levels
each tax jurisdiction changes tax laws tax rates and policies the outcome various ongoing tax audit
examinations and the impact foreign currency transactions and translation result variability these
factors the Company effective tax rates the future may not similar the effective tax rates for the current
prior years
The Company effective tax rates were and and respectively The
provision for income taxes for includes million estimate for the impact the enactment the
Tax Act Excluding the million income tax expense for the Tax Act the effective tax rate
would have been and this effective income tax rate includes million percentage point
reduction the income tax expense result the adoption new accounting guidance related stock based
compensation See Note for further information regarding the adoption this standard
The Tax Act changed the tax system territorial system including base broadening measures
requiring the taxation the Company historical unremitted foreign earnings through deemed repatriation
which resulted million income tax provision that reduced net income per share for the twelve
months ended December well eliminating reducing certain domestic deductions and credits and
limiting the deductibility interest expense and executive compensation The million income tax provision
primarily consists estimated Transition Tax million well estimated income tax provisions for
state and withholding taxes million and million provision associated with the remeasurement the
Company deferred tax assets and liabilities from the new corporate income tax rate The
Transition Tax will paid over eight year period starting and will not accrue interest The final
impact the Tax Act may differ from these estimates due among other things changes
interpretations analysis and assumptions made the Company additional guidance that may issued the
Department the Treasury and tax planning actions that the Company may undertake
The income tax provision for included million tax benefit related release valuation
allowance certain net operating loss carryforwards the income tax provision included million
tax benefit related the completion tax audit examinations The remaining differences between effective tax
rates can primarily attributed differences the proportionate amounts pre tax income recognized
jurisdictions with different effective tax rates
Liquidity and Capital Resources
Condensed Consolidated Statements Cash Flows thousands
Year Ended December
Net income
Depreciation and amortization
Stock based compensation
Deferred income taxes
Excess tax benefit related stock option plans
Gain sale assets
process research and development and other non cash charges
Change accounts receivable
Change inventories
Change accounts payable and other current liabilities
Change deferred revenue and customer advances
Effect the Tax Act
Other changes
Net cash provided operating activities
Net cash used investing activities
Net cash used financing activities
Effect exchange rate changes cash and cash equivalents
Increase cash and cash equivalents
Cash Flow from Operating Activities
Net cash provided operating activities was million million and million and
respectively The changes within net cash provided operating activities include the following significant changes
the sources and uses net cash provided operating activities aside from the changes net income
The changes accounts receivable were primarily attributable timing payments made customers
and timing sales Days sales outstanding was days December and
The changes inventory were primarily attributable anticipated annual increases sales volumes
well new product launches
The changes accounts payable and other current liabilities were result timing payments
vendors well income tax expenses related the Tax Act which are expected settled
the next twelve months
Net cash provided from deferred revenue and customer advances results from annual increases new
service contracts higher installed base customers renew annual service contracts
Other changes were attributable variation the timing various provisions expenditures prepaid
income taxes and accruals other current assets other assets other liabilities and income tax expenses
related the Tax Act
addition result the adoption new accounting standard related stock based compensation
the Company reclassified million and million excess tax benefits related stock based
compensation and respectively from cash flows from financing activities cash flows
from operating activities
Cash Used Investing Activities
Net cash used investing activities totaled million million and million and
respectively Additions fixed assets and capitalized software were million million and million
and respectively February the Company Board Directors approved expanding its
chemistry synthesis operations The Company anticipates spending estimated million build and equip
this new state the art manufacturing facility which will paid for with existing cash and investments The
Company does not expect issue any debt relation this expansion
During and the Company purchased billion billion and billion
investments respectively while billion billion and billion investments matured respectively
During the Company made million payment for investment developer analytical
system solutions used make measurements predict stability and accelerate product discovery the routine
analytic process monitoring and quality control release processes for life science and biopharmaceutical markets
During and the Company made payments million and million respectively acquire and
license intellectual property relating mass spectrometry technologies yet commercialized Business
acquisitions net cash acquired were million and million during and respectively There
were business acquisitions the Company sold equity investment for million and
the Company received million cash from the sale building the
Cash Used Financing Activities
November the Company entered into the Credit Agreement which provides for billion
revolving facility and million term loan The revolving facility and term loan both mature
November and require scheduled prepayments before that date The Company used billion
the proceeds from the Credit Agreement repay the outstanding amounts under the Credit
Agreement which was terminated early without penalty The Company plans use future proceeds from the
revolving facility for general corporate purposes
The interest rates applicable the Credit Agreement are the Company option equal either the
alternate base rate which rate per annum equal the greatest the prime rate effect such day
the Federal Reserve Bank New York Rate such day plus per annum and the adjusted
LIBO rate such day such day not business day the immediately preceding business day for
deposit dollars with maturity one month plus per annum the applicable month
adjusted LIBO rate EURIBO rate for Euro denominated loans each case plus interest rate margin based
upon the Company leverage ratio which can range between and basis points for alternate base rate loans
and between and basis points for LIBO rate EURIBO rate loans The facility fee the Credit
Agreement ranges between and basis points per annum based the leverage ratio the amount the
revolving facility commitments and the outstanding term loan The Credit Agreement requires that the
Company comply with interest coverage ratio test not less than the end any fiscal quarter for
any period four consecutive fiscal quarters and leverage ratio test not more than the end
any fiscal quarter addition the Credit Agreement includes negative covenants affirmative covenants
representations and warranties and events default that are customary for investment grade credit facilities
Interest the Company fixed rate senior unsecured notes payable semi annually each year Interest
the floating rate senior unsecured notes payable quarterly The Company may prepay all some the senior
unsecured notes any time amount not less than the aggregate principal amount outstanding plus
the applicable make whole amount prepayment premium for Series and senior unsecured notes the
event change control the Company defined the note purchase agreement the Company may
required prepay the senior unsecured notes price equal the principal amount thereof plus
accrued and unpaid interest These senior unsecured notes require that the Company comply with interest
coverage ratio test not less than for any period four consecutive fiscal quarters and leverage ratio
test not more than the end any fiscal quarter addition these senior unsecured notes include
customary negative covenants affirmative covenants representations and warranties and events default
During and the Company net debt borrowings increased million million
and million respectively December the Company had total billion outstanding
debt which consisted million outstanding senior unsecured notes million borrowed under term
loan and billion borrowed under revolving credit facility with both the term loan and revolving credit
facilities under the Credit Agreement December the Company had total amount available
borrow under the Credit Agreement million after outstanding letters credit
December the Company was compliance with all debt covenants
May the Company Board Directors authorized the Company repurchase billion
its outstanding common stock over three year period During and the Company repurchased
million million and million shares the Company outstanding common stock cost
million million and million respectively under the May authorization and other
previously announced programs the Company had purchased aggregate million shares
cost million under the May authorization which now completed December the
Company had total million remaining authorized capacity for future repurchases under the May
authorization addition the Company repurchased million million and million common stock
related the vesting restricted stock units during the years ended December and
respectively result the deemed repatriation the Company offshore cash from the Tax Act the
Company currently anticipates deploying approximately billion cash reduce debt and repurchase the
Company common stock shares the open market during
The Company received million million and million proceeds from the exercise stock
options and the purchase shares pursuant the Company employee stock purchase plan and
respectively
The Company had cash cash equivalents and investments million December The
majority the Company cash cash equivalents and investments are generated from foreign operations with
million held foreign subsidiaries December which million was held currencies
other than dollars The Company believes has sufficient levels cash flow and access its existing cash
cash equivalents and investments fund operations and capital expenditures service debt interest finance
potential acquisitions and continue the authorized stock repurchase program the These cash requirements
are managed the Company cash flow from operations its existing cash cash equivalents and investments
and the use the Company revolving credit facility
Management believes the date this report that its financial position along with expected future
cash flows from earnings based historical trends and the ability raise funds from external sources and the
borrowing capacity from existing committed credit facilities will sufficient service debt and fund working
capital and capital spending requirements authorized share repurchase amounts and potential acquisitions for
least the next twelve months Other than the Company gaining tax efficient access its offshore cash cash
equivalents and investments result the Tax Act there have been recent significant changes the
Company financial position nor are there any anticipated changes warrant material adjustment related
indefinitely reinvested foreign earnings
Contractual Obligations and Commercial Commitments
The following summary the Company known contractual obligations December
thousands
Total
Payments Due Year
After
Notes payable and
debt
Interest senior
unsecured notes
Long term debt
Tax Act liability
Operating leases
Total
Does not include normal purchases made the ordinary course business and uncertain tax positions
discussed below
The interest rates applicable the Credit Agreement are the Company option equal either the
alternate base rate which rate per annum equal the greatest the prime rate effect such day
the Federal Reserve Bank New York Rate such day plus per annum and the adjusted
LIBO rate such day such day not business day the immediately preceding business day for
deposit dollars with maturity one month plus per annum the applicable month
adjusted LIBO rate EURIBO rate for Euro denominated loans each case plus interest rate margin
based upon the Company leverage ratio which can range between and basis points for alternate
base rate loans and between and basis points for LIBO rate EURIBO rate loans The facility fee
the Credit Agreement ranges between and basis points per annum based the leverage
ratio the amount the revolving facility commitments and the outstanding term loan The Credit
Agreement requires that the Company comply with interest coverage ratio test not less than
the end any fiscal quarter for any period four consecutive fiscal quarters and leverage ratio test
not more than the end any fiscal quarter addition the Credit Agreement includes
negative covenants affirmative covenants representations and warranties and events default that are
customary for investment grade credit facilities December the Company was compliance
with all such covenants
The following summary the Company known commercial commitments December
thousands
Amount Commitments Expiration Per Period
Total
Letters credit
After
From time time the Company and its subsidiaries are involved various litigation matters arising the
ordinary course business The Company believes has meritorious arguments its current litigation matters
and believes any outcome either individually the aggregate will not material the Company financial
position results operations
The Company has long term liabilities for deferred employee compensation including pension and
supplemental executive retirement plans The payments related the supplemental retirement plan are not
included above since they are dependent upon when the employee retires leaves the Company and whether the
employee elects lump sum annuity payments During fiscal year the Company expects contribute
approximately million million the Company defined benefit plans
The Company has contingent consideration for earnout pertaining the Medimass acquisition The
earnout payments are not included above since they are dependent upon many factors that cannot predicted
with any certainty The estimated fair value the contingent consideration December
million
The Company licenses certain technology and software from third parties Future minimum license fees
payable under existing license agreements December are immaterial The Company enters into
licensing arrangements with third parties that require future milestone royalty payments contingent upon
future events Upon the achievement certain milestones existing agreements the Company could make
additional future payments million well royalties future net sales not possible predict
with reasonable certainty whether these milestones will achieved the timing for achievement result
these potential payments are not included the table above
The Company accounts for its uncertain tax return reporting positions accordance with the accounting
standards for income taxes which require financial statement reporting the expected future tax consequences
uncertain tax reporting positions the presumption that all concerned tax authorities possess full knowledge
those tax reporting positions well all the pertinent facts and circumstances but prohibit any
discounting unrecognized tax benefits associated with those reporting positions for the time value money
The Company classified interest and penalties related unrecognized tax benefits component the
provision for income taxes all the Company unrecognized tax benefits accrued December
were become recognizable the future the Company would record total reduction approximately
million its income tax provision
With limited exceptions the Company longer subject tax audit examinations significant
jurisdictions for the years ended before December However carryforward tax attributes that were
generated years beginning before January may still adjusted upon examination tax
authorities the attributes are utilized The Company continuously monitors the lapsing statutes limitations
potential tax assessments for related changes the measurement unrecognized tax benefits related net
interest and penalties and deferred tax assets and liabilities
During the year ended December the Company concluded tax audit disputes outside the that
part related matters for which the Company had recorded net uncertain tax benefits The resolution these
tax disputes resulted million reduction the measurement its unrecognized tax benefits for the year
ended December
During the year ended December the Company concluded tax audit disputes that part
related matters for which the Company had recorded net uncertain tax benefits The resolution these tax
disputes resulted million reduction the measurement its unrecognized tax benefits and million
decrease its provision for income taxes for the year ended December
December the Company expects record additional reductions the measurement its
unrecognized tax benefits and related net interest and penalties approximately million within the next
twelve months due potential tax audit settlements and the lapsing statutes limitations potential tax
assessments The Company does not expect record any other material reductions the measurement its
unrecognized tax benefits within the next twelve months
The Company has not paid any dividends and has plans this time pay any dividends the future
Off Balance Sheet Arrangements
The Company has not created and not party any special purpose off balance sheet entities for the
purpose raising capital incurring debt operating parts its business that are not consolidated the extent
the Company ownership interest therein into the consolidated financial statements The Company has not
entered into any transactions with unconsolidated entities whereby has subordinated retained interests
derivative instruments other contingent arrangements that expose the Company material continuing risks
contingent liabilities any other obligation under variable interest unconsolidated entity that provides
financing liquidity market risk credit risk support the Company
The Company enters into standard indemnification agreements its ordinary course business Pursuant
these agreements the Company indemnifies holds harmless and agrees reimburse the indemnified party for
losses suffered incurred the indemnified party generally the Company business partners customers
connection with patent copyright other intellectual property infringement claims any third party with
respect its current products well claims relating property damage personal injury resulting from the
performance services the Company its subcontractors The maximum potential amount future
payments the Company could required make under these indemnification agreements unlimited
Historically the Company costs defend lawsuits settle claims relating such indemnity agreements have
been minimal and management accordingly believes the estimated fair value these agreements immaterial
Critical Accounting Policies and Estimates
Summary
The preparation consolidated financial statements requires the Company make estimates and judgments that
affect the reported amounts assets liabilities revenues and expenses and related disclosure contingent
liabilities Critical accounting policies are those that are central the presentation the Company financial
condition and results operations that require management make estimates about matters that are highly
uncertain and that would have material impact the Company results operations given changes the
estimate that are reasonably likely occur from period period use different estimates that reasonably
could have been used the current period ongoing basis the Company evaluates its policies and
estimates The Company bases its estimates historical experience and various other assumptions that are
believed reasonable under the circumstances the results which form the basis for making judgments
about the carrying values assets and liabilities that are not readily apparent from other sources Actual amounts
may differ from these estimates under different assumptions conditions There are other items within the
Company consolidated financial statements that require estimation but are not deemed critical defined
above Changes estimates used these and other items could potentially have material impact the
Company consolidated financial statements
Revenue Recognition
Sales products and services are generally recorded based product shipment and performance service
respectively The Company deferred revenue the consolidated balance sheets consists the obligation
instrument service contracts and customer payments received advance prior shipment the instrument
December the Company had current and long term deferred revenue liabilities million and
million respectively Revenue recognized when all the following revenue recognition criteria are met
persuasive evidence arrangement exists delivery performance has occurred the vendor fee fixed
determinable collectibility reasonably assured and applicable upon acceptance when acceptance criteria
with contractual cash holdback are specified Shipping and handling costs are included cost sales net
amounts invoiced the customer per the order
Product shipments including those for demonstration evaluation and service contracts are not recorded
revenue until valid purchase order master agreement received specifying fixed terms and prices The
Company generally recognizes product revenue when legal title has transferred and risk loss passes the
customer The Company generally structures its sales arrangements shipping point international equivalent
and accordingly recognizes revenue upon shipment some cases destination based shipping terms are
included sales arrangements which cases revenue generally recognized when the products arrive the
customer site
The Company method revenue recognition for certain products requiring installation accounted for
accordance with multiple element revenue recognition accounting standards With respect the installation
obligations the larger the contractual cash holdback the best estimate selling price the installation
service deferred when the product shipped and revenue recognized multiple element arrangement
when installation complete The Company determines the best estimate selling price installation based
upon number factors including hourly service billing rates and estimated installation hours
Instrument service contracts are typically billed the beginning the maintenance period The amount
the service contract amortized ratably revenue over the instrument maintenance period There are
deferred costs associated with the service contract the cost the service recorded when the service
performed revenue recognized until all revenue recognition criteria have been met
Sales standalone software are accounted for accordance with the accounting standards for software
revenue recognition The Company software arrangements typically include software licenses and maintenance
contracts Software license revenue recognized when persuasive evidence arrangement exists delivery
has occurred the fee fixed determinable collection probable and there are significant post delivery
obligations remaining The revenue associated with the software maintenance contract recognized ratably over
the maintenance term Unspecified rights software upgrades are typically sold part the maintenance
contract when and available basis The Company uses the residual method allocate software revenue
when transaction includes multiple elements and vendor specific objective evidence fair value undelivered
elements exists Under the residual method the fair value the undelivered element maintenance deferred
and the remaining portion the arrangement fee allocated the delivered element software license and
recognized revenue
Returns and customer credits are infrequent and are recorded reduction sales Rights return are not
included sales arrangements Revenue associated with products that contain specific customer acceptance
criteria not recognized before the customer acceptance criteria are satisfied Discounts from list prices are
recorded reduction sales
Loss Provisions Accounts Receivable and Inventory
The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability its
customers make required payments the financial condition the Company customers were deteriorate
resulting impairment their ability make payments additional allowances may required The
Company does not request collateral from its customers but collectibility enhanced through the use credit
card payments and letters credit The Company assesses collectibility based number factors including
but not limited past transaction history with the customer the credit worthiness the customer industry
trends and the macro economic environment Historically the Company has not experienced significant bad debt
losses Sales returns and allowances are estimates future product returns related current period revenue
Material differences may result the amount and timing revenue for any period management made
different judgments utilized different estimates for sales returns and allowances for doubtful accounts The
Company accounts receivable balance December was million net allowances for doubtful
accounts and sales returns million
The Company values all its inventories the lower cost net realizable value first first out
basis FIFO The Company estimates revisions its inventory valuations based technical obsolescence
historical demand projections future demand including that the Company current backlog orders and
industry and market conditions actual future demand market conditions are less favorable than those
projected management additional write downs may required The Company inventory balance
December was recorded its net realizable value million which net write downs
million
Long Lived Assets Intangible Assets and Goodwill
The Company assesses the impairment identifiable intangibles long lived assets and goodwill whenever
events changes circumstances indicate that the carrying value may not recoverable Factors the Company
considers important which could trigger impairment include but are not limited the following
significant underperformance relative historical projected future operating results particularly
pertains capitalized software and patent costs
significant negative industry economic trends competitive products and technologies and
significant changes developments strategic technological collaborations legal matters which affect
the Company capitalized patents purchased technology trademarks and intellectual properties such
licenses
When the Company determines that the carrying value individual intangible asset long lived asset
goodwill may not recoverable based upon the existence one more the above indicators estimate
undiscounted future cash flows produced that intangible asset long lived asset goodwill including its
eventual residual value compared the carrying value determine whether impairment exists the event
that such cash flows are not expected sufficient recover the carrying amount the asset the asset
written down its estimated fair value Net intangible assets long lived assets and goodwill amounted
million million and million respectively December
The Company performs annual impairment reviews its goodwill January each year For goodwill
impairment review purposes the Company has two reporting units Waters and The Company currently does
not expect record impairment charge the foreseeable future however there can assurance that
the time future reviews are completed material impairment charge will not recorded The factors that could
cause material goodwill impairment charge the future include but are not limited the following
significant decline the Company projected revenue earnings cash flows
significant adverse change legal factors business climate
significant decline the Company stock price the stock price comparable companies
adverse action assessment regulator and
unanticipated competition
Income Taxes
part the process preparing the consolidated financial statements the Company required estimate its
income taxes each the jurisdictions which operates addition result the timing the new
Tax Act the the Company has had make reasonable estimates certain amounts related the
deemed repatriation foreign earnings based the existing interpretations the Department the
Treasury and state and local governments These processes involve the Company estimating its actual current tax
exposure taking into account the amount timing and character taxable income tax deductions and credits and
assessing changes tax laws regulations agreements treaties and any new interpretations the taxation the
deemed repatriation foreign earnings Differing treatment items for tax and accounting purposes such
depreciation amortization and inventory reserves result deferred tax assets and liabilities which are included
within the consolidated balance sheets the event that actual results differ from these estimates the
Company adjusts these estimates future periods such changes could materially impact the Company
financial position and results operations
The accounting standards for income taxes require that company continually evaluate the necessity
establishing changing valuation allowance for deferred tax assets depending whether more likely than
not that the actual benefit those assets will realized future periods
Uncertain Tax Positions
The Company accounts for its uncertain tax return reporting positions accordance with the accounting
standards for income taxes which require financial statement reporting the expected future tax consequences
uncertain tax reporting positions the presumption that all concerned tax authorities possess full knowledge
those tax reporting positions well all the pertinent facts and circumstances but prohibit any
discounting unrecognized tax benefits associated with those reporting positions for the time value money
The Company classified interest and penalties related unrecognized tax benefits component the
provision for income taxes December the Company had unrecognized tax benefits million
The Company has been granted contractual tax rate Singapore that requires the achievement
certain operational and financial milestones that the Company expects meet the extent not already achieved
December and maintain through least March part the Company determination
uncertain tax positions the Company regularly assesses its progress against these operational and financial
milestone targets determine whether the milestones can reasonably achieved These milestones were
negotiated with the Singaporean tax authorities and established based the Company historical financial
performance the anticipated customer end market demand particularly certain regions the world and the
Company anticipated future operating plans These assessments require significant judgments and estimates
about the Company ability meet the milestone targets for the following types objectives reaching and
maintaining annual revenue and business spending targets meeting capital expenditures targets attaining and
sustaining employment targets and establishing local research and development and service center The
Company regularly monitors its actual and forecasted sales and operating results against these milestones and the
Company makes the determination whether the future forecasted financial results are most likely
achieved These milestones are very similar nature the previous Singaporean tax holiday contractual
agreements that the Company successfully completed These milestones are not required met until
December the earliest which gives the Company sufficient time make any necessary adjustments
its operating plans achieve the milestones
Currently the Company has determined that more likely than not realize the contractual tax rate
Singapore and has not recognized uncertain tax benefit its balance sheet related the achievement
the contractual milestones Singapore However these milestones can significantly influenced the
business climate Singapore and the Company overall financial performance and the event that the
Company determines that the milestone targets are not expected met the Company would longer able
record tax benefit contractual tax rate income earned Singapore from and after the April
start date the contract period such time the Company would record income tax charge the
affected Singapore income earned back April the Singapore statutory tax rate currently
with corresponding income tax liability recorded the balance sheet For the year ended the effect
applying the contractual tax rate rather than the statutory tax rate income from qualifying activities
Singapore increased the Company net income and net income per diluted share million and
respectively
December the enacted the Tax Act which changed the tax system
territorial tax system including base broadening measures non earnings whereby foreign earnings are
effectively deemed repatriated the well reducing eliminating certain domestic deductions
and credits and limiting the deductibility interest expense and executive compensation Included the
Tax Act Transition Tax which one time mandatory deemed repatriation tax the accumulated foreign
earnings that have not been previously taxed Earnings the form cash and cash equivalents will taxed
rate and all other earnings will taxed rate result the Company historical
unremitted foreign earnings were deemed repatriated and the Company incurred million
estimated tax provision which primarily consisted estimated Transition Tax well estimated income
tax provisions for state and withholding taxes and provision associated with the remeasurement the
Company deferred tax assets and liabilities from the new corporate income tax rate The
Transition Tax will paid over eight year period starting and will not accrue interest The final
impact the Tax Act may differ from these estimates due among other things changes
interpretations analysis and assumptions made the Company additional guidance that may issued the
Department the Treasury and tax planning actions that the Company may undertake
accordance with guidance SEC Staff Accounting Bulletin the final determination the
Transition Tax and the remeasurement our deferred assets and liabilities will completed additional
information becomes available but later than one year from the date enactment the Tax Act
Warranty
Product warranties are recorded the time revenue recognized for certain product shipments While the
Company engages extensive product quality programs and processes including actively monitoring and
evaluating the quality its component suppliers the Company warranty obligation affected product
failure rates material usage and service delivery costs incurred correcting product failure Should actual
product failure rates material usage service delivery costs differ from the Company previous estimates
revisions the estimated warranty liability would required December the Company warranty
liability was million
Litigation
described Item Legal Proceedings Part this Form the Company party various
pending litigation matters With respect each pending claim management determines whether can
reasonably estimate whether loss probable and the probable range that loss and when
management has determined with respect particular claim both that loss probable and that can
reasonably estimate the range that loss the Company records charge equal either its best estimate that
loss the lowest amount that probable range loss The Company will disclose additional exposures when
the range loss subject considerable uncertainty
Pension and Other Retirement Benefits
Assumptions used determining projected benefit obligations and the fair values plan assets for the
Company pension plans and other retirement benefits are evaluated periodically management Changes
assumptions are based relevant Company data Critical assumptions such the discount rate used measure
the benefit obligations and the expected long term rate return plan assets are evaluated and updated
annually The Company has assumed that the weighted average expected long term rate return plan assets
will for its benefit plans and for its non benefit plans
the end each year the Company determines the discount rate that reflects the current rate which the
pension liabilities could effectively settled The Company utilized Milliman Bond Matching model
determine the discount rate for its benefit plans The Company determined the discount rate for its non
benefit plans based the analysis the Mercer Pension Discount Curve for high quality investments
December that best matched the timing the plan future cash flows for the period maturity the
pension benefits Once the interest rates were determined the plan cash flow was discounted the spot interest
rate back the measurement date December the Company determined the weighted average
discount rate for the benefit plans and for the non benefits plans
one quarter percentage point increase the assumed long term rate return would decrease the
Company net periodic benefit cost for the Waters Retirement Plan less than million one quarter
percentage point increase the discount rate would decrease the Company net periodic benefit cost for the
Waters Retirement Plan less than million
Stock based Compensation
The accounting standards for stock based compensation require that all share based payments employees
recognized the statements operations based their fair values The Company has used the Black Scholes
option pricing model and Monte Carlo simulation model determine the fair value its stock option awards
and performance stock unit awards respectively Under the fair value recognition provisions this statement
share based compensation cost measured the grant date based the value the award and recognized
expense over the vesting period Determining the fair value share based awards the grant date requires
judgment including estimating stock price volatility and employee stock option exercise behaviors actual
results differ significantly from these estimates stock based compensation expense and the Company results
operations could materially impacted stock based compensation expense recognized the consolidated
statements operations based awards that ultimately are expected vest the amount the expense has
been reduced for estimated forfeitures These accounting standards require forfeitures estimated the time
grant and revised necessary subsequent periods actual forfeitures differ from those estimates
Forfeitures are estimated based historical experience factors change and the Company employs different
assumptions the application these accounting standards the compensation expense that the Company
records future periods may differ significantly from what the Company has recorded the current period The
Company recognizes the expense using the straight line attribution method
December unrecognized compensation costs and related weighted average lives over which
the costs will amortized were follows millions
Unrecognized
Compensation
Costs
Weighted Average
Life Years
Stock options
Restricted stock units
Performance stock units
Restricted stock
Total
Business Combinations and Asset Acquisitions
The Company accounts for business acquisitions under the accounting standards for business combinations The
results each acquisition are included the Company consolidated results the acquisition date and the
purchase price acquisition allocated tangible and intangible assets and assumed liabilities based
their estimated fair values Any excess the fair value consideration transferred over the estimated fair values
the net assets acquired recognized goodwill Acquired process research and development IPR
included business combination capitalized indefinite lived intangible asset Development costs
incurred after the acquisition are expensed incurred and acquired IPR tested for impairment annually
until completion the acquired programs Upon commercialization this indefinite lived intangible asset then
accounted for finite lived intangible asset and amortized straight line basis over its estimated useful life
subject periodic impairment reviews the research and development project abandoned the indefinitelived asset charged expense Legal costs due diligence costs business valuation costs and all other business
acquisition costs are expensed when incurred
The Company also acquires intellectual property through licensing arrangements These arrangements often
require upfront payments and may include additional milestone royalty payments contingent upon certain
future events IPR acquired asset acquisition opposed business combination expensed
immediately unless there alternative future use Subsequent payments made for the achievement
milestones are evaluated determine whether they have alternative future use should expensed
Payments made third parties subsequent commercialization are capitalized and amortized over the
remaining useful life the related asset and are classified intangible assets
Contingent Consideration
addition the initial cash consideration paid acquire Medimass the Company obligated make
additional earnout payments based royalty due future sales products containing the REIMS
technology accordance with the accounting standards for business combinations the Company determines the
fair value the liability for contingent consideration each reporting date using probability weighted
discounted cash flow model Subsequent changes the fair value the contingent consideration liability are
recorded the results operations The fair value the contingent consideration liability associated with
future earnout payments based several factors including estimated future results and discount rate
reflective the Company creditworthiness change any these unobservable inputs can significantly
change the fair value the contingent consideration Although there contractual limit total future
undiscounted contingent consideration payments were estimated million December based
the Company best estimate the earnout based future sales certain products through
Recent Accounting Standard Changes and Developments
Information regarding recent accounting standard changes and developments incorporated reference from
Part Item Financial Statements and Supplementary Data this document and should considered
integral part this Item See Note the Notes the Consolidated Financial Statements for recently adopted
and issued accounting standards
Item Quantitative and Qualitative Disclosures About Market Risk
The Company global company that operates over countries and result the Company net sales
cost sales operating expenses and balance sheet amounts are significantly impacted fluctuations foreign
currency exchange rates The Company exposed currency price risk foreign currency exchange rate
fluctuations when translates its non dollar foreign subsidiaries financial statements into dollars and
when any the Company subsidiaries purchase sell products services currency other than its own
currency
The Company principal strategy managing exposure changes foreign currency exchange rates
naturally hedge the foreign currency denominated liabilities the Company balance sheet against
corresponding assets the same currency such that any changes liabilities due fluctuations foreign
currency exchange rates are typically offset corresponding changes assets
The Company does not specifically enter into any derivatives that hedge foreign currency denominated
assets liabilities commitments its balance sheet other than portion certain third party accounts
receivable and accounts payable and the Company net worldwide intercompany receivables and payables
which are eliminated consolidation The Company periodically aggregates its net worldwide balances
currency and then enters into foreign currency exchange contracts that mature within days hedge portion
the remaining balance minimize some the Company currency price risk exposure The foreign currency
exchange contracts are not designated for hedge accounting treatment
Principal hedged currencies include the Euro Japanese yen British pound Mexican peso and Brazilian real
December and the Company held foreign currency exchange contracts with notional
amounts totaling million million and million respectively
The Company foreign currency exchange contracts included the consolidated balance sheets are
classified follows thousands
Other current assets
Other current liabilities
December
December
The following summary the activity included cost sales the statements operations related
the foreign currency exchange contracts thousands
Year Ended December
Realized gains losses closed contracts
Unrealized gains losses open contracts
Cumulative net pre tax gains losses
Assuming hypothetical adverse change year end exchange rates strengthening the
dollar the fair market value the foreign currency exchange contracts outstanding December
would decrease pre tax earnings approximately million
The Company cash and cash equivalents are not subject significant interest rate risk due the short
maturities these instruments The Company cash equivalents represent highly liquid investments with
original maturities days less primarily bank deposits treasury bill money market funds and
commercial paper December the carrying value the Company cash and cash equivalents
approximated fair value
The Company exposed the risk interest rate fluctuations from the investments cash generated
from operations Investments with maturities greater than days are classified investments and are held
primarily treasury bills dollar denominated treasury bills and commercial paper bank deposits and
corporate debt securities The Company maintains cash balances various operating accounts excess
federally insured limits and foreign subsidiary accounts currencies other than the dollar
December and million out million and million out million
respectively the Company total cash cash equivalents and investments were held foreign subsidiaries
addition million out million and million out million cash cash equivalents and
investments were held currencies other than the dollar December and respectively
December the Company has holdings auction rate securities commercial paper issued
structured investment vehicles
Assuming hypothetical adverse change year end exchange rates strengthening the
dollar the fair market value the Company cash cash equivalents and investments held currencies
other than the dollar December would decrease approximately million which the
majority would recorded foreign currency translation other comprehensive income within stockholders
equity
Item Financial Statements and Supplementary Data
Management Report Internal Control Over Financial Reporting
Our management responsible for establishing and maintaining adequate internal control over financial
reporting such term defined Rules and under the Exchange Act Because its
inherent limitations internal control over financial reporting may not prevent detect misstatements Also
projections any evaluation effectiveness future periods are subject the risk that controls may become
inadequate because changes conditions that the degree compliance with the policies procedures
may deteriorate
Under the supervision and with the participation our management including our chief executive officer
and chief financial officer conducted evaluation the effectiveness our internal control over financial
reporting based the framework Internal Control Integrated Framework issued the Committee
Sponsoring Organizations the Treadway Commission COSO Based our evaluation under the
framework Internal Control Integrated Framework our management including our chief executive
officer and chief financial officer concluded that our internal control over financial reporting was effective
December
The effectiveness our internal control over financial reporting December has been audited
PricewaterhouseCoopers LLP independent registered public accounting firm stated their report
which included herein
Report Independent Registered Public Accounting Firm
the Board Directors and Stockholders Waters Corporation
Opinions the Financial Statements and Internal Control over Financial Reporting
have audited the accompanying consolidated balance sheets Waters Corporation and its subsidiaries
December and and the related consolidated statements operations comprehensive income
stockholders equity and cash flows for each the three years the period ended December including
the related notes and schedule valuation and qualifying accounts for each the three years the period ended
December appearing under Item collectively referred the consolidated financial
statements also have audited the Company internal control over financial reporting December
based criteria established Internal Control Integrated Framework issued the Committee
Sponsoring Organizations the Treadway Commission COSO
our opinion the consolidated financial statements referred above present fairly all material respects the
financial position the Company December and and the results their operations and their
cash flows for each the three years the period ended December conformity with accounting
principles generally accepted the United States America Also our opinion the Company maintained
all material respects effective internal control over financial reporting December based criteria
established Internal Control Integrated Framework issued the COSO
Change Accounting Principle
discussed Note the consolidated financial statements the Company changed the manner which
accounts for share based payment transactions
Basis for Opinions
The Company management responsible for these consolidated financial statements for maintaining effective
internal control over financial reporting and for its assessment the effectiveness internal control over
financial reporting included the accompanying Management Report Internal Control Over Financial
Reporting Our responsibility express opinions the Company consolidated financial statements and
the Company internal control over financial reporting based our audits are public accounting firm
registered with the Public Company Accounting Oversight Board United States PCAOB and are required
independent with respect the Company accordance with the federal securities laws and the
applicable rules and regulations the Securities and Exchange Commission and the PCAOB
conducted our audits accordance with the standards the PCAOB Those standards require that plan
and perform the audits obtain reasonable assurance about whether the consolidated financial statements are
free material misstatement whether due error fraud and whether effective internal control over financial
reporting was maintained all material respects
Our audits the consolidated financial statements included performing procedures assess the risks material
misstatement the consolidated financial statements whether due error fraud and performing procedures
that respond those risks Such procedures included examining test basis evidence regarding the amounts
and disclosures the consolidated financial statements Our audits also included evaluating the accounting
principles used and significant estimates made management well evaluating the overall presentation
the consolidated financial statements Our audit internal control over financial reporting included obtaining
understanding internal control over financial reporting assessing the risk that material weakness exists and
testing and evaluating the design and operating effectiveness internal control based the assessed risk Our
audits also included performing such other procedures considered necessary the circumstances
believe that our audits provide reasonable basis for our opinions
Definition and Limitations Internal Control over Financial Reporting
company internal control over financial reporting process designed provide reasonable assurance
regarding the reliability financial reporting and the preparation financial statements for external purposes
accordance with generally accepted accounting principles company internal control over financial reporting
includes those policies and procedures that pertain the maintenance records that reasonable detail
accurately and fairly reflect the transactions and dispositions the assets the company provide reasonable
assurance that transactions are recorded necessary permit preparation financial statements accordance
with generally accepted accounting principles and that receipts and expenditures the company are being made
only accordance with authorizations management and directors the company and iii provide reasonable
assurance regarding prevention timely detection unauthorized acquisition use disposition the
company assets that could have material effect the financial statements
Because its inherent limitations internal control over financial reporting may not prevent detect
misstatements Also projections any evaluation effectiveness future periods are subject the risk that
controls may become inadequate because changes conditions that the degree compliance with the
policies procedures may deteriorate
PricewaterhouseCoopers LLP
Boston Massachusetts
February
have served the Company auditor since
WATERS CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December
thousands except per share data
ASSETS
Current assets
Cash and cash equivalents
Investments
Accounts receivable net
Inventories
Other current assets
Total current assets
Property plant and equipment net
Intangible assets net
Goodwill
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS EQUITY
Current liabilities
Notes payable and debt
Accounts payable
Accrued employee compensation
Deferred revenue and customer advances
Accrued income taxes
Accrued warranty
Other current liabilities
Total current liabilities
Long term liabilities
Long term debt
Long term portion retirement benefits
Long term income tax liabilities
Other long term liabilities
Total long term liabilities
Total liabilities
Commitments and contingencies Notes and
Stockholders equity
Preferred stock par value per share shares authorized none issued
December and December
Common stock par value per share shares authorized
and shares issued and shares outstanding
December and December respectively
Additional paid capital
Retained earnings
Treasury stock cost and shares December and
December respectively
Accumulated other comprehensive loss
Total stockholders equity
Total liabilities and stockholders equity
The accompanying notes are integral part the consolidated financial statements
WATERS CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OPERATIONS
Year Ended December
thousands except per share data
Revenues
Product sales
Service sales
Total net sales
Costs and operating expenses
Cost product sales
Cost service sales
Selling and administrative expenses
Research and development expenses
Litigation provisions Note
Purchased intangibles amortization
Acquired process research and development Note
Total costs and operating expenses
Operating income
Interest expense
Interest income
Income before income taxes
Provision for income taxes
Net income
Net income per basic common share
Weighted average number basic common shares
Net income per diluted common share
Weighted average number diluted common shares and equivalents
The accompanying notes are integral part the consolidated financial statements
WATERS CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS COMPREHENSIVE INCOME
Year Ended December
thousands
Net income
Other comprehensive income loss
Foreign currency translation
Unrealized losses gains investments before income taxes
Income tax benefit
Unrealized losses gains investments net tax
Retirement liability adjustment before reclassifications
Amounts reclassified selling and administrative expenses
Retirement liability adjustment before income taxes
Income tax expense benefit
Retirement liability adjustment net tax
Other comprehensive income loss
Comprehensive income
The accompanying notes are integral part the consolidated financial statements
WATERS CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS CASH FLOWS
Year Ended December
thousands
Cash flows from operating activities
Net income
Adjustments reconcile net income net cash provided
operating activities
Stock based compensation
Deferred income taxes
Depreciation
Amortization intangibles
Excess tax benefit related stock option plans
Gain sale assets
process research and development and other non cash
charges
Change operating assets and liabilities net acquisitions
Increase accounts receivable
Decrease increase inventories
Increase other current assets
Increase other assets
Increase accounts payable and other current liabilities
Increase deferred revenue and customer advances
Effect the Tax Act
Increase other liabilities
Net cash provided operating activities
Cash flows from investing activities
Additions property plant equipment and software
capitalization
Business acquisitions net cash acquired
Investment unaffiliated company
Payments for intellectual property licenses
Purchases investments
Maturities and sales investments
Proceeds from sale assets
Net cash used investing activities
Cash flows from financing activities
Proceeds from debt issuances
Payments debt
Payments debt issuance costs
Proceeds from stock plans
Purchases treasury shares
Proceeds from payments for derivative contracts
Net cash used financing activities
Effect exchange rate changes cash and cash equivalents
Increase cash and cash equivalents
Cash and cash equivalents beginning period
Cash and cash equivalents end period
Supplemental cash flow information
Income taxes paid
Interest paid
The accompanying notes are integral part the consolidated financial statements
WATERS CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS STOCKHOLDERS EQUITY
Balance December
Net income
Other comprehensive loss
Issuance common stock
for employees
Employee Stock Purchase
Plan
Stock options
exercised
Tax benefit related stock
option plans
Treasury stock
Stock based
compensation
Balance December
Net income
Other comprehensive loss
Issuance common stock
for employees
Employee Stock Purchase
Plan
Stock options
exercised
Tax benefit related stock
option plans
Treasury stock
Stock based
compensation
Balance December
Net income
Other comprehensive
income
Issuance common stock
for employees
Employee Stock Purchase
Plan
Stock options
exercised
Treasury stock
Stock based
compensation
Balance December
Accumulated
Other
Comprehensive
Income Loss
Total
Stockholders
Equity
Number
Common
Shares
Common
Stock
Additional
Paid
Capital
Retained
Treasury
Earnings
Stock
thousands
The accompanying notes are integral part the consolidated financial statements
NOTES CONSOLIDATED FINANCIAL STATEMENTS
Description Business and Organization
Waters Corporation the Company specialty measurement company that has pioneered analytical
workflow solutions involving liquid chromatography mass spectrometry and thermal analysis innovations
serving the life materials and food sciences for nearly years The Company primarily designs manufactures
sells and services high performance liquid chromatography HPLC ultra performance liquid chromatography
UPLC and together with HPLC referred LC and mass spectrometry MS technology systems and
support products including chromatography columns other consumable products and comprehensive postwarranty service plans These systems are complementary products that are frequently employed together
MS and sold integrated instrument systems using common software platforms standard
technique and utilized broad range industries detect identify monitor and measure the chemical
physical and biological composition materials and purify full range compounds technology
principally conjunction with chromatography employed drug discovery and development including
clinical trial testing the analysis proteins disease processes known proteomics nutritional safety
analysis and environmental testing instruments combine liquid phase sample introduction and
separation system with mass spectrometric compound identification and quantification addition the Company
designs manufactures sells and services thermal analysis rheometry and calorimetry instruments through its
TA product line These instruments are used predicting the suitability and stability fine chemicals
pharmaceuticals water polymers metals and viscous liquids for various industrial consumer goods and
healthcare products well for life science research The Company also developer and supplier
advanced software based products that interface with the Company instruments well other
manufacturers instruments
Basis Presentation and Summary Significant Accounting Policies
Use Estimates
The preparation consolidated financial statements conformity with generally accepted accounting principles
GAAP requires the Company make estimates and judgments that affect the reported amounts assets
liabilities revenues and expenses and related disclosure contingent liabilities the dates the financial
statements ongoing basis the Company evaluates its estimates including those related revenue
recognition product returns and allowances bad debts inventory valuation goodwill and intangible assets
income taxes warranty and installation provisions litigation retirement plan obligations stock based
compensation equity investments and contingencies The Company bases its estimates historical experience
and various other assumptions that are believed reasonable under the circumstances the results which
form the basis for making judgments about the carrying values assets and liabilities that are not readily
apparent from other sources Actual amounts may differ from these estimates under different assumptions
conditions
Risks and Uncertainties
The Company subject risks common companies the analytical instrument industry including but not limited
global economic and financial market conditions fluctuations foreign currency exchange rates fluctuations
customer demand development its competitors new technological innovations costs developing new
technologies levels debt and debt service requirements risk disruption dependence key personnel protection
and litigation proprietary technology shifts taxable income between tax jurisdictions and compliance with
regulations the Food and Drug Administration and similar foreign regulatory authorities and agencies
Principles Consolidation
The consolidated financial statements include the accounts the Company and its subsidiaries which are wholly
owned The Company consolidates entities which owns controls fifty percent more the voting
shares All inter company balances and transactions have been eliminated
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Translation Foreign Currencies
The functional currency each the Company foreign operating subsidiaries the local currency its
country domicile except for the Company subsidiaries Hong Kong Singapore and the Cayman Islands
where the underlying transactional cash flows are denominated currencies other than the respective local
currency domicile The functional currency the Hong Kong Singapore and Cayman Islands subsidiaries
the dollar based the respective entity cash flows
For most the Company foreign operations assets and liabilities are translated into dollars
exchange rates prevailing the balance sheet date while revenues and expenses are translated average
exchange rates prevailing during the period Any resulting translation gains losses are included accumulated
other comprehensive income the consolidated balance sheets The Company net sales derived from
operations outside the United States were and and respectively Gains and
losses from foreign currency transactions are included net income the consolidated statements operations
and foreign currency transactions resulted net losses million and million and
net gain million respectively
Seasonality Business
The Company typically experiences increase sales the fourth quarter result purchasing habits for
capital goods customers that tend exhaust their spending budgets calendar year end
Cash Cash Equivalents and Investments
Cash equivalents represent highly liquid investments with original maturities days less primarily
bank deposits treasury bill money market funds and commercial paper Investments with longer maturities
are classified investments and are held primarily treasury bills dollar denominated treasury bills
and commercial paper bank deposits and corporate debt securities
Investments are classified available for sale accordance with the accounting standards for investments
debt and equity securities All available for sale securities are recorded fair market value and any unrealized
holding gains and losses the extent deemed temporary are included accumulated other comprehensive
income stockholders equity net the related tax effects any adjustment fair value reflects decline
the value the investment the Company considers all available evidence evaluate the extent which the
decline other than temporary and records loss charge the statement operations The
Company classifies its investments exclusive those categorized cash equivalents
The Company maintains cash balances various operating accounts excess federally insured limits
and foreign subsidiary accounts currencies other than the dollar December and
million out million and million out million respectively the Company
total cash cash equivalents and investments were held foreign subsidiaries addition million out
million and million out million cash cash equivalents and investments were held
currencies other than the dollar December and respectively
Accounts Receivable and Allowance for Doubtful Accounts
Trade accounts receivable are recorded the invoiced amount and not bear interest The allowance for
doubtful accounts the best estimate the amount probable credit losses the existing accounts receivable
The allowance based number factors including historical experience and the customer creditworthiness The allowance for doubtful accounts reviewed least quarterly basis Past due balances over
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
days and over specified amount are reviewed individually for collectibility Account balances are charged
against the allowance when the Company determines probable that the receivable will not recovered The
Company does not have any off balance sheet credit exposure related its customers The allowance for sales
returns the best estimate the amount future product returns related current period revenue and based
historical experience
The following summary the activity the Company allowance for doubtful accounts and sales
returns for the years ended December and thousands
Allowance for Doubtful Accounts and Sales Returns
Balance
Beginning Period
Additions
Deductions
Balance
End
Period
Concentration Credit Risk
The Company sells its products and services significant number large and small customers throughout the
world with net sales the pharmaceutical industry approximately both and and
None the Company individual customers accounted for more than annual Company sales
The Company performs continuing credit evaluations its customers and generally does
not require collateral but certain circumstances may require letters credit deposits Historically the
Company has not experienced significant bad debt losses
Inventory
The Company values all its inventories the lower cost net realizable value first first out basis
FIFO
Income Taxes
Deferred income taxes are recognized for temporary differences between the financial statement and income tax
basis assets and liabilities using tax rates effect for the years which the differences are expected
reverse valuation allowance provided offset any net deferred tax assets based upon the available
evidence more likely than not that some all the deferred tax assets will not realized Appropriate
long term liabilities have also been recorded recognize uncertain tax return reporting positions
Property Plant and Equipment
Property plant and equipment are recorded cost Expenditures for maintenance and repairs are charged
expense while the costs significant improvements are capitalized Depreciation provided using the straightline method over the following estimated useful lives buildings fifteen thirty years building
improvements five ten years leasehold improvements the shorter the economic useful life life
lease and production and other equipment three ten years Upon retirement sale the cost the assets
disposed and the related accumulated depreciation are eliminated from the consolidated balance sheets and
related gains losses are reflected the consolidated statements operations
Asset Impairments
The Company reviews its long lived assets for impairment accordance with the accounting standards for
property plant and equipment Whenever events circumstances indicate that the carrying amount asset
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
may not recoverable the Company evaluates the recoverability the carrying value the asset based the
expected future cash flows relying number factors including but not limited operating results
business plans economic projections and anticipated future cash flows the asset deemed not recoverable
written down fair value and the impairment recorded the consolidated statements operations
Business Combinations and Asset Acquisitions
The Company accounts for business acquisitions under the accounting standards for business combinations The
results each acquisition are included the Company consolidated results the acquisition date and the
purchase price acquisition allocated tangible and intangible assets and assumed liabilities based
their estimated fair values Any excess the fair value consideration transferred over the estimated fair values
the net assets acquired recognized goodwill Acquired process research and development IPR
included business combination capitalized indefinite lived intangible asset Development costs
incurred after the acquisition are expensed incurred and acquired IPR tested for impairment annually
until completion the acquired programs Upon commercialization this indefinite lived intangible asset then
accounted for finite lived intangible asset and amortized straight line basis over its estimated useful life
subject periodic impairment reviews the research and development project abandoned the indefinitelived asset charged expense Legal costs due diligence costs business valuation costs and all other business
acquisition costs are expensed when incurred
The Company also acquires intellectual property through licensing arrangements These arrangements often
require upfront payments and may include additional milestone royalty payments contingent upon certain
future events IPR acquired asset acquisition opposed business combination expensed
immediately unless there alternative future use Subsequent payments made for the achievement
milestones are evaluated determine whether they have alternative future use should expensed
Payments made third parties subsequent commercialization are capitalized and amortized over the
remaining useful life the related asset and are classified intangible assets
Goodwill and Other Intangible Assets
The Company tests for goodwill impairment using fair value approach the reporting unit level annually
earlier event occurs circumstances change that would more likely than not reduce the fair value
reporting unit below its carrying amount Additionally the Company performs annual goodwill impairment
assessment for its reporting units January each year The goodwill and other intangible assets accounting
standards define reporting unit operating segment one level below operating segment discrete
financial information prepared and reviewed management For goodwill impairment review purposes the
Company has two reporting units Waters and TA Goodwill allocated the reporting units the time
acquisition Under the impairment test reporting unit carrying amount exceeds its estimated fair value
goodwill impairment recognized the extent that the carrying amount goodwill exceeds the implied fair
value the goodwill The fair value reporting units was estimated using discounted cash flows technique
which includes certain management assumptions such estimated future cash flows estimated growth rates and
discount rates
The Company intangible assets include purchased technology capitalized software development costs
costs associated with acquiring Company patents trademarks and intellectual properties such licenses debt
issuance costs and acquired IPR Purchased intangibles are recorded their fair market values the
acquisition date and amortized over their estimated useful lives ranging from one fifteen years Other
intangibles are amortized over period ranging from one ten years Debt issuance costs are amortized over the
life the related debt Acquired IPR amortized from the date completion the acquired program over
its estimated useful life IPR and indefinite lived intangibles are tested annually for impairment
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Software Development Costs
The Company capitalizes internal and external software development costs for products offered for sale
accordance with the accounting standards for the costs software sold leased otherwise marketed
Capitalized costs are amortized cost sales over the period economic benefit which approximates
straight line basis over the estimated useful lives the related software products generally three ten years
The Company capitalized million and million direct expenses that were related the development
software and respectively Net capitalized software included intangible assets totaled
million and million December and respectively See Note Goodwill and Other
Intangibles
The Company capitalizes internal software development costs for internal use accordance with the
accounting standards for goodwill and other intangible assets Capitalized internal software development costs
are amortized over the period economic benefit which approximates straight line basis over ten years Net
capitalized internal software included property plant and equipment totaled million both December
and
Other Investments
The Company accounts for its investments that represent less than twenty percent ownership and for which the
Company does not have significant influence using the accounting standards for investments debt and equity
securities Investments for which the Company does not have the ability exercise significant influence and for
which there not readily determinable market value are accounted for under the cost method accounting
The Company periodically evaluates the carrying value its investments accounted for under the cost method
accounting and carries them the lower cost estimated net realizable value For investments which the
Company owns controls between twenty and forty nine percent the voting shares over which exerts
significant influence over operating and financial policies the equity method accounting used The
Company share net income losses equity investments included the consolidated statements
operations and was not material any period presented
During the year ended December the Company made million investment developer
analytical system solutions used make measurements predict stability and accelerate product discovery the
routine analytic process monitoring and quality control release processes for life science and biopharmaceutical
markets This investment was accounted for under the cost method accounting
During the year ended December the Company sold equity investment that was accounted for
using the equity method accounting and was included other assets the consolidated balance sheet for
million cash
Fair Value Measurements
accordance with the accounting standards for fair value measurements and disclosures certain the
Company assets and liabilities are measured fair value recurring basis December and
Fair values determined Level inputs utilize observable data such quoted prices active markets
Fair values determined Level inputs utilize data points other than quoted prices active markets that are
observable either directly indirectly Fair values determined Level inputs utilize unobservable data points
for which there little market data which require the reporting entity develop its own assumptions
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The following table represents the Company assets and liabilities measured fair value recurring
basis December thousands
Total
December
Quoted Prices
Active
Markets
for Identical
Assets
Level
Significant
Other
Observable
Inputs
Level
Significant
Unobservable
Inputs
Level
Assets
Treasury securities
Foreign government securities
Corporate debt securities
Time deposits
Equity securities
Waters Restoration Plan assets
Foreign currency exchange contracts
Total
Liabilities
Contingent consideration
Foreign currency exchange contracts
Total
The following table represents the Company assets and liabilities measured fair value recurring
basis December thousands
Total
December
Quoted Prices
Active
Markets
for Identical
Assets
Level
Significant
Other
Observable
Inputs
Level
Significant
Unobservable
Inputs
Level
Assets
Treasury securities
Foreign government securities
Corporate debt securities
Time deposits
Equity securities
Waters Restoration Plan assets
Foreign currency exchange contracts
Total
Liabilities
Contingent consideration
Foreign currency exchange contracts
Total
Fair Value Restoration Plan Assets
The Restoration Plan nonqualified defined contribution plan and the assets were held registered
mutual funds and have been classified Level The fair values the assets the plan are determined through
market and observable sources from daily quoted prices nationally recognized securities exchanges
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Fair Value Cash Equivalents Investment and Foreign Currency Exchange Contracts
The fair values the Company cash equivalents investments and foreign currency exchange contracts are
determined through market and observable sources and have been classified Level These assets and
liabilities have been initially valued the transaction price and subsequently valued typically utilizing thirdparty pricing services The pricing services use many inputs determine value including reportable trades
benchmark yields credit spreads broker dealer quotes current spot rates and other industry and economic
events The Company validates the prices provided third party pricing services reviewing their pricing
methods and obtaining market values from other pricing sources
Fair Value Contingent Consideration
The fair value the Company liability for contingent consideration relates the July acquisition
Medimass Research Development and Service Kft and determined using probability weighted discounted
cash flow model which uses significant unobservable inputs and has been classified Level Subsequent
changes the fair value the contingent consideration liability are recorded the results operations The
fair value the contingent consideration liability associated with future earnout payments based several
factors including the estimated future results and discount rate that reflects both the likelihood achieving the
estimated future results and the Company creditworthiness change any these unobservable inputs can
significantly change the fair value the contingent consideration Although there contractual limit the fair
value future contingent consideration payments was estimated million both December and
December based the Company best estimate the earnout based future sales certain
products some which are currently development through
Fair Value Other Financial Instruments
The Company cash accounts receivable accounts payable and variable interest rate debt are recorded cost
which approximates fair value due their short term nature The carrying value the Company fixed interest
rate debt was million December and The fair value the Company fixed interest rate
debt was estimated using discounted cash flow models based estimated current rates offered for similar debt
under current market conditions for the Company The fair value the Company fixed interest rate debt was
estimated million and million December and respectively using Level
inputs
Derivative Transactions
The Company global company that operates over countries and result the Company net sales
cost sales operating expenses and balance sheet amounts are significantly impacted fluctuations foreign
currency exchange rates The Company exposed currency price risk foreign currency exchange rate
fluctuations when translates its non dollar foreign subsidiaries financial statements into dollars and
when any the Company subsidiaries purchase sell products services currency other than its own
currency
The Company principal strategy managing exposure changes foreign currency exchange rates
naturally hedge the foreign currency denominated liabilities the Company balance sheet against
corresponding assets the same currency such that any changes liabilities due fluctuations foreign
currency exchange rates are typically offset corresponding changes assets
The Company does not specifically enter into any derivatives that hedge foreign currency denominated
assets liabilities commitments its balance sheet other than portion certain third party accounts
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
receivable and accounts payable and the Company net worldwide intercompany receivables and payables
which are eliminated consolidation The Company periodically aggregates its net worldwide balances
currency and then enters into foreign currency exchange contracts that mature within days hedge portion
the remaining balance minimize some the Company currency price risk exposure The foreign currency
exchange contracts are not designated for hedge accounting treatment
Principal hedged currencies include the Euro Japanese yen British pound Mexican peso and Brazilian real
December and the Company held foreign currency exchange contracts with notional
amounts totaling million million and million respectively
The Company foreign currency exchange contracts included the consolidated balance sheets are
classified follows thousands
December
December
Other current assets
Other current liabilities
The following summary the activity included cost sales the statements operations related
the foreign currency exchange contracts thousands
Year Ended December
Realized gains losses closed contracts
Unrealized gains losses open contracts
Cumulative net pre tax gains losses
Stockholders Equity
May the Company Board Directors authorized the Company repurchase billion its
outstanding common stock over three year period During and the Company repurchased
million million and million shares the Company outstanding common stock cost
million million and million respectively under the May authorization and other
previously announced programs December the Company repurchased aggregate
million shares cost million under the May repurchase program which now completed
December the Company repurchased aggregate million shares cost million
under the May repurchase program and has total million authorized for future repurchases
addition the Company repurchased million million and million common stock related the
vesting restricted stock units during the years ended December and respectively The
Company believes that has the financial flexibility fund these share repurchases given current cash levels
and debt borrowing capacity well invest research technology and business acquisitions further
grow the Company sales and profits
Revenue Recognition
Sales products and services are generally recorded based product shipment and performance service
respectively The Company deferred revenue the consolidated balance sheets consists the obligation
instrument service contracts and customer payments received advance prior shipment the instrument
Revenue recognized when all the following revenue recognition criteria are met persuasive evidence
arrangement exists delivery performance has occurred the vendor fee fixed determinable collectibility
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
reasonably assured and applicable upon acceptance when acceptance criteria with contractual cash
holdback are specified Shipping and handling costs invoiced the customer are included net sales while the
costs associated with shipping and handling are included cost sales
Product shipments and service contracts are not recorded revenue until valid purchase order master
agreement received specifying fixed terms and prices The Company generally recognizes product revenue
when legal title has transferred and risk loss passes the customer The Company generally structures its
sales arrangements shipping point international equivalent and accordingly recognizes revenue upon
shipment some cases destination based shipping terms are included sales arrangements which cases
revenue generally recognized when the products arrive the customer site
The Company method revenue recognition for certain products requiring installation accounted for
accordance with multiple element revenue recognition accounting standards With respect the installation
obligations the larger the contractual cash holdback the best estimate selling price the installation
service deferred when the product shipped and revenue recognized multiple element arrangement
when installation complete The Company determines the best estimate selling price installation based
upon number factors including hourly service billing rates and estimated installation hours
Instrument service contracts are typically billed the beginning the maintenance period The amount
the service contract amortized ratably revenue over the instrument maintenance period There are
deferred costs associated with the service contract the cost the service recorded when the service
performed revenue recognized until all revenue recognition criteria have been met
Sales standalone software are accounted for accordance with the accounting standards for software
revenue recognition The Company software arrangements typically include software licenses and maintenance
contracts Software license revenue recognized when persuasive evidence arrangement exists delivery
has occurred the fee fixed determinable collection probable and there are significant post delivery
obligations remaining The revenue associated with the software maintenance contract recognized ratably over
the maintenance term Unspecified rights software upgrades are typically sold part the maintenance
contract when and available basis The Company uses the residual method allocate software revenue
when transaction includes multiple elements and vendor specific objective evidence fair value undelivered
elements exists Under the residual method the fair value the undelivered element maintenance deferred
and the remaining portion the arrangement fee allocated the delivered element software license and
recognized revenue
Returns and customer credits are infrequent and are recorded reduction sales Rights return are not
included sales arrangements Revenue associated with products that contain specific customer acceptance
criteria not recognized before the customer acceptance criteria are satisfied Discounts from list prices are
recorded reduction sales
Product Warranty Costs
The Company accrues estimated product warranty costs the time sale which are included cost sales
the consolidated statements operations While the Company engages extensive product quality programs
and processes including actively monitoring and evaluating the quality its component suppliers the
Company warranty obligation affected product failure rates material usage and service delivery costs
incurred correcting product failure The amount the accrued warranty liability based historical
information such past experience product failure rates number units repaired and estimated costs
material and labor The liability reviewed for reasonableness least quarterly
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The following summary the activity the Company accrued warranty liability for the years ended
December and thousands
Balance
Beginning Period
Accruals for
Warranties
Settlements
Made
Balance
End Period
Accrued warranty liability
Advertising Costs
All advertising costs are expensed incurred and are included selling and administrative expenses the
consolidated statements operations Advertising expenses were million for and were million for
both and
Research and Development Expenses
Research and development expenses are comprised costs incurred performing research and development
activities including salaries and benefits facilities costs overhead costs contract services and other outside
costs Research and development expenses are expensed incurred During and the Company
incurred million and million charges respectively for acquired process research and development
related the licensing certain intellectual property relating mass spectrometry technologies yet
commercialized and for which there was future alternative use the acquisition date These licensing
arrangements are significantly related new biologically focused applications well other applications
and require the Company make additional future payments million certain milestones are
achieved well royalties future net sales
Stock Based Compensation
The Company has two stock based compensation plans which are described Note Stock Based
Compensation
Earnings Per Share
accordance with the earnings per share accounting standards the Company presents two earnings per share
EPS amounts Income per basic common share based income available common shareholders and the
weighted average number common shares outstanding during the periods presented Income per diluted
common share includes additional dilution from potential common stock such stock issuable pursuant the
exercise stock options outstanding
Retirement Plans
The Company sponsors various retirement plans which are described Note Retirement Plans
Comprehensive Income
The Company accounts for comprehensive income accordance with the accounting standards for
comprehensive income which establish the accounting rules for reporting and displaying comprehensive income
These standards require that all components comprehensive income reported financial statement that
displayed with the same prominence other financial statements
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Recently Adopted Accounting Standards
July accounting guidance was issued which clarifies the measurement inventory The new guidance
requires inventory measured the lower cost and net realizable value Net realizable value the
estimated selling prices the ordinary course business less reasonably predictable costs completion
disposal and transportation This guidance effective for annual and interim periods beginning after
December The Company adopted this standard January and this standard did not have
material effect the Company financial position results operations and cash flows
March accounting guidance was issued which simplifies the accounting for share based payment
transactions including the income tax consequences classification awards either equity liabilities and
classification the statement cash flows This guidance was effective for annual and interim reporting
periods beginning after December The new guidance required adopted prospective basis
for the statement operations and the Company has elected retrospectively apply the cash flow aspects this
new guidance addition the Company has elected continue estimate forfeitures the time grant and
update forfeiture estimates throughout the requisite service period The Company adopted this standard
January and recognized excess tax benefit related stock based compensation which decreased
income tax expense for million and added net income per diluted share These excess tax
benefits were previously recorded equity and there were cumulative effect adjustments retained earnings
result the adoption this standard addition the Company reclassified million and million
excess tax benefits related stock based compensation from cash flows from financing activities cash flows
from operating activities for and respectively
Recently Issued Accounting Standards
May amended accounting guidance was issued regarding the recognition revenue from contracts with
customers The objective this guidance significantly enhance comparability and clarify principles
revenue recognition practices across entities industries jurisdictions and capital markets This guidance was
originally effective for annual and interim reporting periods beginning after December however the
Financial Accounting Standards Board FASB amended the standard August delay the effective
period date one year annual and interim periods beginning after December Adoption prior
December was not permitted March the FASB clarified the implementation guidance
principal versus agent considerations and April clarification was made regarding certain aspects
identifying performance obligations and licensing implementation guidance May additional guidance
was issued related disclosure remaining performance obligations well other amendments guidance
collectibility non cash consideration and the presentation sales and other similar taxes collected from
customers The Company did not early adopt this accounting standard and will apply the modified retrospective
method The Company does not expect that the adoption this standard will have material impact the
Company financial position results operations and cash flows
January accounting guidance was issued which primarily affects the classification and
measurement certain financial instruments principally equity investments and certain financial liabilities
Under the new guidance there will longer available for sale classification for equity securities with
readily determinable fair values Changes the fair value equity investments will recognized through
earnings Equity investments carried cost should adjusted for changes observable prices applicable
and qualitatively assessed for impairment annually Changes the fair value financial liabilities under the fair
value option due instrument specific credit risk will recognized separately other comprehensive income
The new guidance also requires financial assets and financial liabilities presented separately and grouped
measurement category the notes the financial statements This guidance effective for annual and interim
reporting periods beginning after December and early adoption certain provisions this guidance
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
permitted The Company currently does not expect that the adoption this standard will have material effect
the Company financial position results operations and cash flows
February accounting guidance was issued regarding the accounting for leases This new
comprehensive lease standard amends various aspects existing accounting guidance for leases The core
principle the new guidance will require lessees present the assets and liabilities that arise from leases
their balance sheets This guidance effective for annual and interim reporting periods beginning after
December and early adoption permitted The Company expects that the adoption this standard will
have material effect the Company balance sheet however not expected have overall material
impact the Company results operations and cash flows Please see Note Other Commitments and
Contingencies for additional information
June accounting guidance was issued that modifies the recognition credit losses related
financial assets such debt securities trade receivables net investments leases off balance sheet credit
exposures and other financial assets that have the contractual right receive cash Current guidance requires the
recognition credit loss when considered probable that loss event has occurred The new guidance
requires the measurement expected credit losses based upon relevant information including historical
experience current conditions and reasonable and supportable forecasts that affect the collectability the asset
such expected credit losses may recognized sooner under the new guidance due the broader range
information that will required determine credit loss estimates The new guidance also amends the current
other than temporary impairment model used for debt securities classified available for sale When the fair
value available for sale debt security below its amortized cost the new guidance requires the total
unrealized loss bifurcated into its credit and non credit components Any expected credit losses
subsequent recoveries will recognized earnings and any changes not considered credit related will continue
recognized within other comprehensive income This guidance effective for annual and interim periods
beginning after December The Company currently does not expect that the adoption this standard
will have material effect the Company financial position results operations and cash flows
August accounting guidance was issued that clarifies the classification certain cash flows The
new guidance addresses eight specific areas where current accounting guidance either unclear does not
specifically address classification issues This guidance effective for annual and interim periods beginning
after December and early adoption permitted The Company currently does not believe that the
adoption this standard will have material impact the Company cash flows
October accounting guidance was issued regarding intra entity transfers assets other than
inventory The new guidance eliminates the deferral tax effects intra entity transfers other than inventory
and requires entity recognize the income tax consequences when the transfer occurs This guidance
effective for annual and interim periods beginning after December and early adoption permitted The
Company does not believe that the adoption this standard will have material impact the Company
financial position results operations and cash flows
January accounting guidance was issued that clarifies the definition business The new
guidance provides more robust framework use determining when set assets and activities
business thus narrowing the definition and the amount transactions accounted for business combinations
This guidance effective for annual and interim periods beginning after December and early
application permitted under certain circumstances The Company will apply this guidance prospectively any
business combination transactions that take place after adoption this new guidance
January accounting guidance was issued that simplifies the accounting for goodwill impairment
The guidance eliminates step the goodwill impairment test which requires hypothetical purchase price
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
allocation This guidance effective for annual and interim periods beginning after December and early
adoption permitted The Company currently does not expect that the adoption this standard will have
material effect the Company financial position results operations and cash flows
March accounting guidance was issued regarding the presentation net periodic pension cost and
net periodic postretirement benefit cost The new guidance requires that employer disaggregate the service
cost component from other components net benefit cost with service cost reported the same line items
other compensation costs and the other components net benefit costs presented outside income from
operations This guidance effective for annual and interim periods beginning after December and
early adoption permitted The Company currently does not believe that the adoption this standard will have
material impact the Company financial position results operations and cash flows Please see Note
Retirement Plans for additional information
March accounting guidance was issued amend the amortization period for certain purchased
callable debt securities held premium Specifically the amortization period for certain callable debt securities
will shortened end the earliest call date This guidance effective for annual and interim periods
beginning after December and early adoption permitted The Company currently does not believe that
the adoption this standard will have material impact the Company financial position results
operations and cash flows
May accounting guidance was issued that clarifies the accounting for change the terms
conditions share based payment award The standard provides more specific guidance for determining when
change award requires modification accounting and when should deemed purely administrative
nature This guidance effective for annual and interim periods beginning after December and early
adoption permitted The Company currently does not believe that the adoption this standard will have
material impact the Company financial position results operations and cash flows
Marketable Securities
The Company marketable securities within cash equivalents and investments included the consolidated
balance sheets are detailed follows thousands
Amortized
Cost
December
Unrealized Unrealized
Gain
Loss
Fair
Value
Treasury securities
Foreign government securities
Corporate debt securities
Time deposits
Equity securities
Total
Amounts included
Cash equivalents
Investments
Total
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Amortized
Cost
December
Unrealized Unrealized
Gain
Loss
Fair
Value
Treasury securities
Foreign government securities
Corporate debt securities
Time deposits
Equity securities
Total
Amounts included
Cash equivalents
Investments
Total
The estimated fair value marketable debt securities maturity date follows thousands
December
December
Due one year less
Due after one year through three years
Total
Realized gains and losses sales investments were not material and
Inventories
Inventories are classified follows thousands
December
Raw materials
Work progress
Finished goods
Total inventories
During and the Company recorded inventory related excess and obsolescence provisions
million million and million respectively
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Property Plant and Equipment
Property plant and equipment consist the following thousands
December
Land and land improvements
Buildings and leasehold improvements
Production and other equipment
Construction progress
Total property plant and equipment
Less accumulated depreciation and amortization
Property plant and equipment net
During and the Company retired and disposed approximately million million
and million property plant and equipment respectively most which was fully depreciated and
longer use Gains disposal were immaterial for the years ended December and
February the Company Board Directors approved expanding its chemistry synthesis
operations The Company anticipates spending estimated million build and equip this new
state the art manufacturing facility which will paid for with existing cash and investments The Company
does not expect issue any debt relation this expansion
Acquisitions
September the Company acquired all the outstanding stock Rubotherm GmbH Rubotherm
manufacturer gravimetric analysis systems for approximately million cash million which was paid
closing and additional million paid after closing settle certain liabilities Rubotherm develops and
manufactures analytical test instruments for thermogravimetric and sorption measurements that are used both
industrial and academic research laboratories disciplines that include chemistry material science and
engineering The Rubotherm acquisition will help support and further expand product offerings within TA
thermal analysis business
November the Company acquired all the outstanding stock MPE Orbur Group Limited and its
sole operating subsidiary Midland Precision Equipment Company Ltd MPE manufacturer
instrumentation components for million net cash acquired MPE highly skilled manufacturer and
former Waters supplier that produces critical components that support the Company instrument systems
MPE was acquired bring this key supplier house reduce manufacturing costs the future and reduce
risk our supply chain
the fourth quarter the Company acquired certain assets its Malaysian sales and service
distributor for million cash
May the Company acquired the net assets the ElectroForce business the Bose Corporation
ElectroForce manufacturer testing systems for million cash ElectroForce core business the
manufacturing dynamic mechanical testing systems used characterize medical devices biologic and
engineered materials The ElectroForce test instruments are based unique motor designs that are quiet energyefficient scalable and deliver precise performance over wide range force and frequency ElectroForce was
acquired expand TA product offering into new markets while leveraging the technology infrastructure and
customer bases the combined organizations
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The principal factor that resulted recognition goodwill these acquisitions that the purchase price was
based part cash flow projections assuming the integration any acquired technology distribution channels and
products with the Company products which considerably greater value than utilizing each the acquired
companies technology customer access products standalone basis The goodwill also includes value assigned
assembled workforce which cannot recognized intangible asset Specifically the goodwill acquired with
MPE consists the value assigned its workforce and the future incremental sales synergies anticipated
each acquisition the sellers provided the Company with customary representations warranties and
indemnification which would settled the future and when breach the contractual representation
warranty condition occurs The pro forma effect the ongoing operations for Waters Corporation Rubotherm
MPE the Malaysian sales and service distributor and ElectroForce either individually the aggregate
though these acquisitions had occurred the beginning the periods covered this report was immaterial
Goodwill and Other Intangibles
The carrying amount goodwill was million and million December and respectively
During the year ended December the effect foreign currency translation increased goodwill million
The Company intangible assets included the consolidated balance sheets are detailed follows
thousands
December
December
Gross
Carrying
Amount
Accumulated
Amortization
WeightedAverage
Amortization
Period
Gross
Carrying
Amount
Accumulated
Amortization
WeightedAverage
Amortization
Period
Capitalized software
Purchased intangibles
Trademarks and IPR
Licenses
Patents and other intangibles
years
years
years
years
years
years
years
years
Total
years
years
The gross carrying value intangible assets and accumulated amortization for intangible assets increased
million and million respectively the year ended December due the effects foreign
currency translation Amortization expense for intangible assets was million for each the years ended
December and Amortization expense for intangible assets estimated million per
year for each the next five years
Debt
November the Company entered into new credit agreement the Credit Agreement that
provides for billion revolving facility and million term loan The revolving facility and term loan
both mature November and require scheduled prepayments before that date The Company used
billion the proceeds from the Credit Agreement repay the outstanding amounts under the
Company existing multi borrower credit agreement dated June the Credit Agreement which
was terminated early without penalty The Company plans use future proceeds from the revolving facility for
general corporate purposes
The interest rates applicable the Credit Agreement are the Company option equal either the
alternate base rate which rate per annum equal the greatest the prime rate effect such day
the Federal Reserve Bank New York Rate such day plus per annum and the adjusted
LIBO
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
rate such day such day not business day the immediately preceding business day for deposit
dollars with maturity one month plus per annum the applicable month adjusted LIBO
rate EURIBO rate for Euro denominated loans each case plus interest rate margin based upon the
Company leverage ratio which can range between and basis points for alternate base rate loans and
between and basis points for LIBO rate EURIBO rate loans The facility fee the Credit
Agreement ranges between and basis points per annum based the leverage ratio the amount the
revolving facility commitments and the outstanding term loan The Credit Agreement requires that the
Company comply with interest coverage ratio test not less than the end any fiscal quarter for
any period four consecutive fiscal quarters and leverage ratio test not more than the end
any fiscal quarter addition the Credit Agreement includes negative covenants affirmative covenants
representations and warranties and events default that are customary for investment grade credit facilities
both December and the Company had total million outstanding senior
unsecured notes Interest the fixed rate senior unsecured notes payable semi annually each year Interest
the floating rate senior unsecured notes payable quarterly The Company may prepay all some the senior
unsecured notes any time amount not less than the aggregate principal amount outstanding plus
the applicable make whole amount prepayment premium for Series and senior unsecured notes the
event change control the Company defined the note purchase agreement the Company may
required prepay the senior unsecured notes price equal the principal amount thereof plus
accrued and unpaid interest These senior unsecured notes require that the Company comply with interest
coverage ratio test not less than for any period four consecutive fiscal quarters and leverage ratio
test not more than the end any fiscal quarter addition these senior unsecured notes include
customary negative covenants affirmative covenants representations and warranties and events default
The Company had the following outstanding debt December and thousands
December
Foreign subsidiary lines credit
Senior unsecured notes Series due March
Credit agreement
Total notes payable and debt current
Total long term debt
Total debt
Senior unsecured notes Series due February
Senior unsecured notes Series due March
Senior unsecured notes Series due March
Senior unsecured notes Series due June
Senior unsecured notes Series due June
Senior unsecured notes Series floating rate due June
Senior unsecured notes Series due May
Senior unsecured notes Series floating rate due May
Senior unsecured notes Series due May
Credit agreement
Unamortized debt issuance costs
Series senior unsecured notes bear interest month LIBOR for that floating rate interest period plus
Series senior unsecured notes bear interest month LIBOR for that floating rate interest period plus
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
December and the Company had total amount available borrow under existing
credit agreements million and million respectively after outstanding letters credit The
weighted average interest rates applicable the senior unsecured notes and credit agreement borrowings
collectively were and December and respectively December the
Company was compliance with all debt covenants
The Company and its foreign subsidiaries also had available short term lines credit totaling million
and million December and respectively for the purpose short term borrowing and
issuance commercial guarantees December and the weighted average interest rates
applicable these short term borrowings were and respectively
Annual maturities debt outstanding December are follows thousands
Total
Thereafter
Total
Income Taxes
Income tax data for the years ended December and follows thousands
Year Ended December
The components income from operations before income taxes are
follows
Domestic
Foreign
Total
Year Ended December
The current and deferred components the provision for income taxes
operations are follows
Current
Deferred
Total
The jurisdictional components the provision for income taxes operations
are follows
Federal
State
Foreign
Total
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The enacted the Tax Cuts and Jobs Act the Tax Act December Enactment
Date
The Tax Act contains several key provisions including but not limited the following
one time tax the mandatory deemed repatriation pre foreign earnings and profits
referred the toll charge
Reduction the Corporate tax rate from for tax years beginning after December
Introduction new tax certain off shore earnings referred Global Intangible Low Taxed
Income GILTI effective tax rate for tax years beginning after December
increasing for tax years beginning after December with partial offset foreign
tax credits and
Introduction territorial tax system beginning providing dividends received
deduction certain qualified dividends from foreign subsidiaries
During the fourth quarter recorded incremental income tax provision million which
comprised the following
estimated income tax provision million for the one time deemed repatriation pre
accordance with the Tax Act the toll charge liability may paid over eight years
such have recorded million and million long term income tax liabilities and accrued
income taxes current respectively December
estimated net income tax provision million for the remeasurement our deferred tax assets
and liabilities the newly enacted tax rate and
result the Tax Act and the Company expectations about distributing certain cash balances
from its foreign subsidiaries the the Company also recorded estimated income tax provisions for
estimated state income taxes and foreign withholding taxes million
The million income tax provision recorded was based currently available information and
interpretations applying the provisions the Tax Act the time filing this Annual Report Form
accordance with authoritative guidance issued the Securities and Exchange Commission SEC
the income tax effect the Tax Act represent provisional amounts for which our accounting incomplete
but for which reasonable estimates were determined and recorded during the fourth quarter The
guidance provides for measurement period one year from the Enactment Date which provisional
amounts may adjusted when additional information obtained prepared and analyzed Adjustments
provisional amounts identified during the measurement period should recorded income tax provision
benefit the period the adjustment determined
continue evaluate the impacts the Tax Act and consider the amounts recorded
provisional addition are still evaluating the GILTI provisions the Tax Act and its impact any
our consolidated financial statements December Companies are allowed adopt
accounting policy either recognize deferred taxes for GILTI treat such tax cost the year incurred
have not yet determined our accounting policy because determining the impact the GILTI provisions requires
additional analysis such did not record deferred income tax expense benefit related the GILTI
provisions our consolidated statement operations for the year ended December and will finalize
this analysis and determination during the measurement period
The Company recorded provisional amount for its toll charge which represents its reasonable estimate
the liability due for the mandatory deemed repatriation its foreign Determining the provisional toll
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
charge liability required significant effort based number estimates and factors that need further
analyzed and finalized including but not limited the following
Analyzing our accumulated foreign and related foreign tax pools including historical practices and
assertions made determining such and
Determining the composition including intercompany receivables and payables specified foreign
corporations our foreign that held cash liquid assets and other assets several
measurement dates different tax rate applied each when determining the toll charge liability
For the aforementioned factors well the proximity the enactment the Tax Act our
year end had limited time analyze the Tax Act and its various interpretations including any
additional guidance issued through the time filing this Annual Report Form assess how apply
the new law our specific facts and circumstances and determine the toll charge that expect include our
tax return made certain assumptions and estimates determining the provisional toll charge that may
result adjustments when finalize our analysis and accounting for the Tax Act
Certain income tax effects the Tax Act represent provisional amounts for which our analysis
incomplete but for which reasonable estimates were determined and recorded during the fourth quarter
Our actual results may materially differ from our current estimates due among other things further guidance
that may issued federal state tax authorities interpret the Tax Act guidance from the
SEC FASB regarding income tax accounting matters related the Tax Act will continue analyze
the Tax Act and any additional guidance that may issued can finalize the tax effects the
Tax Act our financial statements the measurement period
December result the Tax Act deemed repatriation and plans distribute certain
cash balances from its foreign subsidiaries the have recorded state and foreign withholding taxes
the unremitted earnings our foreign subsidiaries The Company continues indefinitely reinvested
relation the cumulative historical outside basis difference not related the unremitted earnings that were
taxed will continue evaluate our assertions including intentions and plans the cumulative historical
outside basis differences not related the unremitted earnings that were taxed our foreign subsidiaries
December expect finalize our analysis and accounting related the toll charge deferred tax
assets and liabilities and any remaining outside basis differences our foreign subsidiaries during the
measurement period The determination the unrecognized deferred tax liability cumulative historical
outside basis differences that are not related the unremitted earnings that were taxed not practicable
Year Ended December
The differences between income taxes computed the United States
statutory rate and the provision for income taxes are summarized
follows
Federal tax computed statutory income tax rate
Tax Act
Settlement tax audits
State income tax net federal income tax benefit
Net effect foreign operations
Effect stock based compensation
Other net
Provision for income taxes
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The four principal jurisdictions which the Company manufactures are the Ireland the and
Singapore where the marginal effective tax rates were approximately and
respectively December The Company has contractual tax rate qualifying activities
Singapore through March based upon the achievement certain contractual milestones which the
Company expects continue meet The current statutory tax rate Singapore The effect applying
the contractual tax rate rather than the statutory tax rate income from qualifying activities Singapore
increased the Company net income and million million and million
respectively and increased the Company net income per diluted share and respectively
The Company effective tax rates for the years ended December and were
and respectively The provision for income taxes for includes million estimate for the
impact the Tax Act addition the effective tax rate includes the adoption new accounting
guidance related stock based compensation which decreased income tax expense million and
decreased the Company effective tax rate percentage points See Note for further information
regarding the adoption this standard
The income tax provision for included million tax benefit related release valuation
allowance certain net operating loss carryforwards the income tax provision included million
tax benefit related the completion tax audit examinations The remaining differences between effective tax
rates can primarily attributed differences the proportionate amounts pre tax income recognized
jurisdictions with different effective tax rates
The tax effects temporary differences and carryforwards which give rise deferred tax assets and
deferred tax liabilities are summarized follows thousands
December
Deferred tax assets
Net operating losses and credits
Depreciation
Stock based compensation
Deferred compensation
Revaluation equity investments and licenses
Inventory
Accrued liabilities and reserves
Other
Total deferred tax assets
Valuation allowance
Deferred tax assets net valuation allowance
Deferred tax liabilities
Capitalized software
Amortization
Indefinite lived intangibles
Deferred tax liability foreign earnings
Total deferred tax liabilities
Net deferred tax assets
December the Company has provided deferred tax valuation allowance million
which million relates certain foreign net operating losses The Company net deferred tax assets
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
associated with net operating losses and tax credit carryforwards are approximately million
December which represent the future tax benefit foreign net operating loss carryforwards that not
expire under current law
result the adoption new accounting guidance related stock based compensation the Company
longer records excess tax benefits related stock based compensation equity The income tax benefits
associated with equity compensation expense recognized for tax purposes and credited additional paid
capital were million and million for the years ended December and respectively
The Company accounts for its uncertain tax return reporting positions accordance with the accounting
standards for income taxes which require financial statement reporting the expected future tax consequences
uncertain tax reporting positions the presumption that all concerned tax authorities possess full knowledge
those tax reporting positions well all the pertinent facts and circumstances but prohibit any
discounting unrecognized tax benefits associated with those reporting positions for the time value money
The Company continues classify interest and penalties related unrecognized tax benefits component
the provision for income taxes
The following summary the activity the Company unrecognized tax benefits for the years ended
December and thousands
Balance the beginning the period
Changes resulting from completion tax examinations
Other changes uncertain tax benefits
Balance the end the period
With limited exceptions the Company longer subject tax audit examinations significant
jurisdictions for the years ended before December However carryforward tax attributes that were
generated years beginning before January may still adjusted upon examination tax
authorities the attributes are utilized The Company continuously monitors the lapsing statutes limitations
potential tax assessments for related changes the measurement unrecognized tax benefits related net
interest and penalties and deferred tax assets and liabilities
During the year ended December the Company concluded tax audit disputes outside the that
part related matters for which the Company had recorded net uncertain tax benefits The resolution these
tax disputes resulted million reduction the measurement its unrecognized tax benefits for the year
ended December
During the year ended December the Company concluded tax audit disputes that part
related matters for which the Company had recorded net uncertain tax benefits The resolution these tax
disputes resulted million reduction the measurement its unrecognized tax benefits and million
decrease its provision for income taxes for the year ended December
December the Company expects record additional reductions the measurement its
unrecognized tax benefits and related net interest and penalties approximately million within the next
twelve months due potential tax audit settlements and the lapsing statutes limitations potential tax
assessments The Company does not expect record any other material reductions the measurement its
unrecognized tax benefits within the next twelve months
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Litigation
From time time the Company and its subsidiaries are involved various litigation matters arising the
ordinary course business The Company believes has meritorious arguments its current litigation matters
and believes any outcome either individually the aggregate will not material the Company financial
position results operations cash flows During and the Company recorded million
million and million litigation settlement provisions and related costs respectively The accrued patent
litigation expense other current liabilities the consolidated balance sheets December and
Other Commitments and Contingencies
Lease agreements expiring various dates through cover buildings office equipment and automobiles
Rental expense was million million and million for the years ended December and
respectively Future minimum rents payable December under non cancelable leases with
initial terms exceeding one year are follows thousands
and thereafter
Total
The Company licenses certain technology and software from third parties Future minimum license fees
payable under existing license agreements December are immaterial for the years ended
December and thereafter The Company enters into licensing arrangements with third parties that
require future milestone royalty payments contingent upon future events Upon the achievement certain
milestones existing agreements the Company could make additional future payments million
well royalties future net sales
The Company enters into standard indemnification agreements its ordinary course business Pursuant
these agreements the Company indemnifies holds harmless and agrees reimburse the indemnified party for
losses suffered incurred the indemnified party generally the Company business partners customers
connection with patent copyright other intellectual property infringement claims any third party with
respect its current products well claims relating property damage personal injury resulting from the
performance services the Company its subcontractors The maximum potential amount future
payments the Company could required make under these indemnification agreements unlimited
Historically the Company costs defend lawsuits settle claims relating such indemnity agreements have
been minimal and management accordingly believes the estimated fair value these agreements immaterial
Stock Based Compensation
May the Company shareholders approved the Company Equity Incentive Plan Plan
December the Plan has million shares available for grant the form incentive
non qualified stock options stock appreciation rights SARs restricted stock restricted stock units
performance stock units other types awards The Company issues new shares common stock upon
exercise stock options restricted stock unit conversion performance stock unit conversion Under the
Plan the exercise price for stock options may not less than the fair market value the underlying stock the
date grant The Plan scheduled terminate May Options generally will expire later
than ten years after the date which they are granted and will become exercisable directed the
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Compensation Committee the Board Directors and generally vest equal annual installments over fiveyear period SAR may granted alone conjunction with option other award Shares restricted
stock and restricted stock units and performance stock units may issued under the Plan for such
consideration determined the Compensation Committee the Board Directors December
the Company had stock options restricted stock and restricted and performance stock unit awards
outstanding
May the Company shareholders approved the Employee Stock Purchase Plan under which
eligible employees may contribute their earnings toward the quarterly purchase the Company
common stock The plan makes available million shares the Company common stock which includes the
remaining shares available under the Employee Stock Purchase Plan December million
shares have been issued under both the and Employee Stock Purchase Plans Each plan period lasts
three months beginning January April July and October each year The purchase price for each
share stock the lesser the market price the first day the plan period the market
price the last day the plan period Stock based compensation expense related this plan was million for
each the years ended December and respectively
The Company accounts for stock based compensation costs accordance with the accounting standards for
stock based compensation which require that all share based payments employees recognized the
statements operations based their grant date fair values The Company recognizes the expense using the
straight line attribution method The stock based compensation expense recognized the consolidated
statements operations based awards that ultimately are expected vest therefore the amount expense
has been reduced for estimated forfeitures The new stock based compensation accounting guidance offers the
option recognizing forfeitures they occur estimating forfeitures the time grant and necessary
revising subsequent periods actual forfeitures differ from those estimates The Company has elected
remain consistent with prior periods and estimate forfeitures the time grant and necessary revise
subsequent periods which actual forfeitures differ from those estimates Forfeitures are estimated based
historical experience actual results differ significantly from these estimates stock based compensation
expense and the Company results operations could materially impacted addition the Company
employs different assumptions the application these standards the compensation expense that the Company
records the future periods may differ significantly from what the Company has recorded the current period
The consolidated statements operations for the years ended December and include
the following stock based compensation expense related stock option awards restricted stock awards
restricted stock unit awards performance stock unit awards and the employee stock purchase plan thousands
Cost sales
Selling and administrative expenses
Research and development expenses
Total stock based compensation
During the years ended December and the Company recognized million and million
respectively stock compensation expense related the modification certain stock awards upon the
retirement senior executives
Stock Options
determining the fair value the stock options the Company makes variety assumptions and estimates
including volatility measures expected yields and expected stock option lives The fair value each option grant
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
was estimated the date grant using the Black Scholes option pricing model The Company uses implied
volatility its publicly traded options the basis for its estimate expected volatility The Company believes
that implied volatility the most appropriate indicator expected volatility because generally reflective
historical volatility and expectations how future volatility will differ from historical volatility The expected
life assumption for grants based historical experience for the population non qualified stock option
exercises The risk free interest rate the yield currently available Treasury zero coupon issues with
remaining term approximating the expected term used the input the Black Scholes model The relevant data
used determine the value the stock options granted during and are follows
Options Issued and Significant Assumptions Used Estimate Option Fair Values
Options issued thousands
Risk free interest rate
Expected life years
Expected volatility
Expected dividends
Weighted Average Exercise Price and Fair Value Options the Date Grant
Exercise price
Fair value
The following table summarizes stock option activity for the plans for the year ended December
thousands except per share data
Number Shares
Exercise Price
per Share
WeightedAverage
Exercise Price
Outstanding December
Granted
Exercised
Canceled
Outstanding December
The following table details the options outstanding December range exercise prices
thousands except per share data
Exercise
Price Range
Number Shares
Outstanding
WeightedAverage
Exercise Price
Remaining
Contractual Life
Options Outstanding
Number Shares
Exercisable
WeightedAverage
Exercise Price
Total
During and the total intrinsic value the stock options exercised the difference
between the market price exercise and the price paid the employee exercise the options was million
million and million respectively The total cash received from the exercise these stock options was
million million and million for the years ended December and respectively
The aggregate intrinsic value the outstanding stock options December was million
Options exercisable December and were million million and million
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
respectively The weighted average exercise prices options exercisable December and
were and respectively The weighted average remaining contractual life the
exercisable outstanding stock options December was years
December the Company had million stock options that are vested and expected vest The
intrinsic value weighted average exercise price and remaining contractual life the vested and expected vest
stock options were million and years respectively December
December there were million total unrecognized compensation costs related
unvested stock option awards that are expected vest These costs are expected recognized over
weighted average period years
Restricted Stock
During the years ended December and the Company granted thousand thousand and
thousand shares restricted stock respectively The weighted average fair value per share the grant date
the restricted stock granted and was and respectively The
Company has recorded million compensation expense each the years ended December
and related the restricted stock grants December the Company had thousand unvested
shares restricted stock outstanding which have been fully expensed
Restricted Stock Units
The following table summarizes the unvested restricted stock unit award activity for the year ended
December thousands except for per share amounts
Shares
Weighted Average
Fair Value
Unvested December
Granted
Vested
Forfeited
Unvested December
Restricted stock units are generally granted annually February and vest equal annual installments over
five year period The amount compensation costs recognized for the years ended December
and the restricted stock units expected vest were million million and million
respectively December there were million total unrecognized compensation costs related
the restricted stock unit awards that are expected vest These costs are expected recognized over
weighted average period years
Performance Stock Units
During year ended December the Company issued performance stock units which are equity
compensation awards with market vesting condition based the Company Total Shareholder Return
TSR relative the TSR the components the Health Care Index TSR the change value
stock price over time including the reinvestment dividends The vesting schedule ranges from
the target shares awarded
determining the fair value the performance stock units the Company makes variety assumptions
and estimates including volatility measures expected yields and expected terms The fair value each
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
performance stock unit grant was estimated the date grant using the Monte Carlo simulation model The
Company uses implied volatility its publicly traded options the basis for its estimate expected volatility
The Company believes that implied volatility the most appropriate indicator expected volatility because
generally reflective historical volatility and expectations how future volatility will differ from historical
volatility The expected life assumption for grants based the performance period the underlying
performance stock units The risk free interest rate the yield currently available Treasury zero coupon
issues with remaining term approximating the expected term used the input the Monte Carlo simulation
model The correlation coefficient used model the way which each company the Health Care
Index tends move relation each other during the performance period The relevant data used determine
the value the performance stock units granted during are follows
Performance Stock Units Issued and Significant Assumptions Used Estimate Fair Values
Performance stock units issued thousands
Risk free interest rate
Expected life years
Expected volatility
Average volatility peer companies
Correlation Coefficient
Expected dividends
The following table summarizes the unvested performance stock unit award activity for the year ended
December thousands except for per share amounts
Shares
Weighted Average
Fair Value
Unvested December
Granted
Forfeited
Unvested December
The amount compensation costs recognized for the years ended December and the
performance stock units expected vest were million and less than million respectively
December there were million total unrecognized compensation costs related the restricted
stock unit awards that are expected vest These costs are expected recognized over weighted average
period years
Earnings Per Share
Basic and diluted EPS calculations are detailed follows thousands except per share data
Year Ended December
Weighted Average
Per
Net Income
Shares
Share
Numerator
Denominator
Amount
Net income per basic common share
Effect dilutive stock option restricted stock performance stock unit
and restricted stock unit securities
Net income per diluted common share
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Year Ended December
Weighted Average
Per
Net Income
Shares
Share
Numerator
Denominator
Amount
Net income per basic common share
Effect dilutive stock option restricted stock performance stock unit
and restricted stock unit securities
Net income per diluted common share
Year Ended December
Weighted Average
Per
Net Income
Shares
Share
Numerator
Denominator
Amount
Net income per basic common share
Effect dilutive stock option restricted stock and restricted stock unit
securities
Net income per diluted common share
For the years ended December and the Company had million million and
million stock options that were antidilutive respectively due having higher exercise prices than the
Company average stock price during the period These securities were not included the computation
diluted EPS The effect dilutive securities was calculated using the treasury stock method
Accumulated Other Comprehensive Income
The components accumulated other comprehensive income are detailed follows thousands
Currency
Translation
Unrealized Gain
Loss
Retirement Plans
Unrealized Gain
Loss
Investments
Accumulated
Other
Comprehensive
Income Loss
Balance December
Other comprehensive income loss net
tax
Balance December
Retirement Plans
employees are eligible participate the Waters Employee Investment Plan defined contribution
plan immediately upon hire Employees may contribute eligible pay pre tax post tax basis
and the Company makes matching contributions for contributions eligible pay The
Company also sponsors Restoration Plan which nonqualified defined contribution plan Employees
are vested employee and Company matching contributions for both plans For the years ended
December and the Company matching contributions amounted million
million and million respectively
The Company maintains two defined benefit plans the for which the pay credit accruals have been
frozen the Waters Retirement Plan and the Waters Retirement Restoration Plan collectively the Pension
Plans The Company also sponsors other employee benefit plans the including retiree healthcare plan
which provides reimbursement for medical expenses and contributory There are various employee benefit
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
plans outside the United States both defined benefit and defined contribution plans Certain non defined
benefit plans Non Pension Plans are included the disclosures below which are required under the
accounting standards for retirement benefits
The Company contributed million million and million the years ended December
and respectively the non plans primarily defined contribution plans which are currently
outside the scope the required disclosures The eligibility and vesting non plans are consistent with
local laws and regulations
The net periodic pension cost made several components that reflect different aspects the
Company financial arrangements well the cost benefits earned employees These components are
determined using the projected unit credit actuarial cost method and are based certain actuarial assumptions
The Company accounting policy reflect the projected benefit obligation all benefit changes which the
Company committed the current valuation date use market related value assets determine pension
expense amortize increases prior service costs straight line basis over the expected future service
active participants the date such costs are first recognized and amortize cumulative actuarial gains and
losses excess the larger the market related value plan assets and the projected benefit
obligation over the expected future service active participants
Summary data for the Pension Plans Retiree Healthcare Plan and Non Pension Plans are
presented the following tables using the measurement dates December and respectively
The reconciliation the projected benefit obligations for the plans December and
follows thousands
Pension
Plans
Retiree
Healthcare
Plan
Non
Pension
Plans
Pension
Plans
Retiree
Healthcare
Plan
Non
Pension
Plans
Projected benefit obligation January
Service cost
Employee contributions
Interest cost
Actuarial losses gains
Benefits paid
Plan amendments
Plan settlements
Other plans
Currency impact
Projected benefit obligation December
The accumulated benefit obligations for the plans December and are follows
thousands
Healthcare
Plan
Pension
Plans
Accumulated benefit obligation
Not applicable
Non
Pension
Plans
Pension
Plans
Healthcare
Plan
Non
Pension
Plans
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The reconciliation the fair value the plan assets December and follows
thousands
Healthcare
Plan
Healthcare
Plan
Non
Pension
Plans
Fair value plan assets January
Actual return plan assets
Company contributions
Employee contributions
Plan settlements
Benefits paid
Other plans
Currency impact
Fair value plan assets December
Pension
Plans
Non
Pension
Plans
Pension
Plans
The summary the funded status for the plans December and follows thousands
Retiree
Healthcare
Plan
Pension
Plans
Projected benefit obligation
Fair value plan assets
Funded status
Non
Pension
Plans
Pension
Plans
Retiree
Healthcare
Plan
Non
Pension
Plans
The summary the amounts recognized the consolidated balance sheets for the plans December
and follows thousands
Retiree
Healthcare
Plan
Pension
Plans
Non
Pension
Plans
Pension
Plans
Retiree
Healthcare
Plan
Non
Pension
Plans
Long term assets
Current liabilities
Long term liabilities
Net amount recognized December
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The summary the components net periodic pension costs for the plans for the years ended
December and follows thousands
Pension
Plans
Non
Non
Healthcare Pension Pension Healthcare Pension Pension Healthcare
Plan
Plans
Plans
Plan
Plans
Plans
Plan
Service cost
Interest cost
Expected return plan
assets
Settlement loss
Net amortization
Prior service credit
cost
Net actuarial loss
Net periodic pension
benefit cost
Non
Pension
Plans
The summary the changes amounts recognized other comprehensive income loss for the plans for
the years ended December and follows thousands
Non
Non
Non
Pension Healthcare Pension Pension Healthcare Pension Pension Healthcare Pension
Plans
Plan
Plans
Plans
Plan
Plans
Plans
Plan
Plans
Prior service credit
cost
Net gain loss arising
during the year
Amortization
Prior service credit
cost
Net loss
Other Plans
Currency impact
Total recognized other
comprehensive income
loss
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The summary the amounts included accumulated other comprehensive loss stockholders equity for
the plans December and follows thousands
Pension
Plans
Retiree
Healthcare
Plan
Net actuarial loss gain
Prior service credit
Total
Non
Pension
Plans
Pension
Plans
Retiree
Healthcare
Plan
Non
Pension
Plans
The summary the amounts included accumulated other comprehensive loss expected included
next year net periodic benefit cost for the plans December follows thousands
Pension
Plans
Retiree
Healthcare
Plan
Non
Pension
Plans
Net actuarial loss
Prior service credit
Total
The plans investment asset mix follows December and
Pension
Plans
Healthcare
Plan
Non
Pension
Plans
Pension
Plans
Healthcare
Plan
Non
Pension
Plans
Equity securities
Debt securities
Cash and cash equivalents
Insurance contracts and other
Total
The plans investment policies include the following asset allocation guidelines
Pension and Retiree
Healthcare Plans
Policy Target
Range
Equity securities
Debt securities
Cash and cash equivalents
Insurance contracts and other
Non
Pension Plans
Policy Target
The asset allocation policy for the Pension Plans and Retiree Healthcare Plan was developed
consideration the following long term investment objectives achieving return assets consistent with the
investment policy achieving portfolio returns which exceed the average return for similarly invested funds and
maximizing portfolio returns with least return above the one year constant maturity Treasury bond
yield over reasonable measurement periods and based reasonable market cycles
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Within the equity portfolio the retirement plans investments are diversified among market
capitalization and investment strategy The Company targets allocation its retirement plans equity
portfolio invested financial markets outside the United States The Company does not invest its own
stock within the retirement plans assets
Plan assets are measured fair value using the following valuation techniques and inputs
Level
The fair value these types investments based market and observable sources from daily
quoted prices nationally recognized securities exchanges
Level
The fair value the money market funds held with financial institutions based the net asset
value the underlying treasury bill and commercial paper which are valued using third party
pricing services that utilize inputs such benchmark yields credit spreads and broker dealer
quotes determine the value
Level
These bank and insurance investment contracts are issued well known highly rated
companies The fair value disclosed represents the present value future cash flows under the
terms the respective contracts Significant assumptions used determine the fair value
these contracts include the amount and timing future cash flows and counterparty credit risk
There have been changes the above valuation techniques associated with determining the value the
plans assets during the years ended December and
Investments valued NAV consist hedge funds the Pension Plans which are valued based
underlying investments equity securities companies where the hedge fund manager targeting
particular net long net short position the underlying stock The fair value these funds initially based
market and observable sources from daily quoted prices nationally recognized securities exchanges and then
adjustments are made the net asset value the hedge fund account for the effects any liquidation
redemption restrictions The redemption terms for the hedge funds are generally quarterly with day
notification period and there are redemption restrictions
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The fair value the Company retirement plan assets are follows December thousands
Total
December
Quoted Prices
Active
Markets for
Identical
Assets
Level
Total Pension Plans
Retiree Healthcare Plan
Mutual funds
Total Retiree Healthcare Plan
Non Pension Plans
Cash equivalents
Mutual funds
Bank and insurance investment contracts
Total Non Pension Plans
Total fair value retirement plan assets
Investments valued NAV
Total retirement plan assets
Pension Plans
Mutual funds
Significant
Other
Observable
Inputs
Level
Significant
Unobservable
Inputs
Level
The fair value the Company retirement plan assets are follows December thousands
Total
December
Quoted Prices
Active
Markets for
Identical
Assets
Level
Significant
Other
Observable
Inputs
Level
Total Pension Plans
Retiree Healthcare Plan
Mutual funds
Total Retiree Healthcare Plan
Non Pension Plans
Cash equivalents
Mutual funds
Bank and insurance investment contracts
Total Non Pension Plans
Total fair value retirement plan assets
Investments valued NAV
Total retirement plan assets
Pension Plans
Mutual funds
Cash equivalents
Significant
Unobservable
Inputs
Level
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The mutual fund balance the Pension Plans are invested the following categories the
common stock large cap companies the common stock international growth companies
and fixed income bonds issued companies and the government and its agencies
The mutual fund balance the Retiree Healthcare Plan invested the following categories
the common stock large cap companies the common stock international growth
companies and fixed income bonds companies and government
Primarily represents deposit account funds held with various financial institutions
The mutual fund balance the Non Pension Plans primarily invested the following categories
international bonds the common stock international companies mortgages and real
estate and various other global investments
Amount represents bank and insurance guaranteed investment contracts
The mutual fund balance the Pension Plans are invested the following categories the
common stock large cap companies the common stock international growth companies
and fixed income bonds issued companies and the government and its agencies
Primarily represents money market funds held with various financial institutions
The mutual fund balance the Retiree Healthcare Plan invested the following categories
the common stock large cap companies the common stock international growth
companies and fixed income bonds companies and government
The mutual fund balance the Non Pension Plans invested the following categories
international bonds and the common stock international companies mortgages and real
estate and various other global investments
The following table summarizes the changes fair value the Level retirement plan assets for the years
ended December and thousands
Insurance
Guaranteed
Investment
Contracts
Fair value assets December
Net purchases sales and appreciation depreciation
Fair value assets December
Net purchases sales and appreciation depreciation
Fair value assets December
The weighted average assumptions used determine the benefit obligation the consolidated balance
sheets December and are follows
Discount rate
Increases compensation levels
Not applicable
Non
Non
Non
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The weighted average assumptions used determine the net periodic pension cost December
and are follows
Non
Non
Non
Discount rate
Return plan assets
Increases compensation levels
Not applicable
develop the expected long term rate return assets assumption the Company considered historical
returns and future expectations for returns for each asset class well the target asset allocation the pension
portfolio and historical expenses paid the plan one quarter percentage point increase the assumed longterm rate return assets would decrease the Company net periodic benefit cost for the Waters Retirement
Plan less than million one quarter percentage point increase the discount rate would decrease the
Company net periodic benefit cost for the Waters Retirement Plan less than million
During fiscal year the Company expects contribute total approximately million
million the Company defined benefit plans Estimated future benefit payments from the plans
December are follows thousands
Pension and
Retiree Healthcare
Plans
Non
Pension
Plans
Total
Business Segment Information
The accounting standards for segment reporting establish standards for reporting information about operating
segments annual financial statements and require selected information for those segments presented
interim financial reports public business enterprises They also establish standards for related disclosures about
products and services geographic areas and major customers The Company business activities for which
discrete financial information available are regularly reviewed and evaluated the chief operating decision
maker result this evaluation the Company determined that has two operating segments Waters and
TA
The Waters operating segment primarily the business designing manufacturing distributing and
servicing and instruments columns and other precision chemistry consumables that can integrated and
used along with other analytical instruments The operating segment primarily the business designing
manufacturing distributing and servicing thermal analysis rheometry and calorimetry instruments The
Company two operating segments have similar economic characteristics product processes products and
services types and classes customers methods distribution and regulatory environments Because these
similarities the two segments have been aggregated into one reporting segment for financial statement purposes
Please refer the consolidated financial statements for financial information regarding the one reportable
segment the Company
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Net sales for the Company products and services are follows for the years ended December
and thousands
Total product sales
Service net sales
Waters service
service
Total service sales
Total net sales
Product net sales
Waters instrument systems
Chemistry consumables
instrument systems
Geographic sales information presented below for the years ended December and
thousands
Total Asia
Other
Total net sales
Net Sales
United States
Europe
Asia
China
Japan
Asia Other
The Other category includes Canada Latin America and Puerto Rico Net sales are attributable
geographic areas based the region destination None the Company individual customers accounts for
more than annual Company sales
Long lived assets information December and presented below thousands
Long lived assets
United States
Europe
Asia
Other
Total long lived assets
The Other category includes Canada Latin America and Puerto Rico Long lived assets exclude goodwill
other intangible assets and other assets
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
Unaudited Quarterly Results
The Company unaudited quarterly results are summarized below thousands except per share data
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Total
Net sales
Costs and operating expenses
Cost sales
Selling and administrative expenses
Research and development expenses
Litigation provisions
Purchased intangibles amortization
Acquired process research and development
Total costs and operating expenses
Operating income
Interest expense
Interest income
Income before income taxes
Provision for income taxes
Net income loss
Net income loss per basic common share
Weighted average number basic common
shares
Net income loss per diluted common share
Weighted average number diluted common
shares and equivalents
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
Total
Net sales
Costs and operating expenses
Cost sales
Selling and administrative expenses
Research and development expenses
Litigation provisions
Purchased intangibles amortization
Total costs and operating expenses
Operating income
Interest expense
Interest income
Income before income taxes
Provision for income taxes
Net income
Net income per basic common share
Weighted average number basic common
shares
Net income per diluted common share
Weighted average number diluted common shares
and equivalents
NOTES CONSOLIDATED FINANCIAL STATEMENTS Continued
The Company typically experiences increase sales the fourth quarter result purchasing habits
for capital goods customers that tend exhaust their spending budgets calendar year end Selling and
administrative expenses are typically higher after the first quarter each year the Company annual payroll
merit increases take effect Selling and administrative expenses will vary the fourth quarter relation
performance the quarter and for the year the third quarter and first quarter the Company
recorded million and million stock compensation expenses respectively selling and administrative
expenses related the modification certain stock awards upon the retirement senior executives
the first quarter the Company recorded million charge related acquired process
research and development see Note and fourth quarter the company recorded litigation
provisions million and million respectively see Note the fourth quarter the Company
recorded million income tax provision result the Tax Act see Note
Item
Changes and Disagreements with Accountants Accounting and Financial Disclosure
None
Item Controls and Procedures
Evaluation Disclosure Controls and Procedures
The Company chief executive officer and chief financial officer principal executive and principal financial
officer with the participation management evaluated the effectiveness the Company disclosure controls
and procedures defined Rules and under the Exchange Act the end the period
covered this annual report Form Based this evaluation the Company chief executive officer and
chief financial officer concluded that the Company disclosure controls and procedures were effective
December ensure that information required disclosed the Company including its
consolidated subsidiaries the reports that files submits under the Exchange Act accumulated and
communicated the Company management including its chief executive officer and chief financial officer
allow timely decisions regarding the required disclosure and provide reasonable assurance that information
required disclosed the Company the reports that files submits under the Exchange Act
recorded processed summarized and reported within the time periods specified the SEC rules and forms
Management Annual Report Internal Control Over Financial Reporting
See Management Report Internal Control Over Financial Reporting Item page this Form
Report the Independent Registered Public Accounting Firm
See the report PricewaterhouseCoopers LLP Item page this Form
Changes Internal Controls Over Financial Reporting
change was identified the Company internal control over financial reporting defined
Rules and under the Exchange Act during the quarter ended December that has
materially affected reasonably likely materially affect the Company internal control over financial
reporting
Item
Other Information
None
PART III
Item Directors Executive Officers and Corporate Governance
Information regarding the Company directors and any material changes the process which security
holders may recommend nominees the Board Directors contained the definitive proxy statement for the
Annual Meeting Stockholders under the headings Election Directors Directors Meetings and
Board Committees Corporate Governance Report the Audit Committee the Board Directors and
Compensation Directors and Executive Officers Information regarding compliance with Section
the Exchange Act contained the Company definitive proxy statement for the Annual Meeting
Stockholders under the heading Section Beneficial Ownership Reporting Compliance Information
regarding the Company Audit Committee and Audit Committee Financial Expert contained the definitive
proxy statement for the Annual Meeting Stockholders under the headings Report the Audit
Committee the Board Directors and Directors Meetings and Board Committees Such information
incorporated herein reference Information regarding the Company executive officers contained Part
this Form
The Company has adopted Code Business Conduct and Ethics the Code that applies all the
Company employees including its executive officers and directors and that compliance with Item
Regulation The Code has been distributed all employees the Company addition the Code
available the Company website waters under the caption Corporate Governance The
Company intends satisfy the disclosure requirement regarding any amendment waiver provision
the Code applicable any executive officer director posting such information its website The
Company shall also provide any person without charge upon request copy the Code Any such request
must made writing the Secretary the Company Waters Corporation Maple Street Milford
The Company corporate governance guidelines and the charters the audit committee compensation
committee and nominating and corporate governance committee the Board Directors are available the
Company website waters under the caption Corporate Governance The Company shall provide
any person without charge upon request copy any the foregoing materials Any such request must
made writing the Secretary the Company Waters Corporation Maple Street Milford
the Company adopted proxy access bylaw provision that allows eligible stockholders groups
stockholders who have held least the Company common stock continuously for three years
nominate two individuals the Board Directors whichever greater for election the
Company Annual Meeting Stockholders and have those individuals included the Company proxy
materials for that meeting The Company believes that the proxy access bylaw adopted the Company strikes
appropriate balance between providing meaningful proxy access for stockholders and limiting the potential for
abuse
Item Executive Compensation
This information contained the Company definitive proxy statement for the Annual Meeting
Stockholders under the headings Compensation Directors and Executive Officers Compensation
Committee Interlocks and Insider Participation and Compensation Committee Report Such information
incorporated herein reference
Item Security Ownership Certain Beneficial Owners and Management and Related Stockholder
Matters
Except for the Equity Compensation Plan information set forth below this information contained the
Company definitive proxy statement for the Annual Meeting Stockholders under the heading Security
Ownership Certain Beneficial Owners and Management Such information incorporated herein
reference
Equity Compensation Plan Information
The following table provides information December about the Company common stock that may
issued upon the exercise options warrants and rights under its existing equity compensation plans
thousands
Number Securities
Issued Upon Exercise
Outstanding Options
Warrants and Rights
Weighted Average
Exercise Price
Outstanding Options
Warrants and Rights
Number Securities
Remaining Available for
Future Issuance Under
Equity Compensation
Plans excluding
securities reflected
column
Equity compensation plans approved
security holders
Equity compensation plans not approved
security holders
Total
Column includes aggregate thousand ordinary shares issued upon settlement restricted
stock restricted stock units and performance stock units The weighted average share price column
does not take into account restricted stock restricted stock units performance stock units which
not have exercise price
See Note Stock Based Compensation the Notes Consolidated Financial Statements for
description the material features the Company equity compensation plans
Item Certain Relationships and Related Transactions and Director Independence
This information contained the Company definitive proxy statement for the Annual Meeting
Stockholders under the headings Directors Meetings and Board Committees Corporate Governance and
Compensation Directors and Executive Officers Such information incorporated herein reference
Item Principal Accountant Fees and Services
This information contained the Company definitive proxy statement for the Annual Meeting
Stockholders under the headings Ratification Selection Independent Registered Public Accounting Firm
and Report the Audit Committee the Board Directors Such information incorporated herein
reference
PART
Item Exhibits Financial Statement Schedules
Documents filed part this report
Financial Statements
The consolidated financial statements the Company and its subsidiaries are filed part this
Form and are set forth pages The report PricewaterhouseCoopers LLP
independent registered public accounting firm dated February set forth page
this Form
Financial Statement Schedule
See below
Exhibits
Exhibit
Number
Description Document
Second Amended and Restated Certificate Incorporation Waters Corporation
Certificate Amendment Second Amended and Restated Certificate Incorporation Waters
Corporation dated May
Certificate Amendment Second Amended and Restated Certificate Incorporation Waters
Corporation dated July
Certificate Amendment Second Amended and Restated Certificate Incorporation Waters
Corporation dated May
Amended and Restated Bylaws Waters Corporation dated December
Waters Corporation Retirement Plan
Waters Corporation Equity Incentive Plan
First Amendment the Waters Corporation Equity Incentive Plan
Form Director Stock Option Agreement under the Waters Corporation Equity Incentive Plan
amended
Form Director Restricted Stock Agreement under the Waters Corporation Equity Incentive
Plan amended
Form Executive Officer Stock Option Agreement under the Waters Corporation Equity
Incentive Plan amended
Second Amendment the Waters Corporation Equity Incentive Plan
Third Amendment the Waters Corporation Equity Incentive Plan
Amended and Restated Waters Restoration Plan effective January
Change Control Severance Agreement dated February between Waters
Corporation and Mark Beaudouin
Change Control Severance Agreement dated February between Waters
Corporation and Elizabeth Rae
Change Control Severance Agreement dated February between Waters
Corporation and Eugene Cassis
Exhibit
Number
Description Document
Amended and Restated Waters Retirement Restoration Plan effective January
Amended and Restated Waters Corporation Non Employee Director Deferred Compensation
Plan Effective January
Waters Corporation Management Incentive Plan
Waters Corporation Employee Stock Purchase Plan
Note Purchase Agreement dated February between Waters Corporation and the
purchases named therein
First Amendment the Note Purchase Agreement dated February
Note Purchase Agreement dated March between Waters Corporation and the purchases
named therein
Waters Corporation Equity Incentive Plan
Form Waters Stock Option Agreement Executive Officers
Form Waters Stock Option Agreement Directors
Form Waters Restricted Stock Agreement Directors
Form Waters Restricted Stock Unit Agreement for Executive Officers Five Year
Vesting
Form Waters Restricted Stock Unit Agreement for Executive Officers One Year
Vesting
Note Purchase Agreement dated June between Waters Corporation and the purchases
named therein
Change Control Severance Agreement dated April between Waters Corporation and
Michael Silveira
President and Chief Executive Employment Agreement
Change Control Severance Agreement dated September between Waters
Corporation and Christopher Connell
Note Purchase Agreement dated May between Waters Corporation and the
purchasers named therein
Form Waters Performance Stock Unit Award Agreement
Senior Vice President and Chief Financial Officer Employment Agreement
Change Control Severance Agreement dated January between Waters Corporation
and Sherry Buck
Form Change Control Severance Agreement
Employment Agreement dated July between Waters Corporation and Rohit
Khanna
Credit Agreement dated November among Waters Corporation JPMorgan Chase
Bank Morgan Europe Limited and other Lenders party thereto
Subsidiaries Waters Corporation
Consent PricewaterhouseCoopers LLP independent registered public accounting firm
Exhibit
Number
Description Document
Chief Executive Officer Certification Pursuant Section the Sarbanes Oxley Act
Chief Financial Officer Certification Pursuant Section the Sarbanes Oxley Act
Chief Executive Officer Certification Pursuant Section Adopted Pursuant
Section the Sarbanes Oxley Act
Chief Financial Officer Certification Pursuant Section Adopted Pursuant
Section the Sarbanes Oxley Act
The following materials from Waters Corporation Annual Report Form for the year ended
December formatted XBRL Extensible Business Reporting Language the
Consolidated Balance Sheets the Consolidated Statements Operations iii the Consolidated
Statements Comprehensive Income the Consolidated Statements Cash Flows the
Consolidated Statements Stockholders Equity and Notes Consolidated Financial
Statements
Incorporated reference the Registrant Report Form dated March File
Incorporated reference the Registrant Registration Statement Form File
Incorporated reference the Registrant Report Form dated August File
Incorporated reference the Registrant Report Form dated August File
Incorporated reference the Registrant Report Form dated March File
Incorporated reference the Registrant Report Form dated November File
Incorporated reference the Registrant Report Form dated March File
Incorporated reference the Registrant Report Form dated November File
Incorporated reference the Registrant Report Form dated August File
Incorporated reference the Registrant Report Form dated March File
Incorporated reference the Registrant Report Form dated November File
Incorporated reference the Registrant Report Form dated February File
Incorporated reference the Registrant Report Form dated February File
Incorporated reference the Registrant Report Form dated July File
Incorporated reference the Registrant Report Form dated February File
Incorporated reference the Registrant Report Form dated May File
Incorporated reference the Registrant Report Form dated September File
Incorporated reference the Registrant Report Form dated December File
Incorporated reference the Registrant Report Form dated December File
Incorporated reference the Registrant Report Form dated August File
Incorporated reference the Registrant Report Form dated February File
Incorporated reference the Registrant Report Form dated May File
Incorporated reference the Registrant Report Form dated August File
Incorporated reference the Registrant Report Form dated August File
Incorporated reference the Registrant Report Form dated December File
Incorporated reference the Registrant Report Form dated February File
Incorporated reference the Registrant Report Form dated March File
Incorporated reference the Registrant Report Form dated November File
Incorporated reference the Registrant Report Form dated December File
Paper Filing
Management contract compensatory plan required filed Exhibit this Form
This exhibit shall not deemed filed for purposes Section the Exchange Act otherwise
subject the liability that section nor shall deemed incorporated reference into any filing under
the Securities Act amended the Exchange Act whether made before after the date hereof
and irrespective any general incorporation language any filing except the extent the Company
specifically incorporates reference
See Item above
Financial Statement Schedule
The following additional financial statement schedule should considered conjunction with the
consolidated financial statements All other schedules have been omitted because the required information
either not applicable not sufficiently material require submission the schedule
WATERS CORPORATION AND SUBSIDIARIES
SCHEDULE VALUATION AND QUALIFYING ACCOUNTS
For each the three years the period ended December
Valuation allowance for deferred tax assets
Balance
Beginning
Period
Charged
Provision
for Income
Taxes
Other
Balance
End
Period
These amounts have been recorded part the income statement provision for income taxes The income
statement effects these amounts have largely been offset amounts related changes other deferred
tax balance sheet accounts
The change the valuation allowance during the year ended December primarily due the
effect foreign currency translation valuation allowance related net operating loss carryforward
The change the valuation allowance during the year ended December primarily due the
effect foreign currency translation valuation allowance related net operating loss carryforward
and the release valuation allowance related foreign tax credit carryforward due expiration
Item Form Summary
The optional summary Item has not been included this Form
SIGNATURES
Pursuant the requirements Section the Securities Exchange Act the registrant
has duly caused this report signed its behalf the undersigned thereunto duly authorized
WATERS CORPORATION
SHERRY BUCK
Sherry Buck
Senior Vice President and
Chief Financial Officer
Date February
Pursuant the requirements the Securities Exchange Act this report has been signed the
following persons behalf the registrant and the capacities indicated February
CHRISTOPHER CONNELL
Christopher Connell
Chairman the Board Directors President and Chief
Executive Officer principal executive officer
SHERRY BUCK
Sherry Buck
Senior Vice President and Chief Financial Officer
principal financial officer
principal accounting officer
MICHAEL BERENDT
Michael Berendt
Director
EDWARD CONARD
Edward Conard
Director
LAURIE GLIMCHER
Laurie Glimcher
Director
CHRISTOPHER KUEBLER
Christopher Kuebler
Director
FLEMMING ORNSKOV
Flemming Ornskov
Director
JOANN REED
JoAnn Reed
Director
THOMAS SALICE
Thomas Salice
Director
Directors
Executive Officers
Christopher Connell
Chairman and Chief Executive Officer
Waters Corporation
Christopher Connell
Chairman and Chief Executive Officer
Michael Berendt
Life Sciences Industry Consultant
and Investor
Edward Conard
Independent Director and Investor
Laurie Glimcher
President and CEO
Dana Farber Cancer Institute
Principal Investigator and Director
Dana Farber Harvard Cancer Center
Richard and Susan Smith Professor
Medicine Harvard Medical School
Christopher Kuebler
Retired Chairman and Chief
Executive Officer Covance Inc
Flemming Ornskov MBA
Chief Executive Officer Shire plc
JoAnn Reed
Health Care Services Consultant
Thomas Salice
Managing Member
SFW Capital Partners LLC
Mark Beaudouin
Senior Vice President General
Counsel and Secretary
Sherry Buck
Senior Vice President and
Chief Financial Officer
Robert Carson
Senior Vice President
Corporate Development
Michael Harrington
Senior Vice President
Global Markets
Terrence Kelly
Senior Vice President and President
Instruments
Francis Kim
Senior Vice President
Global Operations
Ian King
Senior Vice President
Global Products
Elizabeth Rae
Senior Vice President
Global Human Resources
Transfer Agent
and Registrar
Shareholder correspondence
should mailed
Computershare
Box
Louisville
Overnight correspondence
should mailed
Computershare Investor Services
South Street Suite
Louisville
Shareholder website
computershare investor
Shareholder online inquiries
computershare
investor Contact Enquiry
Shareholder Services
Toll Free Number
Independent Registered
Public Accounting Firm
PricewaterhouseCoopers LLP
Seaport Boulevard
Boston
Phone
Attorneys
Ropes Gray LLP
Prudential Tower
Boylston Street
Boston
Phone
Stockholders Meeting
Date Wednesday May
Location
Waters Corporation
Maple Street
Milford
Directions
Call Ext
waters directionsMilford
Stock Symbol
NYSE WAT
Investor Relations
Bryan Brokmeier CFA
Senior Director Investor Relations
Phone
Email bryan_brokmeier waters
Form
copy the Company filed
with the Securities and Exchange
Commission available without
charge upon written request
Waters Corporation
Maple Street
Milford
Offices
Corporate Headquarters
Waters Corporation
Maple Street
Milford
Phone
Toll Free
Fax
Email info waters
URL waters
Waters The Science What Possible ACQUITY Arc Discovery Series and
Empower are trademarks Waters Corporation All other trademarks are the
property their respective owners
Waters Corporation Printed the March RRD
Waters Corporation
Maple Street
Milford
waters
